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CHAPTER I 
 
BACKGROUND 
 
Introduction 
To efficiently initiate infection of target cells, viruses must become tethered to the 
plasma membrane by engaging cellular receptors.  As the first step in the viral replication 
cycle, attachment is a key determinant of viral tropism and pathogenesis.  The adhesion 
process is often mediated by a viral attachment protein and can involve binding to 
multiple receptors at the cell surface.  For a given virus, the attachment protein has 
evolved to be ideally-suited for its functional requirements, which may include receptor 
binding, conformational rearrangement, multi-step adhesion, and triggering signaling 
events that lead to viral internalization and uncoating.  A detailed understanding of the 
structure and function of a viral attachment protein and the specific mechanisms by 
which it engages cellular receptors can aid the development of antivirals aimed at 
blocking the attachment step, the engineering of viral vectors with enhanced cellular 
targeting capabilities, and an improved understanding of viral disease outcomes.  
Mammalian orthoreoviruses (reoviruses) are nonenveloped, double-stranded (ds) 
RNA viruses that bind to multiple cell-surface molecules and serve as tractable models 
for studies of virus-receptor interactions and viral pathogenesis.  The reovirus attachment 
protein, σ1, is a filamentous, trimeric molecule that extends from the icosahedral vertices 
of reovirus virions.  Reovirus σ1 of some serotypes binds α-linked sialic acid, a 
carbohydrate, and σ1 of all serotypes binds junctional adhesion molecule-A (JAM-A), a 
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dimeric protein involved in cell-cell adhesion and tight junction formation.  X-ray crystal 
structures of a JAM-A-binding fragment of σ1 and the extracellular domain of JAM-A 
have been solved. The structures have revealed interesting features of the two molecules 
and provided clues about their structure-function relationships.  Yet they also have 
generated many new questions.  
When this work was initiated, structural features of σ1 important for mediating 
attachment functions were not known.  An unusual cluster of six aspartic acid residues in 
close proximity at the subunit interface of the σ1 trimer had been identified.  However, 
the precise nature of atomic interactions at this interface and the function of this motif in 
mediating conformational changes in the σ1 head region had not been explored.  The C-
terminal half of σ1 was known to bind JAM-A with high affinity.  However, sequences 
involved in binding and the nature and stoichiometry of σ1-JAM-A interactions had not 
been determined.  While evidence suggested that when locked in a dimeric form JAM-A 
was unable to efficiently bind σ1, it was unclear whether σ1 binds directly to sequences 
within the dimer interface and, if so, how it might access this surface.  In addition, it was 
not known whether differences in the nature or mechanism of JAM-A engagement among 
the reovirus serotypes exist.  
In my dissertation research, I have attempted to elucidate details of the 
mechanism of σ1-JAM-A engagement and understand features of σ1 that confer 
functionality.  This research has been accomplished using a combination of structural, 
genetic, biochemical, biophysical, and biological approaches.  In Chapter II, I report the 
characterization of a novel trimerization motif, the aspartic acid sandwich, which might 
be important for structural rearrangements in σ1.  In Chapter III, I present a systematic 
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analysis of the contributions of individual residues in the JAM-A dimer interface to 
reovirus binding and JAM-A homodimer stability.  In Chapter IV, I report the structure of 
a complex between σ1 and JAM-A and identify sequences in σ1 required for efficient 
JAM-A binding and reovirus infectivity.  These studies will enhance an understanding of 
σ1 structure-function relationships.  More specifically, a detailed understanding of σ1-
JAM-A interactions will yield insight into the role of JAM-A in reovirus pathogenesis 
and provide a basis for vector retargeting as we explore the potential of reovirus for 
vaccine delivery and oncolysis.  
 
Reovirus pathogenesis 
There are three reovirus serotypes, which can be differentiated by the capacity of 
anti-reovirus antisera to neutralize viral infectivity and inhibit hemagglutination (126, 
129).  The three serotypes are each represented by a prototype strain isolated from a 
human host: type 1 Lang (T1L), type 2 Jones (T2J), and type 3 Dearing (T3D).  
Reoviruses have a wide geographic distribution, and virtually all mammals, including 
humans, serve as hosts for infection (154).  However, reovirus is rarely associated with 
disease, except in the very young (97, 147). 
Newborn mice are exquisitely sensitive to reovirus infection and have been used 
as the preferred experimental system for studies of reovirus pathogenesis (160).  
Following oral or intramuscular inoculation of newborn mice, strains of serotype 1 and 
serotype 3 reoviruses invade the central nervous system (CNS), yet by different routes 
and with distinct pathologic consequences.  Serotype 1 reovirus spreads to the CNS 
hematogenously and infects ependymal cells (155, 165), resulting in hydrocephalus 
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(164).  In contrast, serotype 3 reovirus spreads to the CNS by neural routes and infects 
neurons (103, 155, 165), causing lethal encephalitis (147, 164).  Studies using T1L x T3D 
reassortant viruses have shown that the pathways of viral spread (155) and tropism for 
neural tissues (41, 165) segregate with the viral S1 gene, which encodes attachment 
protein σ1 (86, 163).  T1L x T3D reassortant viruses also were used to demonstrate that 
serotype-specific differences in virus binding to primary cultures of ependymal cells and 
neurons are determined by the S1 gene (41, 148).  These studies suggest that σ1 dictates 
the CNS cell types that serve as targets for reovirus infection, presumably by its capacity 
to bind receptors expressed by specific CNS cells. 
 
Structure and function of reovirus attachment protein σ1 
Reovirus particles are approximately 850 Å in diameter (109).  The ten segments 
of dsRNA that compose the reovirus genome are encapsidated within two concentric 
protein shells, the outer capsid and inner core.  Together, the outer capsid and core are 
composed of eight structural proteins.  The bulk of the outer capsid consists of the 
tightly-associated µ1 and σ3 proteins (91).  There are turrets at each of the twelve 
icosahedral vertices of the virion formed by the pentameric λ2 protein, from which the 
viral attachment protein, σ1, extends (6, 28, 42, 54, 55) (Figure I-1). 
The σ1 protein is a filamentous, trimeric molecule about 480 Å in length with 
distinct head-and-tail morphology (54, 55) (Figure I-2A).  Discrete regions of the 
molecule mediate binding to cell-surface receptors.  Sequences in the N-terminal σ1 tail 
bind to carbohydrate, which is known to be sialic acid in either α2,3 or α2,6 linkages for 
serotype 3 reoviruses (28, 29, 40, 58, 120).  The C-terminal σ1 head binds to junctional 
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FIGURE I-1.  Organization and structure of a reovirus virion. (A) Schematic 
representation of a reovirus virion. Outer capsid, inner core, viral attachment protein 
σ1, the λ2 base into which σ1 inserts, and ten viral dsRNA genome segments are 
indicated. (B) Cryo-electron microscopic image reconstruction of a reovirus virion. 
Major outer capsid proteins are pseudocolored and indicated. σ1 molecules are 
represented schematically.  Image adapted from Nason et al. (105).  
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adhesion molecule-A (JAM-A, previously called F11R, JAM, or JAM1) (6, 46).  The σ1 
tail partially inserts into the virion, while the head projects away from the virion surface 
(43, 55) (Figure I-1).  Insertion of the trimeric σ1 protein into a pentameric λ2 base 
results in an unusual symmetry mismatch.  Such symmetry mismatches often produce 
FIGURE I-2. Computer-processed negative-stain electron micrographs of σ1. (A) 
Composite electron micrograph of σ1. N and C termini, head and tail domains, and 
regions of observed flexibility of the molecule are indicated. (B) Individual electron 
micrographs of σl molecules, highlighting distinct morphologies: (a) the head appears 
multi-lobed; (b) the tail is kinked immediately adjacent to the head; (c) the tail is 
kinked near its midpoint. Images adapted from Fraser et al. (54). 
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interactions of limited strength or specificity and indicate a strong potential to undergo 
structural rearrangement. 
Structural analysis of the C-terminal half of T3D σ1 (residues 246-455) has 
revealed a trimeric structure, in which each monomer is composed of a slender tail and a 
compact head (30) (Figure I-3A).  The C-terminal residues that form the head domain 
(310-455) consist of two Greek-key motifs that fold into a β-barrel.  Loops connecting 
the individual strands of the β-barrel are short with the exception of the loop that 
connects β-strands D and E, which contains a 310 helix (Figure I-3B, C).  N-terminal 
residues in the crystallized fragment form a portion of the tail, residues 246-309, which 
consists of three β-spiral repeats (Figure I-3A).  Each repeat is composed of two short β-
strands connected by a four-residue β-turn that has either a proline or a glycine residue at 
its third position (30).  A surface-exposed, variable loop links successive repeats, and 
trimerization generates a triple β-spiral motif that has been observed in the tail domains 
of the attachment proteins of avian reovirus, σC (63), and adenovirus, fiber (158), and in 
the spike protein P5 of bacteriophage PRD1 (101).  The σ1 trimer features a distinct bend 
between the three-fold axes of the head and tail domains.  Although this bend is most 
likely introduced by crystal packing forces, it indicates that the σ1 trimer possesses a 
high degree of flexibility.  The region of flexibility is located between the second and 
third β-spiral repeats in the tail and corresponds to a 4-residue insertion, amino acids 291-
294 (30) (Figure I-3A).   
Sequence analysis has facilitated the development of a model of full-length σ1 
(30).  The σ1 tail is thought to contain an N-terminal α-helical coiled-coil followed by 
eight β-spiral repeats (Figure I-4).  Sequences predicted to form the α-helical coiled coil 
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FIGURE I-3. Crystal structure of reovirus σ1. (A) Ribbon drawing of the σ1 trimer 
with σ1 monomers shown in red, orange, and blue. Each monomer consists of a head 
domain formed by a compact β-barrel and a slender tail with three β-spiral repeats. (B) 
Enlarged view of the σ1 head domain. The two Greek-key motifs, shown in red and 
orange, form a compact, cylindrical β-sheet that contains eight β-strands (A–H). The 
head domain also contains two short helices, shown in blue: one 310 and one α-helix. 
(C) Schematic view of the β-strand arrangement in the σ1 head domain. Colors are as 
in (B). Image adapted from Chappell et. al (30). 
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are required for trimer stability (28, 87, 145, 170).  Electron microscope (EM) images of 
full-length σ1 have shown flexibility at three regions of the molecule, a region near the 
N-terminus, a region that correlates with the transition from the predicted α-helical coiled 
coil to the triple β-spiral, and a region that corresponds to the insertion between β-spiral 
repeats 2 and 3 of the crystallized portion of T3D σ1 (30, 54) (Figures I-2 and I-4).  
These regions of flexibility could facilitate interactions with receptors or enable structural 
rearrangements during viral assembly or disassembly. 
 
Interactions of σ1 with sialic acid  
Reoviruses exhibit the capacity to agglutinate erythrocytes of several mammalian 
species (88).  For serotype 3 reoviruses, hemagglutination is mediated by interactions of 
the σ1 protein with terminal α-linked sialic acid residues on several glycosylated 
erythrocyte proteins such as glycophorin A (57, 121).  The carbohydrate receptors for 
other serotypes of reovirus have not been well characterized.  Sialic acid binding is 
required for reovirus attachment and infection of certain cell types including murine 
erythroleukemia (MEL) cells (29, 128).  Although not all serotype 3 strains are capable of 
binding to sialic acid, the majority bind to this carbohydrate and produce 
hemagglutination.  Sequence polymorphism within the σ1 tail determines the capacity of 
field-isolate reovirus strains to bind to sialic acid and infect MEL cells (39, 128).  
Furthermore, non-sialic acid-binding serotype 3 variants have been adapted to growth in 
MEL cells during serial passage.  These variants have gained the capacity to bind to sialic 
acid and contain sequence changes within a discrete region of the σ1 tail (residues 198-
204) predicted to form a β-spiral (29).  Residues in this vicinity may form part of a sialic 
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JAM-A 
Sialic 
acid 
X-ray 
Model 
FIGURE I-4.  Full-length model of reovirus σ1. The model was generated by adding 
five β-spiral repeats, followed by a trimeric coiled coil formed by elongating an 
existing coiled-coil structure (166), to the N terminus of the crystallized fragment of 
σ1 (30).  Regions of the molecule that interact with JAM-A and sialic acid, and 
approximate molecular dimensions, are indicated.  
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acid-binding site (30, 140).  Experiments using expressed σ1 truncation mutants and 
chimeric molecules derived from T1L and T3D σ1 proteins have confirmed that the sialic 
acid-binding domain of serotype 3 σ1 is contained within this predicted β-spiral region of 
the σ1 tail (28) (Figure I-4).    
Serotype 1 reoviruses also appear to bind sialic acid in some contexts.  T1L, but 
not T3D, has been shown to bind to the apical surface of microfold (M) cells, but not to 
enterocytes, in tissue sections of rabbit Peyer’s patches (67).  In this model, binding was 
inhibited by pre-incubation of the tissue sections with neuraminidase or with lectins that 
specifically recognize α2-3-linked sialic acid.  The capacity of T1L to bind to the apical 
surface of M cells was shown to segregate with the S1 gene using reassortant genetics 
and with reovirus particles recoated with recombinant σ1 protein.  The interaction 
between T1L σ1 and sialic acid is especially intriguing as serotype 1 reoviruses are 
incapable of infecting MEL cells, a property dependent on sialic acid binding that 
segregates with the S1 gene (128), and are insensitive to the growth-inhibitory effects of 
neuraminidase treatment of murine L929 (L) cells (107).   
 
Interactions of σ1 with JAM-A 
Substantial evidence has accumulated to suggest that the σ1 head also binds to 
receptors on the cell surface (8, 44, 107, 152).  Neutralization-resistant variants of T3D 
selected using σ1-specific monoclonal antibody 9BG5 contain mutations in the σ1 head 
that segregate genetically with alterations in neural tropism (8, 76, 137, 138).  This 
finding suggests a role for the σ1 head in receptor binding.  Truncated forms of σ1 
containing only the head domain are capable of specific interactions with cells (44, 45).  
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Concordantly, proteolysis of T3D virions leads to release of a C-terminal receptor-
binding fragment of σ1 and a resultant loss in infectivity (107).  These findings indicate 
that the σ1 head promotes receptor interactions that are distinct from interactions with 
sialic acid mediated by the σ1 tail. 
A flow cytometry-based expression-cloning approach was employed to identify a 
receptor bound by the σ1 head (6).  A non-sialic acid-binding strain of reovirus that 
contains a serotype 3 σ1 protein was used as an affinity ligand to avoid the potential 
complication of isolating heavily glycosylated molecules that might not interact 
specifically with σ1.  A neural precursor cell (NT2) cDNA library was selectively 
enriched for cDNAs that confer binding of fluoresceinated virions to transfected cells.  
Four clones were identified that conferred virus binding.  Each encoded JAM-A, a 
member of the immunoglobulin superfamily (IgSF) postulated to regulate formation of 
intercellular tight junctions (93, 98, 169).  Three lines of evidence support the contention 
that JAM-A is a functional receptor for reovirus (6).  First, JAM-A-specific monoclonal 
antibodies inhibit reovirus binding and infection.  Second, expression of JAM-A in 
nonpermissive cells allows reovirus growth.  Third and most convincingly, the T3D σ1 
protein binds directly to JAM-A with an apparent KD of ~ 6 x 10-8 M.  Together, these 
findings indicate that JAM-A serves as a receptor for the σ1 head.  Surprisingly, JAM-A 
serves as a receptor for both prototype and field-isolate strains of all three reovirus 
serotypes (6, 20).  Therefore, JAM-A does not appear to explain the serotype-dependent 
differences in reovirus tropism observed in the murine CNS.  These observations suggest 
that receptors other than JAM-A, possibly including carbohydrate-based coreceptors, 
influence reovirus pathogenesis.  However, it is unclear whether differences in the 
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mechanism of attachment or affinity for JAM-A, which could contribute to differences in 
tropism, exist among the reovirus serotypes.  
 
Structure and function of JAM-A 
Reovirus receptor JAM-A is a type I transmembrane protein with two 
extracellular Ig-like domains, a transmembrane domain, and a short cytoplasmic tail 
possessing a PDZ-domain-binding motif (93, 98, 118).  JAM-A is an important 
component of barriers known as the zonula occludens or tight junctions that form 
between endothelial and epithelial cells (93, 98, 118).  JAM-A is expressed in diverse 
tissues including the lungs, liver, kidney, pancreas, heart, brain, intestine, and lymph 
nodes (2, 37, 90, 93), all of which are tissues capable of supporting reovirus infection in 
newborn mice (80).  In addition, JAM-A is expressed in monocytes, neutrophils, 
lymphocytes, erythrocytes, and platelets (2, 93, 98, 117, 136, 169).  Several cellular 
proteins are known to interact with JAM-A.  The extracellular domain of JAM-A 
interacts with the leukocyte function-associated antigen-1 (LFA-1, integrin αLβ2) (115).  
Cytosolic proteins including zonula occludens-1 (10, 47), AF-6 (47), multi-PDZ-domain 
protein 1 (66, 156), and partitioning-defective protein-3 (48, 70), interact with the JAM-A 
cytoplasmic tail in a PDZ-domain-dependent manner. Interactions between JAM-A and 
LFA-1 are thought in part to mediate the migration of leukocytes across endothelial and 
epithelial barriers during the course of an inflammatory response (37, 85, 115, 162), 
although precise mechanisms by which JAM-A regulates transendothelial migration are 
not known.  
The crystal structure of the extracellular region of human (h) JAM-A (79, 122) 
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consists of two concatenated Ig-like domains (D1 and D2) (Figure I-5A, B).   Two 
monomers form a symmetrical homodimer in which the monomers engage in an “arm-
wrestling grip” via a large interface between the D1 domains.  The JAM-A dimer 
interface is concave and composed of four β-strands (C’, C, F, and G) (Figure I-5C).  The 
dimeric structure is maintained by an unusual interface that is rich in charged residues 
(122) (Figure I-5C).  The principal means of association between JAM-A monomers 
involves four salt bridges at the center of the interface.  These interactions are mediated 
by the side chains of Arg59, Glu61, Lys63, and Glu121, all of which are buried and 
solvent-inaccessible (122).  Protein-protein contacts are often mediated by hydrophobic 
or polar residues, whereas charged amino acids are more typically found in solvent-
exposed areas.  Although formation of salt bridges is generally viewed as energetically 
favorable, the stability of these interactions depends very much on the nature of the 
surrounding environment.  Apolar surroundings increase the energy gained by salt bridge 
formation, whereas highly polar surroundings or low pH values decrease the stability of 
these contacts.  Of note, JAM-A dimers can dissociate into monomers under conditions 
of moderately high ionic strength or when exposed to low pH (9).  This dynamic nature 
of the JAM-A interface may facilitate efficient binding of the viral attachment protein at 
the cell surface or dissociation of the virus in the low pH environment of the endosome.  
JAM-A belongs to a structurally related family of cell-adhesion molecules. The 
most closely related of these proteins to JAM-A are JAM-B and JAM-C (1, 35, 49), 
neither of which serves as a receptor for reovirus (20, 122).  Although structural 
information is not available for JAM-B and JAM-C, sequence analysis suggests that 
homophilic contacts are conserved between JAM-family members (122).  The 
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FIGURE I-5.  Crystal structure of the hJAM-A extracellular domain. (A and B) 
Ribbon drawings of the hJAM-A dimer, with one monomer shown in orange and the 
other in blue.  Two orthogonal views are displayed. Disulfide bonds are shown in 
green. (C) View of the interface between two hJAM-A monomers. The interface is 
formed by residues on the GFCC' faces of two membrane-distal (D1) domains. The 
view is along a crystallographic dyad. Hydrogen bonds and salt bridges are 
represented by broken cylinders. Amino acids are labeled in single-letter code. Image 
from Prota et. al (122). 
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coxsackievirus and adenovirus receptor (CAR) also contains two extracellular Ig-like 
domains that form similar dimers via the GFCC’ interface.  However, intermolecular 
interactions in CAR are more hydrophobic in nature than those in JAM-A (157).   
 
Model of σ1-JAM-A interactions 
Although structural data for a σ1-JAM-A complex previously were not available, 
experimental results have provided clues about the location of a reovirus-binding site in 
JAM-A.  Expression in nonpermissive cells of JAM-A constructs in which individual 
domains had been substituted with structurally homologous domains of CAR identified 
the membrane-distal D1 Ig-like domain of JAM-A as necessary for reovirus binding (52).  
Chemical crosslinking of the JAM-A dimer diminishes the capacity of T1L reovirus to 
bind JAM-A in vitro and on cells and negates the competitive effects of soluble JAM-A 
on reovirus attachment (52).  These observations suggest that the virus cannot interact 
with a covalently linked JAM-A dimer and, thus, might engage the D1 domain via 
residues that are buried in the dimer interface.  In an attempt to identify residues that are 
required for efficient reovirus binding, several solvent-accessible residues as well as a 
few solvent-inaccessible residues in JAM-A were altered.  Residues selected for this 
analysis are conserved in human and murine homologues of JAM-A, which both serve as 
reovirus receptors (6, 122).  Assaying the mutant constructs for the capacity to bind T1L 
reovirus in solid-phase studies identified residues Ser57 and Tyr75 as important for 
efficient reovirus attachment (52).  Tyr75 is located near the “top” of the JAM-A dimer 
interface on β-strand C’ and forms a hydrogen bond with Glu114 (122) (Figure I-5C).  
Thus, Tyr75 would not be accessible to ligand in the context of fully dimeric JAM-A.  
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Ser57 is located close to Tyr75, at the edge of the JAM-A dimer interface.  Together, 
these results provide support for a binding model in which reovirus engages forms of 
JAM-A that are at least partially dissociated via residues near the “top” and within the 
dimer interface.  However, the extent of the binding site, the nature of interactions, and 
how σ1 might gain access to residues within the dimer interface of JAM-A remain 
unclear.    
Sequence analysis has suggested a potential JAM-A-binding site in σ1.  
Alignment of σ1 sequences from prototype and field-isolate strains of the three reovirus 
serotypes, which each use JAM-A as a receptor (20), identified a cluster of conserved, 
solvent-exposed residues at the lower edge of the BADG sheet of the β-barrel head of σ1, 
including several residues that form the loop connecting β-strands D and E (Figure I-3B) 
(20, 30).  As the largest cluster of conserved residues in the σ1 head, this region 
represents a candidate JAM-A-binding site.  However, we have not identified a prototype 
or field-isolate strain of reovirus incapable of utilizing JAM-A as a receptor (20), and 
selection of JAM-A-resistant variants using soluble JAM-A constructs has been 
unsuccessful to date (K. M. Guglielmi, J. A. Campbell, and T. S. Dermody, unpublished 
observations).  Thus, the location of the JAM-A-binding site in σ1 and the nature of 
interactions between the virus and receptor remain unknown.   
 
Adhesion-strengthening mechanism of reovirus attachment to cells 
Monoreassortant viruses containing the σ1-encoding S1 gene of either non-sialic 
acid-binding strain T3C44 (T3SA-) or sialic acid-binding strain T3C44-MA (T3SA+) in a 
T1L background have been used to study the contribution of sialic acid to stable reovirus 
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attachment to cells (5).  T3SA- and T3SA+ vary by a single amino acid residue at 
position 204 (leucine for T3SA- and proline for T3SA+), which correlates with the 
capacity to bind sialic acid (29).  T3SA+ binds sialic acid with an apparent KD of ~ 5 x 
10-9 M, while T3SA- displays no specific interaction with this carbohydrate (5).  While 
the steady-state avidity of these strains for L cells, as determined by competition binding 
assays, is nearly equivalent (KD ~ 3 x 10-11 M), the avidity of T3SA+ for HeLa cells is 
fivefold higher than that of T3SA- (5).  Kinetic assessments of binding indicate that the 
capacity to engage sialic acid functions primarily to increase the kon value of virus 
attachment to HeLa cells. 
The enhanced infectivity of T3SA+ is mediated by the interaction of σ1 with cell-
surface sialic acid, since preincubation of virus with sialyllactose dramatically reduces 
the efficiency of T3SA+ infection, yet has no effect on T3SA- infectivity (5).  However, 
sialic acid-mediated enhancement of T3SA+ infection occurs only during the initial 
phases of virus-cell interaction, since sialyllactose does not inhibit productive binding of 
T3SA+ after the first 30 minutes of virus adsorption.  In contrast, Fab fragments of a 
monoclonal antibody directed to the JAM-A-binding σ1 head (9BG5) neutralize T3SA+ 
infection efficiently, even when added at late times during adsorption (5). 
Results of the binding studies performed using T3SA+ and T3SA- suggest that 
reovirus attaches to cells using an adhesion-strengthening mechanism, in which initial 
low-affinity binding to sialic acid facilitates secondary higher-affinity binding to JAM-A. 
For sialic acid-binding reovirus strains, the initial interaction between virus and cell is 
likely mediated by sialic acid due to the high surface concentration of this carbohydrate.  
By virtue of its rapid association rate, virus binding to sialic acid would adhere the virion 
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to the cell surface, thereby enabling it to diffuse laterally until it encounters JAM-A.  
Such lateral diffusion has been reported for influenza virus (130) and phage T4 (171).   
 
Reovirus entry 
Once stably tethered to the target cell membrane, reovirus must be internalized to 
initiate its infectious cycle.  The JAM-A cytoplasmic tail is dispensable to confer reovirus 
infectivity in nonpermissive cells, suggesting that signaling events mediated by 
molecules other than JAM-A mediate virus internalization (95).  Several lines of 
evidence support a model of reovirus entry in which β1 integrins serve as reovirus 
internalization receptors.  First, a β1-specific antibody, but not antibodies against several 
other α and β integrin subunits, inhibits reovirus infection of HeLa cells (95).  Second, 
co-expression of β1 and JAM-A in nonpermissive chicken embryo fibroblast cells 
confers reovirus infectivity, whereas expression of JAM-A alone confers only binding to 
these cells.  Third, mouse embryo stem cells lacking β1 show reduced reovirus 
infectivity, but not binding, in comparison to wild-type cells.  The pentameric λ2 protein, 
into which σ1 inserts, contains integrin-binding motifs (RGD and KGE), at least one of 
which is likely to be accessible in virions (43, 95, 105).   Thus, analogous to the 
adenovirus penton base, which binds integrins αvβ3 and αvβ5 (33), λ2 may recognize 
integrins that mediate viral internalization into host cells.  
Viral internalization occurs by receptor-mediated endocytosis that is likely 
clathrin-dependent (4, 50, 127, 146).  Within endosomes, reovirus virions undergo acid-
dependent, proteolytic disassembly to form infectious subvirion particles (ISVPs) (3, 26, 
146) (Figure I-6).  ISVPs are characterized by the loss of outer-capsid protein σ3, a 
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conformational change in attachment protein σ1, and cleavage of outer-capsid protein µ1 
to form particle-associated fragments, δ and φ.  ISVPs penetrate endosomal membranes 
and release transcriptionally active cores into the cytoplasm (25, 26, 113).  Thus, reovirus 
disassembly consists of a highly coordinated series of events that requires exposure to the 
low-pH environment encountered in an endosome. 
 
Conformational changes in σ1 
Accumulating evidence suggests that σ1 undergoes dramatic conformational 
changes during viral disassembly and that these changes facilitate key steps in the cell 
entry process (43, 55, 107).  EM images of negatively stained reovirus virions and ISVPs 
reveal filamentous projections extending up to 400 Å from the surface of ISVPs but not 
FIGURE I-6.  Structure of reovirus virions, ISVPs, and cores. Surface-shaded 
representations of cryo-electron microscopic image reconstructions of reovirus are 
shown, as viewed along a twofold axis of symmetry. Density representing σ1 can be 
seen extending from turrets of λ2 at the icosahedral axes of virions and ISVPs. Cores 
lack σ1. Image adapted from Dryden et. al (43). 
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virions (55).  These images suggest that σ1 adopts a compact form in the virion and a 
more extended one in the ISVP.  Cryo-EM image reconstructions of virions of reovirus 
prototype strains and cores of T1L each lack a discernable density corresponding to σ1 at 
the icosahedral vertices (43, 102) (Figure I-6).  However, in cryo-EM image 
reconstructions of T1L ISVPs, discontinuous density is observed for σ1 extending ~100 
Å from each vertex.  Presumably, the full length of σ1 is not visible in reovirus particles 
because icosahedral averaging was employed for the cryo-EM image reconstructions.  
The trimeric σ1 protein is positioned at an icosahedral five-fold axis; therefore, it does 
not obey icosahedral symmetry.  Moreover, σ1 possesses structural flexibility, which also 
may preclude its visualization by this technique. 
The flexibility of σ1 has been observed in EM images of negatively stained σ1 
molecules isolated from virions, which show bending in individual fibers at specific 
regions within the tail (54) (Figure I-2B), and in the crystal structure of the C-terminal 
half of T3D σ1 (30) (Figure I-3A).  In addition to flexibility within the tail domain, some 
EM images of individual σ1 molecules reveal a head domain that appears multi-lobed, 
suggesting that head might adopt a more open conformation than the one observed in the 
crystal structure (Figures I-2B and I-3).  A highly unusual cluster of conserved aspartic 
acid residues is found at the trimer interface at the base of the σ1 head (30) (Figure I-7).  
These residues may be important for triggering conformational changes in the low-pH 
environment of the endocytic pathway.  Acid-dependent conformational changes in the 
attachment proteins of enveloped viruses, such as influenza virus and tick-borne 
encephalitis virus, are well-documented (19, 144).  Despite the importance of σ1 in 
mediating attachment to host cells, the conformational changes that occur in σ1 during 
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the viral entry and uncoating steps and their significance are, at present, poorly 
understood.  
 
 
Significance of the research 
Reoviruses provide a tractable model system for studies of viral attachment and 
pathogenesis.  Since σ1 is the primary determinant of viral tropism (41, 155, 165), studies 
of its interactions with receptors are critical to understanding mechanisms of reovirus 
FIGURE I-7.  The σ1 head trimer interface. (A) View into the head trimer interface. 
Two monomers are shown as surface representations and the third monomer is shown 
as a blue ribbon. Surface residues that are within 4 Å of residues in the third monomer 
are shown in red (residues conserved in T1L, T2J, and T3D σ1) and yellow (residues 
unique to T3D σ1).  The contact area involving conserved residues Val344, Asp345, 
and Asp346 is boxed, and this region is shown in more detail in (B). (B) View along 
the trimer axis, centered at conserved residues Asp345 and Asp346 (yellow) located at 
the base of the σ1 head. Residues Tyr313, Arg314, and Tyr347 engage in contacts 
with the two aspartic acids. The side chains of Asp345 are likely to be protonated to 
avoid an accumulation of negative charge at the interface. Hydrogen bonds involving 
protonated Asp345 are indicated. Oxygen and nitrogen atoms of side chains are 
shown as red and blue spheres, respectively. The Asp346 main chain amides also are 
shown as blue spheres. Image from Chappell et. al (30). 
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disease.  Yet much remains unknown about how reovirus targets specific cells within the 
host for infection.  Understanding how σ1 engages cellular receptors and contributes to 
early steps in the viral life cycle will permit an enhanced understanding of how viral 
protein structure and function relate to viral disease outcomes.  Many viruses utilize 
attachment and entry strategies that are similar to reovirus, including binding to multiple 
receptors at the cell surface and internalization into the endocytic pathway.  Furthermore, 
many viruses specifically engage IgSF members to achieve attachment to host cells (6, 
12, 36, 59, 61, 94, 139, 149-151, 161).  Thus, mechanisms of attachment elucidated for 
reovirus might contribute to a broader understanding of interactions of other viruses with 
cellular receptors.  In addition, reovirus shows promise as an oncolytic therapeutic (153) 
and is currently being employed in Phase I clinical trials to treat malignant gliomas (53).  
A precise understanding of viral attachment protein structure and function and virus-
receptor interactions might contribute to improved design of viral vectors for oncolytic 
and vaccine delivery purposes.  My research has focused on structure-function 
relationships of reovirus attachment protein σ1 and JAM-A.  This work has led to the 
discovery of a novel protein homotrimerization motif, the aspartic acid sandwich, which 
includes several charged residues in close proximity and might contribute to σ1 structural 
rearrangements.  These studies also have revealed the basis of σ1-JAM-A interactions on 
a near-atomic level and enhanced an understanding of the forces that stabilize the σ1-
JAM-A complex and JAM-A homodimers.  Collectively, my dissertation research has 
enhanced an understanding of the molecular framework that guides reovirus to its cellular 
targets.  
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CHAPTER II 
 
THE REOVIRUS σ1 ASPARTIC ACID SANDWICH: A TRIMERIZATION MOTIF 
POISED FOR CONFORMATIONAL CHANGE 
 
Introduction 
One of the most remarkable features of the previously-determined structure of the 
C-terminal half of σ1, is a cluster of aspartic acid residues at the base of the head domain 
(30) (Figure I-7).  Molecular dynamics studies suggest that these residues are likely to 
play a role in mediating conformational changes in σ1 (22).  However, at a resolution of 
2.6 Å, the structure did not allow precise placement of water molecules and visualization 
of contacts between amino acids with sufficient accuracy to explain how such a unique 
arrangement of amino acids is compatible with a higher-order structure. 
In this study, we determined a high-resolution structure of a fragment of T3D σ1 
that comprises the head domain and a single β-spiral repeat of the tail.  The structure has 
been refined to a resolution of 1.75 Å allowing us to discern with high clarity details of 
the subunit interface in the vicinity of the aspartic acid cluster.  Furthermore, we have 
analyzed two σ1 mutants with alterations in the vicinity of the subunit interface to 
determine the effects on receptor-binding capacity and trimer stability.  Our studies 
suggest that the aspartic acid cluster serves as a molecular switch that, depending on the 
microenvironment, can stabilize or destabilize the formation of a trimeric structure.  
The research described in this chapter was performed in collaboration with past 
and present members of the Thilo Stehle laboratory (Universitat Tübingen).  Dr. Pierre 
Schelling (Millipore) purified, crystallized, and solved the structure of the wild-type T3D 
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σ1 head domain.  I generated and initially purified and characterized the two σ1 head 
domain mutants, σ1H-D345N and σ1H-Y313A, using gel filtration chromatography.  I 
also performed all surface plasmon resonance experiments.  Eva Kirchner (Universitat 
Tübingen) crystallized, determined the structure, and performed gel filtration studies of 
σ1H-D345N.  Eva also prepared the structural figures shown in this chapter.  Bernhard 
Paetzold (Universitat Tübingen) performed crosslinking, gel filtration, and circular 
dichroism (CD) spectroscopy studies of σ1H-Y313A.  
 
Results 
Purification of σ1Η - The previously crystallized T3D σ1 protein (30) contains a flexible 
linker between the C-terminal two β-spiral repeats of the tail.  This flexibility likely 
contributed to the observed diffraction limit of 2.6 Å for these crystals.  To obtain better-
diffracting crystals of T3D σ1, we designed a modified construct containing the entire 
head domain and only the C-terminal β-spiral repeat of the tail (σ1H; residues 293-455).  
We also tested an additional construct comprising only the head domain (residues 309-
455), but it did not yield soluble and trimeric protein, suggesting that the C-terminal β-
spiral contributes to trimer formation.  The protein was produced with a cleavable N-
terminal GST tag and purified via sequential glutathione-affinity chromatography and 
anion exchange chromatography.  Subsequent gel filtration showed that the protein elutes 
at an apparent molecular weight of ~ 45 kDa, consistent with a trimer (data not shown).  
N-terminal sequencing confirmed that the product released following protease treatment 
was the σ1 head domain with two additional amino acids from the protease recognition 
sequence (data not shown). 
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Binding of σ1Η to JAM-A - To determine whether the purified protein folds natively, we 
quantitatively assessed the capacity of σ1Η to bind to JAM-A using SPR.  The JAM-A 
ectodomain, expressed and purified as a GST fusion protein (122), was captured on a 
biosensor surface with a GST-specific antibody.  When injected across the biosensor 
surface, purified σ1Η bound saturably and reversibly to the GST-JAM-A ectodomain but 
not to GST alone (Figure II-1A).  Kinetic analysis of the σ1-GST-JAM-A interaction 
using BIAevaluation 3.0 software indicated a KD of ~7 x 10-9 M, a value that 
approximates the KD determined for a larger fragment of σ1 (6).  These results indicate 
that purified σ1Η is functional and that the JAM-A-binding domain of σ1 lies within 
residues 293-455. 
 
Overall structure of σ1Η at 1.75 Å resolution - Diffraction data were collected at the 
National Synchrotron Light Source (Brookhaven National Laboratory) using crystals of 
purified σ1Η.  The structure was solved by molecular replacement using the previously 
determined lower-resolution structure of a C-terminal fragment of σ1 (30) and refined to 
1.75 Å (Table II-1).  A simulated-annealing omit map for the refined structure calculated 
without model bias demonstrates that the model is accurate (data not shown).  
Concordantly, both working and free R-factors are very low (Table II-1), indicating that 
the structure is well refined and of high quality.  A total of six monomers, arranged into 
two almost identical trimers, are present in the asymmetric unit of the crystals.  A ribbon 
tracing of one trimer is shown in Figure II-1B.  Each σ1 monomer is composed of an 
eight-stranded β-barrel.  The overall conformation of the monomers is very similar, with 
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FIGURE II-1.  Functional and structural characterization of the σ1 head domain. (A) 
T3D σ1H binding to the JAM-A ectodomain. Purified σ1H at a concentration of 300 
nM (red), 30 nM (yellow), and 3 nM (green) was injected across a biosensor surface 
coated with either GST or GST-JAM-A. Binding of σ1Η to GST was set as the 
baseline (grey). The calculated affinity for binding to GST-JAM-A, expressed as 
apparent KD, is approximately 7 x 10-9 M. (B) High-resolution structure of σ1H. 
Shown is a ribbon tracing of the trimer, with the three monomers drawn in red, 
orange, and blue. Termini are labeled in one monomer with N (N terminus) and C (C 
terminus).  
 28 
TABLE II-1. Data collection and refinement statistics for σ1H and σ1H-D345N crystal 
structures.  
 
Data set σ1H σ1H-D345N 
Diffraction data*   
Space group P21 P21 
Unit cell dimensions (Å) a=83.9  
b=51.4  
c=108.9 
a=84.0 
b=51.6 
c=108.9 
Angles (°) β=95.7 β=95.6 
Resolution range (Å) 30 – 1.75 30 – 1.85 
Completeness (%) 96.7 (86.7) 98.7 (97.9) 
Total reflections 300,167 347,405 
Redundancy (%) 3.3 (2.6) 4.4 (4.0) 
Rmerge# (%) 9.3 (42.7) 9.6 (41.6) 
I/σI 15.71 (2.26) 6.5 (1.4) 
Refinement statistics   
Rcryst (%); work set† 22.4 (30.1) 17.5 (23.1) 
Rcryst (%); free set† 27.4 (38.5) 22.5 (27.3) 
Overall B-factor (Å2) 16.0 17.3 
R.m.s.d. bond lengths (Å) 0.008 0.012 
R.m.s.d. bond angles (°) 0.962 1.234 
Number of water molecules 
Ramachandran plot: ‡ 
 most favorable regions 
 additional allowed regions 
 generously allowed regions 
 Disallowed regions 
1220 
 
88.5% 
10.0% 
1.0% 
0.5% 
994 
 
87.9% 
10.5% 
1.5% 
0.0% 
 
* Data sets were collected at 100 K and a wavelength of 1.1 Å (σ1H) and 1.54 Å (σ1H-D345N). Values in 
parentheses refer to the outermost resolution shell (1.75-1.81 Å for σ1H and 1.92-1.85 Å for σ1H-
D345N). 
# Rmerge = Σhkl|I - <I>| / ΣhklI , where I is the intensity of a reflection hkl, and <I> is the average over 
symmetry-related observations of hkl. 
† Rcryst =Σhkl| Fobs – Fcalc | / ΣhklFobs, where Fobs and Fcalc are observed and calculated structure factors, 
respectively. Free set (17) contains 10% of the data. 
‡ Calculated with PROCHECK (23). 
 
the exception of two longer and presumably flexible loops: the G-H loop at the top of 
each monomer and the D-E loop at its base.  With the exception of His388, all σ1 
residues occupy allowed regions in the Ramachandran diagram (23).  However, since the 
density corresponding to His388 is unambiguous, it appears that a salt bridge to Glu348 
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fixes its side chain in the observed conformation.  Asp345 is located in the generously 
allowed region of the Ramachandran diagram; it forms, together with Asp346, a β-
hairpin between β-strands B and C.  The dihedral angles classify this region as a type II' 
β-hairpin (134). 
 
Contacts in the σ1 trimer - Trimer formation buries from solvent an area of 2292 Å2 per 
monomer.  Residues in the tail account for about 25% of this area, primarily through 
hydrophobic interactions between the strands of the β-spiral.  The three β-barrel domains 
that form the head engage in a more complex pattern of interactions.  Multiple contacts 
between the subunits at the outer edges of each monomer result in binding surfaces that 
extend from the base of the head to its top (Figure II-2A).  However, a large cavity exists 
at the center of the trimer, and this cavity is surrounded by smaller regions that lack 
intersubunit contacts (Figure II-2A).  The central cavity measures ~ 15 Å in height and ~ 
10 Å in width and contains a large number of ordered water molecules that are connected 
to the exterior surface through channels at the top of the trimer (Figure II-2B).  The 
cavity probably also contains many less-well ordered water molecules, which are not 
visible in our electron density maps.  Dimensions of the channels leading toward the 
cavity suggest that water molecules can flow freely to the top of the trimer.  In contrast, 
the bottom of the cavity is sealed by the three Tyr347 side chains (Figure II-2A). 
 
The aspartic acid sandwich - An unusual cluster of aspartic acid residues lies just below 
the water-filled cavity.  Each monomer contributes two aspartic acid residues, Asp345 
and Asp346, to this cluster, giving rise to a total of six aspartic acid side chains that are 
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FIGURE II-2.  Architecture of the σ1 head subunit interface. (A) Contacts between 
subunits in the T3D σ1 trimer. Three views, each differing by 90°, are shown. One 
monomer is shown as a black ribbon, and its contact area with the other two 
monomers is represented as a molecular surface. Residues discussed in the text are 
labeled. The contact area was calculated using AREAIMOL (23) as the solvent 
accessible area difference between the trimeric and monomeric forms of the molecule. 
The difference values range from 1 Å2 (dark blue) to 52 Å2 (red). Regions with a high 
area difference have low solvent accessibility in the trimer and thus represent areas 
with high-affinity intersubunit contacts. Surfaces with an area difference of less than 1 
Å2 are not shown. Calculations were performed using a point density/Å2 of 1 and a 
solvent molecule radius of 1.4 Å. (B) Solvent structure at the σ1 head interface. Two 
monomers are shown as a surface representation. The third monomer has been 
removed to allow a view into the trimer interface. Ordered water molecules at the 
interface are represented with spheres. The water molecules shown in blue fill most of 
the central cavity between the monomers and can leave the cavity via channels 
leading to the top and the sides of the trimer (arrows). The two water molecules 
shown in red are located near the Asp345 side chains. These water molecules are 
solvent-inaccessible.  
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arranged in close proximity.  Asp345 and Asp346 are located at the very tip of a β-
hairpin between β-strands B and C (Figure II-3A).  β-hairpins are small structural motifs 
stabilized by a defined backbone hydrogen bond pattern (15).  The hairpins of the three 
monomers face each other, with the side chains of Asp345 making key contacts.  The 
aspartic acids are partitioned between two layers that each contain three tyrosine residues, 
Tyr347 at the top and Tyr313 at the bottom (Figure II-3C and D). 
Each Asp346 side chain forms a salt bridge with Arg314 from a neighboring 
monomer, but the Asp345 side chains are not engaged in any ionic interactions (with 
other residues or with cations) that would negate their negative charges.  The 
accumulation of three negative charges in such a hydrophobic environment would be 
highly unfavorable.  Although hydrogen atoms cannot be seen in our electron density 
maps even at the high resolution obtained (1.75 Å), the location and orientation of the 
carboxyl groups strongly suggests that they are protonated.  A protonated state of Asp345 
is also suggested by molecular dynamics studies of σ1 (22).  Each protonated carboxylate 
forms two hydrogen bonds.  One of these involves the hydrogen atom of the Asp345 
carboxyl group and the carbonyl oxygen of a neighboring Asp346 residue; a second is 
formed between the carbonyl oxygen and the backbone amide group of Asp346 in a 
neighboring monomer (Figure II-3C).  Since these two hydrogen bonds occur three times, 
and since there are few other hydrogen bonds involved in head trimerization, the aspartic 
acid sandwich likely makes a major contribution to trimer stability. 
The cluster of aspartic acids is sandwiched between hydrophobic residues that 
block access of solvent molecules to the carboxylate groups.  One side of this sandwich 
(the “top” in Figure II-3D) is formed by Val344 and Tyr347; the other (the “bottom” in 
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FIGURE II-3.  An aspartic acid sandwich at the σ1 head trimer interface. (A) Ball-
and-stick view of the type II' β-hairpin on which Asp345 is located. Residues 342 to 
349 are shown. Oxygen atoms are shown in red, and nitrogen atoms are shown in 
blue. Main-chain hydrogen bonds are represented with black dotted lines. Letters B 
and C refer to β-strands in σ1H. (B) Arrangement of β-hairpins and the aspartic acid 
cluster as seen from the top of the molecule. The view is along the three-fold axis. The 
β-strands are depicted as arrows, and β-strands of one monomer are labeled. Side 
chains of Asp345 and Asp346 are shown in ball-and-stick representation. (C) 
Schematic view of the aspartic acid cluster, shown in the same orientation as that in 
panel B. Residues that interact with Asp345 are shown in orange (monomer A), green 
(monomer B), and blue (monomer C). Hydrogen bonds are shown as dotted lines. W1 
and W2 represent the two water molecules trapped inside the cluster. (D) Ball-and-
stick representation of the aspartic acid cluster and surrounding residues. The view is 
perpendicular to the three-fold axis. Residues discussed in the text are labeled in one 
monomer. The two trapped water molecules are represented with red spheres. The 
color code is the same as that used in panel C.  
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Figure II-3D) is formed by Tyr313 and Met309.  Two well-ordered water molecules 
located directly on the three-fold axis are also present in this arrangement of amino acids 
(Figure II-2B).  These water molecules interact with Tyr313 and Asp345, respectively, 
and they are held in place by an extensive hydrogen bond network (Figure II-3C and D).  
Buried water molecules can sometimes be exchanged without major unfolding.  
However, residues in the immediate vicinity of the two water molecules have temperature 
factors that are among the lowest of the entire structure (data not shown), suggesting that 
thermal mobility is low in this area.  Thus, it is unlikely that the water molecules can be 
exchanged. 
 
Purification and characterization of σ1H-Y313A - To explore potential conformational 
changes of σ1, we generated substitutions of two key residues of the cluster, Tyr313 
(Y313A) and Asp345 (D345N).  The mutant proteins were analyzed for receptor-binding 
properties and the capacity to form trimers.  We reasoned that substitution of Tyr313 with 
a smaller amino acid might allow influx of water molecules to the aspartic acid cluster, 
thereby causing the trimer to undergo structural changes triggered by charged Asp345 
side chains.  The σ1H-Y313A mutant protein was expressed as a GST fusion in bacteria, 
purified by glutathione affinity, proteolytically cleaved from the GST tag on-column, and 
further purified using gel filtration.  Purified σ1H-Y313A is soluble and elutes as a 
monomer by gel filtration chromatography (Figure II-4).  Treatment of σ1H-Y313A with 
each of three different crosslinking reagents of various lengths (11.4 to 16.1 Å) failed to 
alter the chromatographic mobility of the mutant protein (data not shown).  σ1H-Y313A 
was incapable of binding to JAM-A by either gel filtration (data not shown) or SPR 
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(Figure II-5), indicating that a trimeric form of σ1 is required for JAM-A engagement.  
CD spectra of σ1H-Y313A show a secondary structure content of the protein similar to 
that of wild-type σ1H, suggesting that σ1H-Y313A monomers are folded properly (data 
not shown).  Thus, our results indicate that residue Tyr313 is required for trimerization 
and that the trimeric form of σ1 is essential for receptor binding 
 
Characterization and structure analysis of σ1H-D345N - To determine whether structural 
and functional changes occur upon replacement of Asp345 with asparagine, we 
engineered a D345N mutation in the wild-type T3D σ1Η construct.  We anticipated that 
hydrogen bonds might form between the asparagine residues, stabilizing the trimer 
FIGURE II-4.  Gel filtration of T3D σ1 head mutants. Purified σ1H (blue), σ1H-
D345N (red), and σ1H-Y313A (yellow) constructs were applied to a Superdex 75 gel 
filtration column in 20 mM Tris pH 7.5, 100 mM NaCl. The D345N mutant elutes at 
the same time as the wild-type protein, indicating that it forms a trimer, whereas the 
Y313A mutant shows a significantly smaller molecular weight that corresponds to 
monomeric protein.  
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interface in much the same manner as accomplished by the protonated Asp345 side 
chains.  The mutant protein was purified using the strategy employed for purification of 
wild-type T3D σ1H.  The σ1H-D345N mutant forms trimers at neutral pH (Figure II-4) 
and binds to JAM-A with an affinity similar to that of wild-type σ1H (Figure II-5).  Thus, 
σ1H-D345N is biochemically and functionally indistinguishable from the wild-type 
protein. 
FIGURE II-5.  Binding of T3D σ1 head mutants to the JAM-A ectodomain. Purified 
point mutants of σ1H at 300 nM (red), 30 nM (yellow), and 3 nM (green) 
concentrations were injected across a biosensor surface coated with either GST or 
GST-JAM-A. Binding of σ1H point mutants to GST was set as the baseline (grey 
line). The identity of the mutants is indicated. The calculated affinity for binding of 
σ1H-D345N to GST-JAM-A, expressed as apparent KD, is approximately 1 x 10-8 M. 
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To test whether the D345N mutation in T3D σ1H alters the conformation of the 
aspartic acid sandwich, we determined the structure of σ1Η-D345N.  The mutant protein 
was crystallized using conditions similar to those employed to crystallize the wild-type 
protein.  We collected a complete data set from the σ1Η-D345N crystals to 1.85 Å and 
solved the structure by molecular replacement using the wild-type protein structure as a 
model (Table II-1).  The σ1Η-D345N mutant crystallized as a trimer with a structure that 
is nearly identical to that of wild-type σ1H (Figure II-1B).  At the subunit interface, the 
two water molecules observed just above and below residues 345 are at almost exactly 
the same position in σ1H-D345N (Figure II-6).  The amino groups of Asn345 form the 
same hydrogen-bond pattern as the hydroxyl group of protonated Asp345.  Thus, the 
mutant structure provides evidence that in trimeric, wild-type σ1 all Asp345 residues are 
protonated. 
 
Discussion 
Formation of σ1 trimers - Although a C-terminal fragment of σ1 has been crystallized 
(30), further characterization at an atomic level of resolution has enhanced an 
understanding of its trimeric nature.  Interactions that form the trimer are highly complex.  
The base of the trimer is held firmly together by hydrophobic interactions, a standard 
means of inducing the formation of oligomeric structures.  In contrast, contacts at the 
center and top of the trimer involve interrupted surfaces, cavities filled with water 
molecules, trapped individual water molecules, very few hydrophobic contacts, and 
protonated side chains that form hydrogen bonds.  These types of interactions are unusual 
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for protein-protein contacts.  We think that the σ1 head is designed to exist as both 
monomeric and trimeric species.  In fact, the mutation of only one residue, Tyr313, 
results in soluble, folded protein that is entirely monomeric.  A single substitution at the 
base of the trimer therefore suffices to completely abolish trimer formation, indicating 
that the lower-affinity contacts at the center and top of the σ1 head are not sufficient for 
stabilization of the trimer. 
Comparison of deduced amino acid sequences of σ1 proteins from prototype and 
field-isolate reovirus strains reveals that Asp345 and Asp346 are highly conserved (20, 
30).  Additionally, hydrophobic residues that form the “top” and “bottom” of the aspartic 
FIGURE II-6.  Structure of σ1H-D345N. Superposition of wild-type T3D σ1H and 
σ1H-D345N at the aspartic acid cluster. Ribbon drawings of the σ1H and σ1H-
D345N backbones are shown in grey, oxygen atoms are shown in red, and nitrogen 
atoms are shown in blue. The Asn345 side chains of σ1H-D345N (green) show the 
same conformation as those of wild-type σ1H (yellow). The water molecules above 
and below the cluster also occupy virtually identical positions in both molecules.  
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acid sandwich show a high degree of conservation.  Phenyl ring-containing side chains 
are found at positions 313 and 347 in a σ1 sequence alignment (30).  For example, strain 
T1L contains phenylalanine and tryptophan residues and strain T2J contains tyrosine and 
tryptophan residues at positions corresponding to Tyr313 and Tyr347 in T3D σ1.  
Furthermore, a hydrophobic residue (isoleucine, leucine, methionine, or valine) is found 
at position 309, and a valine is absolutely conserved at position 344.  The striking level of 
sequence conservation at these positions suggests that the aspartic acid sandwich serves 
an essential function in reovirus replication. 
 
Engagement of JAM-A - Our analysis shows that the σ1H-Y313A mutant is soluble and 
monomeric.  Furthermore, since its CD spectrum is similar to that of wild-type σ1H, 
σ1H-Y313A appears to be properly folded.  However, the mutant protein does not bind 
JAM-A.  The most likely interpretation of these findings is that a trimeric form of σ1 is 
required for JAM-A engagement.  We envision two possible explanations for these 
results.  First, the JAM-A-binding site may extend across more than one monomer.  
Second, the surface structure of the JAM-A-binding region may be stable only in the 
context of a trimer.  We think it unlikely that JAM-A makes a direct contact with Tyr313 
or with residues in close proximity.  Tyr313 is not exposed to solvent in the trimeric 
wild-type protein and would be unlikely to encounter JAM-A at its position in the head 
trimer interior.  
The structure of σ1 is closely related to that of the adenovirus attachment protein, 
fiber (30).  Moreover, the receptors for reovirus and adenovirus, JAM-A and CAR, 
respectively, also share significant structural and functional homology and may engage 
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their viral ligands in a similar manner (141).  We note that the adenovirus fiber knob 
binds to its receptor CAR via contacts between two knob subunits and a single receptor 
molecule.  If this mode of binding is conserved in σ1, it would be affected by alterations 
at the trimer interface. 
We observed a single magnesium ion adjacent to residues Asp365 and Glu419 at 
the center of the concave surface of σ1H (data not shown).  This surface of σ1 has been 
proposed to participate in interactions with JAM-A (52, 141).  The side chains of Asp365 
and Glu419 are exposed to solvent and exist in close spatial proximity to side chains of 
Arg427 and Arg429.  These residues would be positioned to engage in salt-bridge 
interactions with charged residues in the receptor.  In support of this idea, analysis of 
point mutants of JAM-A suggests that acidic and basic residues in the JAM-A dimer 
interface are required for high-affinity interactions with σ1 ([65]; discussed in Chapter 
III). 
 
An unusual cluster of aspartic acid residues at the trimer interface – The structure of σ1 
reveals an unusual cluster of solvent-inaccessible, conserved aspartic acid residues at the 
head trimer interface.  A key aspect of these residues is that they are located at the very 
tip of a β-hairpin.  As judged by its temperature factors (data not shown), the β-hairpin is 
rigid and possesses limited mobility.  Three lines of evidence support the conclusion that 
the side chains of Asp345 must be protonated to allow formation of the trimer.  First, 
molecular dynamics studies show that the introduction of negative charges at the Asp345 
side chains destabilizes the trimer, causing partial separation of the three chains at the 
base of the σ1 head (22).  Second, the mutant σ1H-D345N protein assembles into a 
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trimeric structure that is indistinguishable from that of wild-type protein.  Remarkably, 
the arrangement of water molecules in the vicinity of residue 345 in both the wild-type 
and mutant structures is identical.  Since the asparagine side chain is an excellent mimic 
for a protonated aspartic acid but not for a charged aspartate, the structural similarities 
between the two proteins argue strongly that the wild-type protein contains protonated 
Asp345 residues.  Third, alanine substitution of a residue that shields Asp345 from 
solvent, Tyr313, results in monomeric protein.  It is likely that mutation of Tyr313 
renders Asp345 solvent-accessible, causing it to lose its proton at neutral pH. 
The hypothesis that Asp345 in σ1 is protonated is also supported by the finding of 
a similar cluster of aspartic acids in the G protein of vesicular stomatitis virus (VSV) 
(124).  Although the global architecture of VSV G differs substantially from reovirus σ1, 
VSV G also forms a trimer that features three aspartic acids that face each other at the 
trimer interface.  The location and orientation of the aspartic acid clusters in VSV G and 
σ1 are in fact surprisingly similar (Figure II-7).  In both cases, hydrogen bonds are 
thought to mediate interactions between protonated aspartic acid side chains.  These 
hydrogen bonds lie in a plane that is perpendicular to the trimer axes, and deprotonation 
would lead to destabilization of the trimer.  In both molecules, the aspartic acids emanate 
from well-ordered backbone structures with low mobility (an α-helix in VSV G and a β-
hairpin in σ1).  Most interestingly, both clusters contain trapped water molecules that 
form hydrogen bonds with the protonated carboxylate groups. 
 
 Implications for viral attachment and entry - What are the implications of the aspartic 
acid cluster for σ1 function in viral attachment and cell entry?  Both VSV and reovirus 
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FIGURE II-7.  Comparison of aspartic acid clusters in reovirus σ1 (A) and VSV G 
(B). In both cases, the view is along the threefold axis. Ribbon drawings of the 
complete trimers are shown on the left in each case to depict the location of the 
clusters (red circles). Ribbon tracings of the backbones are shown in grey, carbon 
atoms of aspartic acid residues Asp268 (VSV G) and Asp345 and Asp346 (σ1) are 
shown in orange, and oxygen atoms are shown in red. Hydrogen bonds are 
represented with dotted lines.  
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enter cells via the endosomal pathway and thus encounter a low-pH environment during 
the entry process.  The VSV G structure has been interpreted as a low-pH conformer of 
the molecule (124).  In keeping with this conclusion, it is possible that the σ1 structure 
reported here also represents a form of the protein found at low pH.  Both VSV G and 
reovirus σ1 were crystallized at close-to-neutral pH, but the conditions used for 
crystallization are far from physiologic in both cases and may easily create an 
environment that favors protonated aspartic acids.  Thus, the aspartic acid cluster may act 
as a molecular switch that disfavors trimerization when charged but favors trimerization 
when the protein encounters a low-pH environment that allows it to be protonated.  
Because the aspartic acids project from rigid structural motifs, they may prevent 
trimerization in environments that favor deprotonation.  
Conformational changes of viral proteins in response to ligand binding or 
exposure to acidic pH are well established (19, 31, 81).  These changes allow viruses to 
expose previously hidden epitopes for ligand binding and membrane penetration.  For 
example, the influenza virus hemagglutinin undergoes a massive rearrangement upon 
exposure to acidic pH.  This conformational change is enabled by prior proteolytic 
cleavage and leads to the formation of α-helical coiled-coil structures that expose a 
hydrophobic fusion peptide.  Importantly, the hemagglutinin structure at neutral pH 
represents a metastable form of the protein, as the low pH conformer, once formed, is 
stable even at neutral pH (32).  The conspicuous location of Asp345 at the σ1 trimer 
interface suggests that the aspartic acid cluster serves a similar function to mediate a 
structural transition between a form of the protein that is at least partially detrimerized in 
the head region and a fully trimerized molecule (as seen in the crystal structure here).  
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Evidence for the existence of a partially detrimerized σ1 head domain comes from EM 
images of individual σ1 molecules, in which the head domain appears bi- or multi-lobed 
([54] and Figure I-2).  Based on our current data, it appears that the fully trimerized 
protein is the energetically favored form.  Placed in the context of the entire virion, such a 
conformational change might facilitate events during reovirus entry subsequent to viral 
attachment, such as internalization into the endocytic pathway and proteolytic 
disassembly to form infectious subvirion particles.  
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CHAPTER III 
 
REOVIRUS BINDING DETERMINANTS IN JUNCTIONAL ADHESION 
MOLECULE-A 
 
 
Introduction 
Previous research findings identified JAM-A as a serotype-independent reovirus 
receptor (6, 20) and showed that the σ1 head domain binds to JAM-A with high affinity 
(6, 131).  Studies in which CHO cells were transfected with plasmids encoding chimeric 
CAR-JAM-A receptor constructs or JAM-A domain-deletion mutants provided evidence 
that the N-terminal D1 domain of JAM-A (Figure III-1A) is required for reovirus 
attachment and infection (52).  Chemical cross-linking of JAM-A diminishes the capacity 
of reovirus to bind JAM-A in vitro and on cells and negates the competitive effects of 
soluble JAM-A on reovirus attachment (52), suggesting that reovirus binds a surface of 
JAM-A that is at lest partially obscured in the dimer.  However, the precise nature of σ1-
JAM-A interactions is not understood.  While virus binding to the GFCC’C” surface of 
the D1 domain of an IgSF member would not be unexpected, the highly charged nature of 
the residues that compose the GFCC’C” surface of JAM-A D1 (Figure III-1B), coupled 
with the observation that this surface is buried in JAM-A homodimers, make it an 
unusual target for reovirus binding.  Moreover, it is not apparent how JAM-A-binding 
contributes to serotype-dependent differences in reovirus tropism in the murine CNS.   
In this study, I engineered point mutations in the dimer-contributing surface of the 
D1 domain of JAM-A, purified the resultant mutants, and characterized effects of the 
 45 
FIGURE III-1.  Structure and location of residues in the JAM-A D1 domain. (A) Ribbon 
drawing of the hJAM-A dimer, with one monomer shown in yellow and the other in green. (B) 
View of the interface between two hJAM-A monomers. The interface is formed by residues on 
the GFCC’ faces of two D1 domains. The view is along a crystallographic dyad. Oxygen 
atoms are shown in red, nitrogen in blue, and sulfur in purple. Hydrogen bonds and salt 
bridges are represented by dashed lines.  Amino acids are labeled in single-letter code. (C) 
View of the GFCC’ β-sheet that composes the dimer interface of one JAM-A monomer, 
labeled as in panel B.  Side chains are shown for residues that were altered in this study. 
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mutations on JAM-A homodimerization and binding to σ1H or intact reovirus 
virions.  In complementary experiments, I tested the capacity of CHO cells expressing 
full-length JAM-A point mutants to support binding and infection by prototype strains 
from each of the three reovirus serotypes.  My results indicate that binding of reovirus 
T3D σ1 to JAM-A requires residues in β-strands C and C’ within the dimer interface and 
that JAM-A binding requirements differ among the reovirus serotypes.  These findings 
enhance an understanding of reovirus-receptor interactions and suggest that the nature of 
JAM-A contacts might contribute to differences in pathogenesis among reovirus 
serotypes.  
I would like to acknowledge Eva Kirchner (Universitat Tübingen) for performing 
the gel filtration experiments shown in Figure III-5 and for generating Figures III-1 and 
III-10, which show the X-ray crystal structure of JAM-A, location of residues in the D1 
domain, and a model of the σ1 binding site in JAM-A.  I would also like to acknowledge 
Dr. Geoffrey Holm (Vanderbilt University) for generation of the GST-D2 construct used 
in this study.  
 
Results 
Analysis of σ1H binding to GST-JAM-A - For studies of σ1-JAM-A interactions, I 
purified an N-terminal GST fusion with the extracellular region of JAM-A (122).  
Bacteria were transfected with plasmids encoding GST-JAM-A, harvested by 
centrifugation, and lysed by sonication.  GST-JAM-A constructs were purified from 
bacterial lysates using glutathione-affinity chromatography (52).  To determine whether 
GST-JAM-A is capable of binding σ1, I captured GST-JAM-A on the surface of a 
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biosensor chip via a covalently linked GST-specific antibody.  I then injected purified 
T3D σ1H (131) at three different concentrations and detected association with GST-
JAM-A by SPR (Figure III-2A).  σ1H did not show any specific binding to the GST-
specific antibody or to GST captured on the biosensor surface (data not shown).  
However, σ1H bound GST-JAM-A with an affinity of ~ 2.4 x 10-9 M, which 
approximates previous calculations of σ1 affinity for JAM-A (6, 131).  To determine 
whether the isolated D1 Ig-like domain of JAM-A is capable of σ1 engagement, I 
expressed and purified N-terminal GST fusions with only the D1 or D2 Ig-like domains 
of JAM-A.  Protease treatment of the purified proteins removed the GST tag, but did not 
degrade either Ig-like domain, which suggests that the proteins are properly folded (data 
not shown).  I assessed the capacity of the fusion proteins to bind σ1H using the SPR 
strategy employed for GST-JAM-A.  While σ1H bound GST-D1 with a similar affinity to 
GST-JAM-A, GST-D2 was incapable of capturing σ1H (Figure III-2B).  Together with 
data obtained using chimeric receptor molecules (52), these results indicate that the 
membrane distal D1 domain of JAM-A is sufficient for high-affinity interactions with σ1.  
 
Generation and characterization of JAM-A point mutants - To identify specific residues 
in the D1 domain required for σ1 binding, I generated individual alanine substitutions of 
residues with surface-exposed side chains in the JAM-A dimer interface (Figure III-1C 
and Table III-1).  Two groups of residues were targeted for mutagenesis: (i) those that 
form intersubunit contacts-Arg59, Glu61, Lys63, Leu72, Tyr75, Met110, and Glu121, 
and (ii) those that do not-Asp65, Thr70, Asn76, Thr106, Thr108, Ser112, and Lys123.  
GST-JAM-A point mutants were purified by glutathione affinity chromatography and 
 48 
FIGURE III-2.  Characterization of σ1H binding to GST-JAM-A. (A) Binding of σ1H to 
GST-JAM-A. Purified σ1H, at a concentration of 167 nM (red), 16.7 nM (yellow), or 1.67 nM 
(green) was injected for 5 min across a biosensor surface on which GST fused to the JAM-A 
ectodomain previously had been captured. Buffer alone was injected for 6.7 min. The baseline 
is 167 nM σ1H binding to GST (grey).  The KD of σ1H binding to GST-JAM-A is 
approximately 2.4 x 10-9 M. (B) Binding of σ1H to GST-JAM-A Ig-like domains. Purified 
σ1H, at a concentration of 167 nM, was injected for 5 min across a biosensor surface on which 
GST-JAM-A fusion proteins previously had been captured. Buffer alone was injected for 6.7 
min. The resultant traces show binding to GST-JAM-A (yellow), GST-D1 (red), and GST-D2 
(green). The baseline is 167 nM σ1H binding to GST (grey). Binding is expressed in 
resonance units (RU).  
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TABLE III-1.  Primer pairs used to engineer point mutations in JAM-A a 
 
JAM-A Mutation Forward primer Reverse primer 
R59Ab 5’ GGCTTTTCTTCTCCCGCGGTGGAGTGG 
AAGTTTG 
5’ CAAACTTCCACTCCACCGCGGGAGAA 
GAAAAGCC 
E61Ab 5’ CTTCTCCCCGTGTGGCGTGGAAGTTTG  
ACC 
5’ GGTCAAACTTCCACGCCACACGGGGA 
GAAG 
K63Ab 5’ CCCGTGTGGAGTGGGCATTTGACCAAG 
GAGAC 
5’ GTCTCCTTGGTCAAATGCCCACTCCAC 
ACGGG 
D65A 5’ GAGTGGAAGTTTGCCCAAGGAGACACC 5’ GGTGTCTCCTTGGGCAAACTTCCACTC 
T70A 5’ CAAGGAGACACCGCCAGACTCGTTTG  5’ CAAACGAGTCTGGCGGTGTCTCCTTG 
L72A 5’ CAAGGAGACACCACCAGAGCCGTTTGC 
TATAATAACAAG 
5’ CTTGTTATTATAGCAAACGGCTCTGGT 
GGTGTCTCCTTG 
Y75A 5’CCACCAGACTCGTTTGCGCCAATAACA 
AGATCACAGCTTCC 
5’ GGAAGCTGTGATCTTGTTATTGGCGCA 
AACGAGTCTGGTGG 
N76A 5’ CCAGACTCGTTTGCTATGCCAACAAGA 
TCACAGCTTC 
5’ GAAGCTGTGATCTTGTTGGCATAGCAA 
ACGAGTCTGG 
T106A 5’ CGGGAAGACACTGGGGCGTACACTTG 
TATGGTC 
5’ GACCATACAAGTGTACGCCCCAGTGTC 
TTCCCG 
T108A 5’ GACACTGGGACATACGCGTGTATGGTC 
TCTGAGG 
CCTCAGAGACCATACACGCGTATGTCCCA 
GTGTC 
M110A 5’ GGACATACACTTGTGCGGTCTCTGAGG 
AAGG 
5’ CCTTCCTCAGAGACCGCACAAGTGTAT 
GTCC 
S112A 5’ CATACACTTGTATGGTCGCGGAGGAAG 
GCGGCAACAG 
5’ CTGTTGCCGCCTTCCTCCGCGACCATA 
CAAGTGTATG 
E121Ab 5’ CAACAGCTATGGGGCGGTCAAGGTCAAG 5’ CTTGACCTTGACCGCCCCATAGCTGTTG 
K123A 5’ CAACAGCTATGGGGAGGTCGCGGTCA 
AGCTCATCGTGCTTG  
5’ CAAGCACGATGAGCTTGACCGCGACC 
TCCCCATAGCTGTTG 
E61Ab 5’ CTCCCCGTGTGGACTGGAAGTTTGAC 5’ GTCAAACTTCCAGTCCACACGGGGAG  
K63Rb 5’ CGTGTGGAGTGGAGGTTTGACCAAGG  5’ CCTTGGTCAAACCTCCACTCCACACG  
R59A/E61Ab 5’ GCTTTTCTTCTCCCGCTGTGGCGTGGA 
AGTTTG  
5’ CAAACTTCCACGCCACAGCGGGAGAA 
GAAAAGC 
E61A/K63Ab 5’ CGTGTGGCGTGGGCATTTGACCAAGG 
AGACACCAC  
5’ GTGGTGTCTCCTTGGTCAAATGCCCAC 
GCCACACG 
 
a  Primer pairs were used to engineer point mutations in the JAM-A extracellular domain in pGEX 4T-3. 
Underlined nucleotides denote changes from the wild-type sequence.  
b  Primer pairs also were used to engineer point mutations in full-length JAM-A in pcDNA 3.1+.   
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used in GST precipitation assays to identify mutations that ablate σ1 binding.  In these 
experiments, glutathione coated beads were used to capture GST fusion proteins, which 
in turn were used to capture purified σ1H.  As anticipated, σ1H was captured efficiently 
by GST-JAM-A and GST-D1 but not detectably by beads alone, GST, or GST-D2 
(Figure III-3).  The majority of the JAM-A dimer interface point mutants were capable of 
binding σ1H.  However, mutants E61A, K63A, L72A, and N76A were incapable of 
binding σ1H as detected by Coomassie blue staining or immunoblotting, despite similar 
capture of the mutants on the beads (Figure III-3 and data not shown).  Residues Leu72 
and Asn76 are located at the top of the dimer interface in β-strand C’ and the C’C’’ loop, 
respectively (Figure III-2).  Leu72 participates in a hydrophobic interaction with Tyr119 
on an apposing JAM-A monomer.  Residues Glu61 and Lys63 are located in β-strand C 
and participate in salt-bridge interactions that stabilize JAM-A dimers (6, 131).  These 
data suggest that σ1 engages JAM-A via residues at the top of and within the dimer 
interface.  
 
Kinetics of σ1H binding to GST-JAM-A point mutants - To quantitatively assess the 
effects of mutations in the JAM-A dimer interface on interactions with σ1, GST-JAM-A 
point mutants were captured on a biosensor surface and tested for σ1H binding by SPR.  
Based on the kinetics and affinity of the interaction with σ1H, the majority of the JAM-A 
mutants clustered into one of four groups.  The first group (I) includes point mutants that 
display binding kinetics similar to wild-type JAM-A (Figure III-4A and Table III-2).  
Group I includes mutants with alterations of residues Thr70 in β-strand C’ and nearby 
residue Thr106 in β-strand F, which do not contribute to intersubunit interactions at the 
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FIGURE III-3.  Precipitation of σ1H with purified GST-JAM-A point mutants. Glutathione 
agarose was incubated with buffer alone (NP), GST, or GST fused to the JAM-A D1, D2, 
entire extracellular domain (JAM-A), or point mutants shown at 4°C for 1 h. The glutathione 
agarose was pelleted, washed, and incubated with purified T3D σ1H at 4°C for an additional 1 
h. The glutathione agarose was washed, pelleted, resuspended in SDS sample buffer, and 
boiled. Samples were resolved by SDS-PAGE and stained with Coomassie brilliant blue to 
visualize captured proteins. Input T3D σ1H also was resolved following boiling in SDS 
sample buffer. Molecular weights of protein standards in kDa are indicated on the left. 
Proteins are labeled on the right   
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JAM-A dimer interface.  The second group of GST-JAM-A mutants (II) exhibited faster 
association kinetics than wild-type JAM-A by ~ 5-10 fold, resulting in higher calculated 
affinities for σ1 than wild-type JAM-A (Figure III-4B and Table III-2).  Upon injection 
of wash buffer, much of the σ1H was removed from these mutants.  However, 
specifically bound σ1H protein exhibited a similar off-rate to wild-type GST-JAM-A.  
Group II includes mutants T108A, M110A, and E121A.  Thr108, Met110, and Glu121 
are located within the dimer interface in proximity to one another on β-strands F and G 
(Figure III-1C).  Glu121 participates in salt-bridge interactions that stabilize the dimer 
interface.  Met110 participates in hydrophobic interactions with an apposing JAM-A 
monomer.  The third group (III) includes GST-JAM-A mutants R59A, Y75A, and N76A 
(Figure III-4C and Table III-2), which exhibited a faster σ1H on-rate than wild-type 
JAM-A but also a faster off-rate, resulting in affinities similar to wild-type.  The N76A 
mutant exhibited a slower on-rate and a lower level of σ1 binding, relative to the other 
mutants in this group, and binding returned to baseline levels after several minutes of 
wash buffer injection.  This result agrees with results obtained in the GST precipitation 
assay, in which the N76A mutant of JAM-A was incapable of capturing σ1H domain 
(Figure III-3).  Arg59, Tyr75, and Asn76 are located near the “top” of the dimer 
interface, in proximity to residues Glu61, Lys63, and Leu72 (Fig. III-1C).  The final 
group of JAM-A point mutants includes E61A, K63A, and L72A (Figure III-4D), which 
showed very low levels of σ1H binding above background.  Upon injection of wash 
buffer, the binding signal returned to baseline level immediately, indicating that the 
observed binding was not specific for any of the mutants.  I also was unable to find 
suitable binding models for the interaction of these mutants with σ1H using  
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BIAevaluation software (data not shown).  These results are in accord with results 
obtained using GST precipitation assays, in which no σ1H was bound detectably by the 
E61A, K63A, or L72A GST-JAM-A point mutants.  These data reinforce the importance 
of Glu61, Lys63, and Leu72 as mediators of σ1-JAM-A interactions and suggest that 
these residues serve as contact points for the σ1 head.  
 
Oligomeric state of JAM-A point mutants - Since two residues that participate in salt-
bridge interactions at the JAM-A dimer interface are required for efficient σ1 binding, I 
questioned whether mutation of these residues or other residues in the dimer interface 
alters the capacity of JAM-A to form dimers.  To answer this question, the extracellular  
FIGURE III-4.  Binding of σ1H to GST-JAM-A point mutants. Purified σ1H, at a 
concentration of 167 nM, was injected for 5 min across a biosensor surface on which GST-
JAM-A fusion proteins, as indicated, had been captured. Buffer alone was injected for 6.7 
min. The resultant traces show binding to GST-JAM-A and GST-JAM-A point mutants, as 
indicated. The resultant sensograms are grouped based on binding kinetics: (A) kon and koff 
similar to wild-type JAM-A, (B) faster kon than wild-type JAM-A, (C) faster kon and koff than 
wild-type, and (D) no specific binding. The baseline is 167 nM σ1H binding to GST (grey).  
Binding is expressed in resonance units (RU). 
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TABLE III-2.  Kinetics of σ1H binding to GST-JAM-A point mutants a  
Group JAM-A Mutant 
Association 
rate (1/Ms) 
Dissociation 
rate (1/s) 
Dissociation 
constant (M) 
I Wild-type 8.9 x 104 2.5 x 10-4 2.8 x 10-9 
 D1 8.9 x 104 3.1 x 10-4 3.5 x 10-9 
 T70A 7.1 x 104 9.9 x 10-4 1.4 x 10-8 
 T106A 7.8 x 104 4.5 x 10-4 5.8 x 10-9 
     
II T108A 4.1 x 105 6.1 x 10-4 1.5 x 10-9 
 M110A 6.5 x 105 3.5 x 10-4 5.4 x 10-10 
 E121A 5.7 x 105 8.5 x 10-4 1.5 x 10-9 
     
III R59A 3.8 x 105 8.4 x 10-3 2.2 x 10-8 
 Y75A 5.0 x 105 7.0 x 10-3 1.4 x 10-8 
 N76A 7.3 x 104 3.5 x 10-3 4.7 x 10-8 
 
a Association and dissociation rates and dissociation constants were calculated using BIAevaluation 3.0 
software. Mutants are grouped as in Figure III-4. Group IV mutants did not display specific binding.  
 
domains of wild-type JAM-A and selected JAM-A point mutants were released from the 
GST tag by thrombin cleavage and resolved using gel-filtration chromatography.  The 
extracellular domain of wild-type JAM-A eluted as a single peak, with an apparent 
molecular weight of ~ 48 kDa, indicating that it forms a dimer (Table III-3 and data not 
shown) (122).  Likewise, alanine substitutions of Ser112 and Lys123, which do not 
participate in intersubunit contacts, do not alter the apparent oligomeric state of JAM-A 
(Table III-3).  In sharp contrast, JAM-A extracellular domains with alanine substitutions 
of Arg59, Glu61, Lys63, or Glu121, which form salt bridges across the dimer interface, 
or Tyr75, which forms a hydrogen bond with Glu114 from an apposing monomer, eluted 
from the column as a single species with an apparent molecular weight of ~ 30 kDa.  This 
elution peak likely represents solely monomeric JAM-A, with a slightly exaggerated 
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apparent molecular weight due to its elongated shape.  These data indicate that each salt-
bridge pair and Tyr75 individually is required for stability of JAM-A dimers.  
 
TABLE III-3.  Characterization of JAM-A point mutants by gel filtration a   
JAM-A 
Mutant 
Apparent  
MW (kDa) 
Apparent  
Oligomeric State 
σ1 
Binding 
Wild-type 46.1 dimeric + 
R59A 32.5 monomeric + 
E61A 32.5 monomeric - 
K63A 33.8 monomeric - 
Y75A 27.8 monomeric + 
S112A 49.8 dimeric + 
E121A 30.0 monomeric + 
K123A 46.1 dimeric + 
 
a Apparent molecular weights were calculated by graphing Ve-Vo against the log10 MW of protein 
standards, performing linear regression, and back-calculating, based on elution time.   
 
To determine whether σ1 engages monomeric or dimeric forms of the JAM-A 
extracellular domain, we assessed binding of σ1H to the JAM-A extracellular domain in 
solution using gel filtration chromatography.  Incubation of purified wild-type JAM-A 
and σ1H in a 3:1 molar ratio (three JAM-A monomers to one σ1 trimer), results in 
formation of a higher molecular weight complex that contains both JAM-A and σ1H 
(Figure III-5A and data not shown).  Similar findings were made following incubation of 
the extracellular domain of dimeric JAM-A mutant S112A or the monomeric mutant 
E121A with σ1H (Figure III-5).  In both cases, a complex was formed that eluted from 
the size-exclusion column at the same time as the complex observed following incubation 
of wild-type JAM-A with σ1H.  As expected, monomeric JAM-A point mutant E61A 
does not form a detectable complex when incubated with σ1H (Figure III-5D).  Since 
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mutant forms of JAM-A that are incapable of forming dimers retain the capacity to 
interact with σ1H, we conclude that σ1 engages monomeric forms of JAM-A. 
 
Reovirus binding and infectivity of CHO cells expressing mutant forms of JAM-A - In the 
context of a virion, multiple copies of σ1 likely engage JAM-A simultaneously.  Thus, at 
the cell surface, viral avidity might alter the capacity of reoviruses to bind JAM-A or 
FIGURE III-5.  Characterization of σ1H-JAM-A extracellular domain mixtures using gel 
filtration chromatography. Purified T3D σ1H and wild-type JAM-A (A) or JAM-A point 
mutants S112A (B), E121A (C), and E61A (D) were mixed in a 3:1 molar ratio and incubated 
on ice for 40 min. The mixtures (yellow) or individual purified proteins (red and blue) were 
applied to a Superdex 75 gel-filtration column, and proteins in the column fractions were 
detected by A280. Dimeric forms of wild-type JAM-A and S112A elute earlier than monomeric 
forms E121A and E61A. Wild-type JAM-A, S112A, and E121A each form a complex with σ1 
that elutes from the column at approximately the same time, thus with similar apparent 
molecular weight, for each protein mixture.  
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JAM-A mutants.  To assess the capacity of reovirus to bind JAM-A mutants in cell 
culture, I transiently transfected CHO cells, which are poorly permissive for reovirus 
infection (20, 52), with plasmids encoding wild-type (122) or mutant forms of full-length 
JAM-A.  Transfected cells were incubated for 24 h to allow receptor expression and 
adsorbed with reovirus virions.  Surface expression of JAM-A and reovirus binding were 
assessed by flow cytometry (Figure III-6).  Wild-type JAM-A and each of the JAM-A 
mutants were expressed at the surface of transfected cells to approximately equivalent 
levels, providing confidence that the mutant constructs are properly folded.  In agreement 
with previous studies (20, 52), JAM-A is not detectably expressed on the surface of CHO 
cells transfected with empty vector.  Virions of T3SA-, a non-sialic acid-binding reovirus 
strain with a serotype 3 σ1 identical in sequence to T3D in the σ1 head domain (5), 
bound poorly to vector-transfected CHO cells.  However, I observed specific binding to 
CHO cells expressing wild-type JAM-A.  T3SA- binding approximated JAM-A 
expression at the surface of CHO cells expressing the majority of the point mutants.  
However, T3SA- binding to cells expressing the K63A or L72A mutants was diminished, 
and no binding above background was observed to cells expressing the E61A mutant 
form of JAM-A.  These results closely mimic the binding of T3D σ1H to JAM-A mutants 
in the GST precipitation and SPR assays (Figures III-3 and III-4).  Interestingly, mutation 
of Glu61 to aspartate or Lys63 to arginine was not associated with the binding defects 
observed for the E61A and K63A mutants (Figure III-6), indicating that the acidic or 
basic properties of these residues are important for reovirus engagement.   
To compare JAM-A binding determinants for reoviruses of the three serotypes, I 
used flow cytometry to assess binding of virions of strains T1L and T2J to CHO cells 
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FIGURE III-6.  Reovirus T3SA- binding to CHO cells expressing JAM-A mutants. CHO cells 
(106) were transiently transfected with plasmids encoding the indicated receptor constructs. 
Following incubation for 24 h to permit receptor expression, cells were lifted from plates 
using EDTA and stained with hJAM-A-specific mAb J10.4 or adsorbed with reovirus T3SA- 
(105 particles/cell). Cell-surface expression of receptor constructs and virus binding was 
assessed by flow cytometry. 
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expressing wild-type and mutant forms of JAM-A.  Similar to T3SA-, each virus bound 
poorly to vector-transfected cells, whereas T1L and T2J binding to cells expressing wild-
type JAM-A approximated levels of JAM-A expression (Figure III-7).  Interestingly, 
more events were observed for T1L and T2J binding to CHO cells expressing JAM-A 
than for T3SA-, although the same number of reovirus particles was used in each case.  In 
contrast to T3SA-, T1L and T2J bound equivalently to CHO cells expressing wild-type 
and mutant forms of JAM-A (data not shown).  To determine whether T1L and T2J might 
share similar binding determinants with T3D and T3SA- but with less stringency, I 
constructed double point mutants R59A/E61A and E61A/K63A.  As anticipated, T3SA- 
showed no specific binding to CHO cells expressing either of the JAM-A double point 
mutants (Figure III-7).  Although not with the same magnitude as T3SA-, both T1L and 
T2J showed diminished binding to CHO cells expressing the double point mutants, with 
T1L exhibiting highly impaired binding to CHO cells expressing the R59A/E61A JAM-A 
mutant.  
To assess the functional significance of mutations in JAM-A that alter reovirus 
binding, I quantified infectivity of T1L, T2J, and T3SA- following adsorption to CHO 
cells expressing full-length wild-type or mutant forms of JAM-A by indirect 
immunofluorescence (5).  Infectivity of T3SA- was significantly decreased (~ 50%) 
following infection of CHO cells expressing the E61A and K63A mutants in comparison 
to cells expressing wild-type JAM-A (Figure III-8).  Consistent with the flow cytometry 
experiments, conservation of charge at residues Glu61 and Lys63 by substituting 
aspartate and arginine, respectively, rescued the infectivity defect.  T3SA- infectivity was 
decreased almost to the level of background following adsorption to CHO cells 
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FIGURE III-7.  Reovirus T1L, T2J, and T3SA- binding to CHO cells expressing JAM-A 
mutants.  CHO cells (106) were transiently transfected with plasmids encoding the indicated 
receptor constructs. Following incubation for 24 h to permit receptor expression, cells were 
lifted from plates using EDTA and stained with hJAM-A-specific mAb J10.4 or adsorbed with 
reovirus T1L, T2J, or T3SA- (105 particles/cell). Cell-surface expression of receptor 
constructs and virus binding was assessed by flow cytometry. 
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FIGURE III-8.  Reovirus infection of CHO cells expressing JAM-A mutants. CHO cells (2 x 
105) were transiently transfected with empty vector (pcDNA) or plasmids encoding wild-type 
or mutant forms of JAM-A. Following incubation for 24 h to permit receptor expression, cells 
were adsorbed with reovirus at a multiplicity of infection of (A) 1 (T1L), (B) 5 (T2J), or (C) 
10 (T3SA-) pfu/cell at room temperature for 1 h. Cells were washed with PBS, incubated in 
complete medium at 37°C for 20 h, and stained for reovirus antigen. Infected cells were 
identified by indirect immunofluorescence and quantified by counting cells exhibiting 
cytoplasmic staining in three confluent fields of view per experiment. The results are 
expressed as the mean fluorescent focus units (FFU) per field of view for triplicate 
experiments.  Error bars indicate S. D. *, P < 0.05 in comparison to cells expressing wild-type 
JAM-A.  
 62 
expressing the double point mutants R59A/E61A and E61A/K63A.  As predicted by the 
binding results, T1L also showed a striking loss of infectivity in cells expressing the 
R59A/E61A JAM-A mutant and a slight decrease in infectivity in cells expressing the 
K63A or E61A/K63A mutant.  T2J showed only a very modest decrease in infectivity, 
less than 25%, in CHO cells expressing the R59A mutant or either of the double point 
mutants, in accordance with the flow cytometry results.  Taken together, these data 
confirm results obtained from binding assays using the T3D σ1 head domain and suggest 
that T1L, T2J, and T3SA- engage JAM-A using different residues or at distinct sites.  
 
Reovirus virions binding to GST-JAM-A point mutants - The tethering of reovirus to the 
CHO cell surface might involve interactions with molecules other than JAM-A, such as 
carbohydrates or integrins.  To assess interactions of virions of the three reovirus 
serotypes with JAM-A in a more simplified system, I captured GST-JAM-A or select 
GST-JAM-A salt-bridge mutants on a biosensor surface and measured the binding of 
purified T1L, T2J, and T3SA- virions using SPR.  Virions of all three serotypes 
demonstrated specific binding to JAM-A but not GST (Figure III-9 and data not shown), 
with T1L and T2J showing greater maximal binding than T3SA-.  Interestingly, all three 
viruses showed enhanced binding to the E121A mutant in comparison to wild-type JAM-
A (Figure III-9).  While none of the viruses bound the GST-JAM-A E61A or K63A 
mutants, only T2J bound the R59A mutant.  These SPR results were surprising, given 
that neither T1L nor T2J demonstrated impaired binding or infectivity in CHO cells 
expressing any single point mutant of JAM-A and that the T3D σ1 head showed a 
moderate affinity for R59A in multiple assays.  Taken together, these finding suggest that 
 63 
FIGURE III-9.  Binding of reovirus virions to GST-JAM-A point mutants. Purified reovirus 
virions of (A) T1L, (B) T2J, or (C) T3SA-, at a concentration of 5 x 1012/ml, were injected for 
5 min across a biosensor surface on which GST-JAM-A fusion proteins had been captured. 
Buffer alone was injected for 10 min. The resultant traces show binding to GST-JAM-A and 
GST-JAM-A point mutants, as indicated. The baseline is virus binding to GST (grey). Binding 
is expressed in resonance units (RU). 
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serotype 1, 2, and 3 reoviruses engage JAM-A via an overlapping, but not necessarily 
identical, binding site and that interactions with JAM-A are not the sole determinants of 
reovirus binding and infectivity of CHO cells.      
 
Discussion 
T3D σ1H binding determinants in JAM-A - Recognition of cellular receptors by viruses is 
a key determinant of target cell selection and disease pathogenesis in infected host 
organisms.  Reoviruses of different serotypes display distinct tropism and illness 
outcomes in newborn mice.  These viruses bind to several receptors on the target cell 
surface, including sialic acid for serotype 3 reoviruses (40) and JAM-A for all serotypes 
(6).  However, the contributions of individual receptors to end-organ disease are 
incompletely understood.  The goal of experiments performed in this study was to 
identify reovirus binding determinants in JAM-A.  Using a combination of GST 
precipitation, SPR, gel filtration, flow cytometry, and fluorescent focus assays, I 
identified three residues in JAM-A that are strictly required and three additional residues 
that contribute to serotype 3 reovirus binding and infectivity.  These residues are located 
at the top of and within the JAM-A dimer interface in β-strands C, C’, and the C’- C” 
loop, suggesting that reovirus attachment protein σ1 engages monomeric forms of JAM-
A.  
I generated alanine substitutions of residues with solvent-exposed side chains in 
the JAM-A dimer interface in the context of a GST-JAM-A fusion protein.  Analysis of 
the point mutants using GST precipitation assays led to the identification of Glu61, 
Lys63, Leu72, and Asn76 that individually are required for efficient binding of  T3D 
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σ1H.  Glu61 and Lys63 have charged side chains and participate in salt-bridge contacts 
that stabilize the JAM-A dimer interface.  Leu72 and Asn76 are located in proximity to 
Glu61 and Lys63, and Leu72 participates in hydrophobic interactions with Tyr119 from 
an apposing JAM-A monomer.  SPR findings were concordant with GST precipitation 
results and indicate that mutation of specific residues in the JAM-A dimer interface can 
enhance or diminish the rate of association and dissociation of T3D σ1H.  Specifically, 
M110A, T108A, and E121A mutations enhanced association of σ1, leading to higher 
calculated binding affinities in comparison to wild-type JAM-A.  On the other hand, 
R59A and Y75A displayed faster association with σ1H, but also faster dissociation, 
resulting in an affinity similar to wild-type.  Charged residues required for JAM-A-σ1 
interactions in biochemical assays, Glu61 and Lys63, also are required for the binding of 
intact serotype 3 reovirus virions to JAM-A in cultured cells and on a biosensor surface.  
 
Model of reovirus-JAM-A interactions - Gel filtration chromatography of purified, mutant 
JAM-A extracellular domains revealed that mutation to alanine of any residue in the 
JAM-A dimer interface that contributes to salt-bridge interactions as well as one residue, 
Tyr75, which makes a hydrogen-bond contact with Glu114, abolishes the capacity of 
JAM-A to form dimers in solution at neutral pH.  These data indicate that each salt-
bridge interaction and the Tyr75-Glu114 hydrogen-bond interaction are essential 
mediators of JAM-A dimer formation.  Both monomeric and dimeric point mutants of 
JAM-A are capable of binding σ1H, suggesting that a monomeric form of JAM-A is the 
relevant σ1 binding partner.  Based on elution profiles, it is formally possible that the σ1-
JAM-A complex contains dimeric JAM-A and monomeric σ1.  However, we think it 
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unlikely that dimeric JAM-A is in the complexes, since the monomeric E121A mutant of 
JAM-A forms complexes with σ1 that are indistinguishable by gel filtration from wild-
type complexes.  It also is unlikely that monomeric σ1 interacts with JAM-A, given that a 
σ1 point mutant that is incapable of trimer formation, σ1H-Y313A, is incapable of JAM-
A binding (131). 
Our data support a model of reovirus-JAM-A interactions in which the T3D σ1 
head domain interacts with residues near the top of the dimer interface, such as Arg59, 
Tyr75, and Asn76, followed by higher-affinity interactions with residues within the dimer 
interface of JAM-A monomers, primarily Glu61 and Lys63 in β-strand C and Leu72 in β-
strand C’ (Figure III-10).  In this model, σ1 is anticipated to bind with high affinity only 
to JAM-A monomers.  How might σ1 access monomeric forms of JAM-A? Comparisons 
of the hJAM-A and murine (m)JAM-A crystal structures suggest that small movements 
of one JAM-A monomer with respect to the apposing monomer occur in a physiologic 
context (122).  Such movements might provide σ1 the opportunity to interact with 
residues closer to the solvent-exposed regions of the JAM-A dimer interface, such as 
Arg59, Tyr75, and Asn76, as the dimer shifts slightly to a more open conformation.  This 
interaction could potentially orient σ1 to access the dimer interface, where interactions 
that lead to high-affinity binding occur.  In support of this model, mutation of Arg59, 
Tyr75, or Asn76 to alanine leads to reduced levels of binding and faster association and 
dissociation kinetics between JAM-A and the σ1H, whereas mutation of Glu61, Lys63, 
or Leu72 to alanine ablates binding altogether.   
It is possible that the variably impaired binding observed for mutants with 
alterations of residues Arg59, Tyr75, or Asn76 is simply a result of the proximity of these 
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amino acids to critical contact residues Glu61, Lys63, and Leu72.  However, mutation of 
residues Thr108, Met110, and Glu121, which also are located in proximity to the 
proposed high-affinity contact residues, leads to faster association without diminishment 
of dissociation, resulting in overall higher affinity of σ1 for JAM-A.  Mutation of Arg59, 
Tyr75, or Glu121 disrupts dimer formation.  Based on these data, I predict that mutation 
of Thr108 or Met110 also would alter JAM-A dimer contacts to some degree, permitting 
σ1 to access the dimer interface more quickly.  Faster access to the dimer interface might 
explain the enhanced σ1H association rates observed for all JAM-A mutants of residues 
with side chains proximal to required residues Glu61, Lys63, and Leu72.  However, 
enhanced access to the dimer interface fails to explain the faster σ1H off-rate observed 
with the R59A, Y75A, and N76A mutants.  Rather, the enhanced dissociation kinetics 
FIGURE III-10.  Predicted serotype 3 binding region in JAM-A. View of the JAM-A D1 
domain dimer. One monomer is oriented as in Figure III-1C and is shown as a space-filling 
representation. The apposing monomer is shown as a red ribbon drawing. Residues Glu61, 
Lys63, and Leu72 (dark green) are required for efficient serotype 3 reovirus engagement of 
JAM-A and are proposed to serve as critical contacts for T3D σ1. Residues Arg59, Tyr75, and 
Asn76 (light green) are proposed to serve as additional contacts.   
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observed for these mutants suggest a more direct, role in reovirus binding for Arg59, 
Tyr75, and Asn76.  The incapacity of T3SA- virions to bind the R59A mutant lends 
further support to the contention that Arg59 serves as a direct contact point for serotype 3 
σ1.     
   
Reovirus specificity among JAM family members - It is noteworthy that the four salt-
bridge-forming residues in the JAM-A dimer interface, Arg59, Glu61, Lys63, and 
Glu121, are conserved among mJAM-A and hJAM-A, hJAM-B, and hJAM-C.  However, 
of these proteins, only hJAM-A and mJAM-A mediate reovirus infection of non-
permissive cells (6, 20).  This observation suggests that charged residues Glu61 and 
Lys63 are necessary, but not sufficient, for efficient serotype 3 reovirus binding.  The 
molecular context of these residues also must contribute to efficient σ1 binding.  In 
support of this idea, Leu72 and Asn76 are conserved between mJAM-A and hJAM-A but 
not hJAM-B and hJAM-C.   
 
Serotype-specific differences - Our binding and infectivity data from CHO cells 
transfected with JAM-A mutants and SPR data using virions highlight differences in 
attachment among the reovirus serotypes.  All of the viruses exhibited enhanced binding 
to the E121A mutant in comparison to wild-type JAM-A, likely because Glu121 lies 
outside of the binding site for all of the viruses and its mutation enhances access to the 
dimer interface by ablating dimer formation.  In SPR studies of T1L and T3SA-, residues 
Arg59, Glu61, and Lys63 individually are required for reovirus binding.  Thus, it appears 
that T1L utilizes a binding site that is similar to the serotype 3 binding site.  However, for 
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JAM-A expressed on CHO cells, a requirement for residues Arg59 and Glu61 for 
efficient T1L binding and infectivity is apparent only when both residues are mutated 
simultaneously, while a small infectivity diminishment is observed when Lys63 is 
altered.  In contrast, binding and infectivity of JAM-A-expressing CHO cells by reovirus 
strain T3SA- individually requires residues Glu61 or Lys63, with some additional 
contribution from Arg59.  Based on results from studies using CHO cells expressing 
JAM-A mutants, it does not appear that T2J shares contact points with serotype 1 or 3 
reoviruses.  T2J shows a slight decrease in binding to CHO cells transfected with JAM-A 
double point mutants R59A/E61A and E61A/K63A, but infectivity was not significantly 
diminished in these cells.  Yet in SPR experiments, T2J virions demonstrated a clear 
requirement for Glu61 and Lys63, but not Arg59, suggesting that the serotype 2 binding 
site in JAM-A overlaps, but is not identical, with the serotype 1 and 3 binding sites.  
These findings constitute the first evidence that different serotypes of reovirus engage 
JAM-A via different contact residues.   
Why are individual point mutations sufficient to render virions of all serotypes 
incapable of binding to JAM-A on a biosensor surface but not to strongly affect 
interactions of T1L and T2J with JAM-A at the surface of a CHO cell?  I envision three 
potential contributing factors.  First, interactions with molecules other than JAM-A on 
CHO cells might mask JAM-A binding deficiencies.  Reoviruses, including T1L and T2J, 
are capable of agglutinating human erythrocytes (88), suggesting that they bind 
carbohydrates.  While T3SA- σ1 encodes a polymorphism that ablates sialic acid binding, 
T1L and T2J retain native carbohydrate-binding capacity.  Since reoviruses employ an 
adhesion-strengthening mechanism of cell attachment (5), initial engagement of 
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carbohydrate prior to adhering tightly to JAM-A may confer an attachment advantage to 
T1L and T2J over T3SA-.  Carbohydrate binding could tether T1L and T2J virions to the 
CHO cell surface, enabling them to diffuse laterally to bind JAM-A or JAM-A point 
mutants and integrins.  If a single point mutation in JAM-A only modestly diminished the 
binding affinity of σ1, which would be expected if the binding surface is sufficiently 
large, then avidity effects might still permit stable cell attachment.  However, in the case 
of T3SA-, the virus would not be tethered to the cell and therefore must have a high 
affinity for JAM-A to achieve stable cell attachment.  Thus, engagement of carbohydrates 
or other unidentified low-affinity receptors on the CHO cell surface might mask defects 
in reovirus-JAM-A interactions in binding and infectivity studies.  Second, binding 
defects may be exaggerated in SPR experiments, in which conditions at the biosensor 
surface may diminish avidity effects.  For example, the rigidity of the surface may 
prevent virions from simultaneously engaging as many JAM-A molecules as might be 
bound in the fluid membrane of a CHO cell.  Furthermore, for my experiments, JAM-A 
was captured on the biosensor surface via an N-terminal GST tag.  The physical 
positioning of the D1 domain between an N-terminal GST tag and the C-terminal D2 
domain might sterically hinder virus access to the binding surface, thereby diminishing 
virus binding to JAM-A on the biosensor chip versus properly-oriented, untagged JAM-A 
molecules expressed on CHO cells.  Third, serotype 1 and 2 σ1 might bind to JAM-A 
with higher affinity than serotype 3 σ1.  This idea is supported by my SPR data with 
virions, in which additional receptors play no role, yet binding to JAM-A by T1L and T2J 
is enhanced in comparison to T3SA-.  On the CHO cell surface, enhanced avidity for 
JAM-A might compensate for individual point mutations, leading to smaller changes in 
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binding and infectivity in our assays.  Of note, differences in affinity for the primary 
cellular receptor α-dystroglycan have been shown to mediate strain-specific differences 
in tropism for lymphocytic choriomeningitis virus (135).  It is possible that a similar 
mechanism plays a role in serotype-dependent differences in reovirus pathogenesis.  
In this study, I identified reovirus binding determinants in the most membrane-
distal Ig-like domain of JAM-A and provided evidence that σ1 engages monomeric forms 
of JAM-A.  I also provided the first evidence that reoviruses of different serotypes 
engage JAM-A via non-identical binding sites or with different affinities.  Thus, although 
all serotypes of reovirus can utilize JAM-A as a receptor, JAM-A binding may still 
contribute to differential pathogenesis outcomes in vivo among the serotypes.  This work 
has established a foundation for future studies aimed at understanding the roles of 
reovirus-receptor interactions in pathogenesis.  
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CHAPTER IV 
 
CRYSTAL STRUCTURE OF THE HEAD DOMAIN OF MAMMALIAN REOVIRUS 
σ1 BOUND TO JUNCTIONAL ADHESION MOLECULE-A 
 
Introduction 
Our studies have indicated that the D1 domain of JAM-A is both necessary and 
sufficient to mediate interactions with reovirus (52, 65) and identified residues in the 
surface of JAM-A D1 that mediates dimer formation required for these interactions (52, 
65, 122).  However, the precise nature of σ1-JAM-A interactions and the mechanism by 
which σ1 gains access to this surface are unknown.  To define the structural basis of σ1-
JAM-A interactions, we crystallized a complex of the head domain of T3D σ1 and the D1 
Ig-like domain of human JAM-A and determined its structure at 3.2 Å resolution.  We 
used plasmid-based reverse genetics to engineer reoviruses expressing mutant forms of 
σ1 to determine the contributions of specific residues that contact JAM-A.  These studies 
reveal the biochemical basis of σ1-JAM-A interactions and provide clues about how σ1 
successfully engages the JAM-A dimer interface. 
This study was peformed in collaboration with Eva Kirchner in Dr. Thilo Stehle’s 
laboratory (Universitat Tübingen).  I would like to acknowledge Eva for the purification 
and crystallization of complexes between the reovirus σ1 head and the JAM-A D1 
domain and cryopreservation of the crystals.  I assisted Eva in the collection of 
diffraction data and the earliest stages of structure determination.  Eva completed the 
structure determination and refinement steps, performed gel filtration experiments, and 
prepared the figures showing structures of σ1 and JAM-A presented in this chapter.  I 
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generated, purified, and characterized all reoviruses containing mutations in the JAM-A 
binding region of σ1 using assays of viral binding, including SPR and flow cytometry, 
and infectivity, including time courses of infection and plaque assays.  
   
Results 
Complex formation and crystallization – The T3D σ1 head domain (σ1H; residues 293-
455) and the D1 domain of human JAM-A (D1; residues 28-129) were purified using 
GST-affinity purification (65, 131).  In each case, domain boundaries were chosen to 
eliminate regions of known flexibility (30, 122) and retain binding capacity (65, 122, 
131).  After removal of GST, the sequence of each protein was identical to the native 
sequence with the exception of two amino acids at the N-terminus: Gly291 and Ser292 
for σ1H and Gly26 and Ser27 for D1.  None of these amino acids contribute to complex 
formation.  As gel filtration studies indicated that one σ1H trimer binds up to three D1 
monomers (data not shown), purified proteins were mixed with an excess of D1.  
Following incubation, σ1H-D1 complexes were separated from excess D1 by gel 
filtration. 
During screening and optimization of crystallization conditions, only a single 
crystal form was obtained.  SDS-PAGE analysis indicated that the crystals contained both 
σ1H and D1 (data not shown).  Diffraction data were collected at the Swiss Light Source 
(Villigen, Switzerland) using several crystals.  The structure was determined by 
molecular replacement using the previously determined structures of σ1H (131) and the 
D1 domain of JAM-A (122) and refined to 3.2 Å resolution (Table IV-1).  Two residues 
of σ1H, Asp345 and His388, are found in the generously allowed and disallowed regions 
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of the Ramachandran plot, respectively.  Both residues have similar conformations in the 
high-resolution crystal structure of unliganded σ1H (131).  The crystallographic 
asymmetric unit consists of two σ1H trimers, each bound to three D1 monomers. The 
presence of six independent copies enabled us to carry out non-crystallographic 
averaging and refinement using non-crystallographic symmetry restraints, both of which 
helped to establish a high-quality model. 
 
TABLE IV-1.  Data collection and refinement statistics for the σ1H-JAM-A complex 
 
 
Diffraction dataa 
 
Space group P21212 
Unit cell dimensions (Å) a = 105.7, b = 123.8, c = 131.0 
Resolution range (Å)  30 - 3.2 
Completeness (%) 85.4 (59.4) 
Total reflections 84,231 
Unique reflections 24,856 
Redundancy 3.4 (1.6) 
Rmerge (%)b 16.5 (21.0) 
I/σI 5.6 (1.7) 
 
Refinement statistics 
 
Rcryst (%); work setc 23.0 (32.9) 
Rcryst (%); test setc 26.7 (34.9) 
Overall B-factor (Å2) 62.7 
Root mean square deviation, bond lengths (Å) 0.011 
Root mean square deviation, bond angles (°) 1.560 
Ramachandran plot:d  
   Most favorable regions (%) 80.8 
   Additional allowed regions (%) 18.3 
   Generously allowed regions (%) 0.5 
   Disallowed regions (%) 0.5 
 
a Data were collected at 100 K and a wavelength of 0.92 Å. Values in parentheses refer to the outermost 
resolution shell (3.20-3.31 Å). 
b Rmerge = ∑hkl |I-<I>|/∑hkl I, where I is the intensity of a reflection hkl, and <I> the average over symmetry-
related observations of hkl. 
c Rcryst = ∑hkl |Fobs – Fcalc|/∑hkl Fobs,where Fobs and Fcalc are observed and calculated structure factors, 
respectively. Free set (17) contains 10% of the data. 
d Calculated with PROCHECK (83).  
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Overall structure of the complex - The complex consists of a σ1H trimer ligated by three 
D1 domains.  When viewed along the three-fold non-crystallographic symmetry axis, its 
overall structure resembles a three-bladed propeller, with σ1H forming the hub and D1 
forming the blades (Figure IV-1A).  Each D1 monomer interacts with one σ1H monomer, 
making extensive contacts that shield a combined area of 1622 Å2 from solvent.  Crystal 
packing results in additional contacts between the molecules.  However, the interactions 
we describe are common to all σ1H-D1 pairs.  D1 residues involved in contact formation 
are located at the most membrane-distal part (top) of the domain and on the face of JAM-
A that mediates homodimer formation.  These regions in D1 pack tightly into a recessed 
region of σ1H just below the β-barrel (Figure IV-1B, C).  Residues at the D1 dimer 
interface form extensive contacts with the D-E loop and 310 helix of σ1H at the upper 
boundary of this recessed region, whereas the top of D1 contacts residues in the C-
terminal β-spiral repeat of the σ1 tail at the lower boundary of the recessed region.  In 
comparison to structures of isolated σ1 (30, 131) and JAM-A (122), the architectures of 
both σ1H and D1 in the complex are largely preserved.  Differences are observed 
primarily in side-chain orientations at the interfaces between σ1H and D1. 
Four of the six σ1H-D1 pairs present in the asymmetric unit have similar 
structures and feature identical interactions.  The analysis of the complex presented here 
is based on these pairs.  The remaining two σ1H-D1 pairs exhibit larger intermolecular 
distances of up to 1.2 Å, resulting in fewer contacts and higher crystallographic 
temperature factors.  Moreover, the total buried surface areas for these two interacting 
pairs are about 60 Å2 smaller.  The crystal packing is extremely tight for a protein 
complex of this size, with only 50% solvent content (99).  The only gaps in the packing 
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occur directly beneath those D1 chains that exhibit larger intermolecular distances to σ1.  
Flash-cooling of crystals prior to data collection, as was done here, may have partially 
dislodged D1 from its binding site (125). 
 
Interaction of reovirus σ1H with JAM-A D1 - Reovirus σ1H latches onto JAM-A D1 
using two main contact areas: a larger region centered at the D-E loop and its 310 helix, 
just below the β-barrel, and a second, smaller region formed by the top of the β-spiral and 
FIGURE IV-1.  Structure of the σ1H-D1 complex. (A, B) Ribbon drawings of the complex 
between trimeric σ1Η and monomeric D1, viewed along the three-fold symmetry axis (A) and 
from the side (B). σ1Η monomers are shown in blue, yellow, and red; D1 is shown in green. 
(C) Surface representation of the contact area of reovirus σ1Η (left, orange) and D1 (right, 
green). Interacting partners are shown as ribbon traces. (D) Ribbon drawings of D1 (left) and 
σ1Η (right). Secondary structure elements are labeled. Contact residues (distance cutoff 4 Å) 
in the σ1H-D1 interface are colored green (D1) or orange (σ1H). 
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the α-helix (Figure IV-1D).  These two regions resemble “jaws” that engage the D1 
domain at its interdomain interface and at its top (Figure IV-2A).  Although exact 
placement of individual atoms is not possible at 3.2 Å resolution, there is unambiguous 
electron density in a composite annealed omit map for all side chains in the interface 
(data not shown), allowing for assignment of contacts. 
The upper, larger σ1H jaw contacts the D1 interdomain interface.  Contacts are 
largely of a polar nature, featuring numerous hydrogen bonds and two salt bridges.  These 
interactions are centered around the σ1H 310 helix, in which residues Thr380, Gly381, 
and Asp382 interact with D1 residues Glu61, Asn76, and Arg59, respectively (Figure IV-
2B).  These contacts are augmented by interactions between σ1H D-E loop residues 
Val371 and Glu384 and D1 residues Asn76, Lys78, and Lys63, and by contacts between 
Asp423 in the F-G loop of σ1H and main-chain nitrogen atom of Ala81 in D1 (Figure 
IV-2C).  In addition to these polar interactions, D1 residues Leu72 and Tyr75 are 
engaged in extensive hydrophobic contacts with D-E loop residues and the terminal part 
of β-strand F in σ1H (Figure IV-2C).  Of note, my previous point mutagenesis study 
(Chapter III) showed that D1 residues Arg59, Glu61, Lys63, Leu72, Tyr75, and Asn76 
contribute to σ1 binding (65).  An interesting characteristic of the contacts involving the 
D1 interface is that most of the residues engaged in interactions with σ1H form contacts 
of a similar nature in the D1-D1 homodimer.  For example, D1 residue Arg59 forms a 
salt bridge with Asp382 in the complex and a salt bridge with D1 residue Glu61 in the 
D1-D1 dimer.  Similarly, Leu72 and Tyr75, which mediate hydrophobic contacts in the 
complex, also do so in the D1-D1 dimer. 
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FIGURE IV-2.  Contacts at the σ1H-D1 interface. (A) Overview displaying the location of 
residues in the σ1H-D1 complex shown in panels B-D. D1 and σ1Η are colored green and 
orange, respectively. (B) Interactions between D1 and residues in the 310 helix in the D-E loop 
of σ1H. Secondary-structure elements are depicted in lighter shading. (C) Additional 
interactions between D1 and σ1Η in the same region. The view is rotated laterally 180° 
relative to panel B. (D) Interactions at the F-G and B-C loops of D1 with σ1H. (B-D) Carbon 
atoms are shown in green (D1) or orange (σ1H), oxygen atoms in red, and nitrogen atoms in 
blue. Dotted lines represent hydrogen bonds and salt bridges. For clarity, some non-interacting 
residues are not shown. Amino acids are labeled in single-letter code. 
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Contacts mediated by the lower, smaller jaw of σ1H lack hydrogen bonds and salt 
bridges.  Instead, extensive hydrophobic interactions with substantial surface 
complementarity are found, indicating that this contact area also plays an important role 
in defining specificity and providing high affinity.  In σ1H, interactions involve β-spiral 
residue Tyr298, a mostly hydrophobic surface of the α-helix connecting the β-spiral with 
the β-barrel, the non-polar portion of the Arg316 side chain, and Pro377 in the D-E loop 
(Figure IV-2D).  These residues essentially surround the D1 F-G loop, which contains 
several partially hydrophobic residues.  The nearby B-C loop of D1 also faces towards 
the σ1H β-spiral.  Its closest contact, at about 4.7 Å, is between the hydroxyl group of D1 
residue Ser57 and the hydrophobic portion of Arg297 in σ1H.  Ser57 also has been 
implicated in σ1 binding (52). 
 
Rescue of reoviruses with engineered mutations in σ1 - To identify contributions of 
individual residues in σ1 to JAM-A engagement, I employed plasmid-based reverse 
genetics (78) to engineer mutations into the σ1 protein of T3D.  Mutant viruses were 
isolated following cotransfection of murine L cells with nine RNA-encoding plasmids 
corresponding to wild-type T3D genes and a tenth plasmid corresponding to the σ1-
encoding S1 gene incorporating site-specific mutations.  Thus, each resultant virus is 
isogenic, with the exception of the S1 gene and its protein product, viral attachment 
protein σ1.  Guided by the structure of the σ1H-D1 complex, I engineered individual 
substitution mutations in several residues in the JAM-A-binding region of σ1, including 
Asn369, Val371, Thr380, Gly381, Asp382, and Glu384 in the D-E loop and Trp421 and 
Asp 423 in β-strand F and the F-G loop.  Although the efficiency of rescue varied, all of 
 80 
the mutant viruses were recovered, with the exception of D382A and W421V (Table IV-
2).  However, upon cotransfection of a plasmid encoding wild-type σ1, I was able to 
rescue W421V by pseudotyping for the first round of replication. Although a D382A 
mutant virus was not recovered, a T380A/D382A double-point mutant was isolated.  
However, this virus reverted to the parental sequence at position 382, as indicated by an 
equal nucleotide signal for both Asp and Ala codons in RNA extracted from purified 
virions (data not shown).  With the exception of V371A and W421V, each of the mutant 
viruses produced sufficiently high titers to permit viral purification.  For the purified 
wild-type and mutant viruses, I employed plaque assays to determine particle to plaque-
forming unit (pfu) ratios using L cells (Figure IV-3).  Alanine substitutions at positions 
T380 and G381 increased the particle to pfu ratio by approximately three-fold and two-
fold over wild-type, respectively, suggesting that residues Thr380 and Gly381 play a role 
in the efficiency of viral infectivity, possibly because of the importance of their 
interactions with JAM-A. The most inefficient mutant reovirus was the T380/D382A 
double point mutant, with a particle to pfu ratio that was nearly seven-fold greater than 
the parental virus, despite some portion of the viral population already having reverted to 
the parental sequence at position 382. 
 
Contribution of individual σ1 residues to JAM-A engagement - To determine the JAM-A-
binding capacity of the sequence-verified mutant viruses, I captured GST alone or GST-
JAM-A on a biosensor chip and employed SPR to assess viral binding (65).  Purified 
reovirus particles (5 × 1012/ml) were injected across the biosensor surface, and 
association and dissociation with GST-JAM-A were measured over time.  In each case,  
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TABLE IV-2.  Engineered mutant reoviruses  
 
Virus name Location of σ1 mutation 
Interaction of residue with 
JAM-A  Rescue titer
a 
WT --- --- ~ 3 x 105 pfu/ml 
N369A Terminus of β-strand D --- ~ 2 x 104 pfu/ml 
V371A D-E loop H-bond with K63 ~ 3 x 103 pfu/ml 
T380A 310 helix in D-E loop H-bond with E61 ~ 1 x 105 pfu/ml 
G381A 310 helix in D-E loop H-bonds with E61 and N76 ~ 3 x 104 pfu/ml 
D382A 310 helix in D-E loop Salt bridge with R59 
Unable to rescue after 
five attempts 
E384A D-E loop H-bond with N76, salt-bridge with K78 ~ 5 x 10
2 pfu/ml 
W421V Terminus of β-strand F Hydrophobic packing against Y75 and L72 ~ 40 pfu/ml 
D423A F-G loop H-bond with A81 ~ 5 x 105 pfu/ml 
T380A/D382A 310 helix in D-E loop 
H-bond with E61, salt-
bridge with R59 ~ 20 pfu/ml 
 
a Rescue titer is the viral titer assessed using L cell monolayers 6 d post-transfection.  
 
an immediate association of reovirus particles with GST was detected (Figure IV-4).  
However, the particles dissociated immediately upon injection of wash buffer, indicating 
that the interaction was not specific.  In the case of the wild-type virus and several of the 
mutants, association with GST-JAM-A exceeded the background levels of binding to 
GST, indicating a specific binding interaction.  Like the wild-type strain, N369A, 
D423A, and E384A bound specifically to GST-JAM-A.  N369A and D423A exhibited 
slightly lower maximal binding signals, whereas E384A displayed enhanced binding to 
GST-JAM-A.  In sharp contrast, T380A and G381A showed no specific binding to GST-
JAM-A, suggesting that Thr380 and Gly381 contribute importantly to the interaction with 
JAM-A.  These results are in accord with the larger particle to pfu ratios exhibited by 
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FIGURE IV-3.  Particle to plaque forming unit ratios for reovirus mutants. (A) Particle 
numbers of purified wild-type and mutant reoviruses, determined in triplicate using a 
conversion factor of 1 OD260 = 2.1 x 1012 particles/ml. Error bars indicate S. D. (B) Titers of 
purified wild type and mutant reoviruses, determined in quadruplicate by plaque assay. Titers 
are graphed on a log10 scale. Error bars indicate S. D. (C) Particle to PFU ratios for wild-type 
and mutant reoviruses. The mean particle number was divided by the mean titer for each 
purified virus to obtain the values shown. WT, wild-type virus.  
 
 83 
these viruses (Figure IV-3).  Thr380 and Gly381 are located in the 310 helix of the σ1 D-
E loop, Asn369 and Glu384 are located in the D-E loop on either side of the 310 helix, 
and Asp423 is located at the terminus of β-strand D (Figure IV-2). 
FIGURE IV-4.  SPR analysis of reovirus mutants binding to JAM-A. Purified reovirus (5 × 
1012 particles/ml) was injected for 5 min across a biosensor surface on which GST fused to the 
JAM-A ectodomain previously had been captured. Following injection of virus, buffer alone 
was injected across the biosensor surface. Traces show binding and dissociation from GST 
(grey) and GST-JAM-A (color or black).  Binding is expressed in resonance units (RU).   
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To determine effects of substitution mutations in the JAM-A-binding region of σ1 
using a more physiologic system, we employed flow cytometry to assess the binding of 
wild-type and mutant viruses to CHO cells transfected with hJAM-A.  Approximately 
100% of CHO cells expressing JAM-A were bound by wild-type virus (Figure IV-5).  
However, both T380A and G381A demonstrated a statistically significant reduction in 
binding to JAM-A-expressing CHO cells, although much less than the reduction in 
FIGURE IV-5.  Flow-cytometric analysis of reovirus binding to cells. CHO cells (106) were 
transiently transfected with plasmids encoding the indicated full-length JAM-A. Following 
incubation for 24 h to permit receptor expression, cells were lifted from plates using EDTA 
and stained with hJAM-A-specific mAb J10.4 or adsorbed with the indicated reovirus (105 
particles/cell). Cell-surface expression of receptor JAM-A and virus binding was assessed by 
flow cytometry. Results are expressed as a ratio of the percentage of cells with bound reovirus 
divided by the percentage of cells expressing JAM-A. WT, wild-type virus. Data were 
collected from three independent experiments. Error bars indicate S. D. *, P < 0.05 in 
comparison to wild-type virus.   
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binding to GST-JAM-A detected by SPR (Figure IV-4). The difference in binding to cells 
versus GST-JAM-A observed for these viruses is likely due to carbohydrate binding and 
increased capacity to engage JAM-A anchored in a membrane rather than immobilized on 
a rigid biosensor surface. 
 
Growth of mutant reoviruses in cultured cells - To test whether differences in JAM-A 
binding capacity displayed by the mutant viruses influence viral yield, I adsorbed L cells 
with the wild-type or mutant viruses at an MOI of 0.01 pfu/cell and quantified viral titer 
following 0, 24, 48, 72, or 96 h of incubation (Figure IV-6).  Infecting at a lower MOI 
enabled me to use the poorly-growing mutant viruses that produced insufficient titer for 
binding analyses.  Based on growth kinetics and peak titers, the mutant viruses clustered 
into three groups.  The first contains E384A and D423A, which exhibited growth kinetics 
and peak titers indistinguishable from wild-type virus.  The second contains N369A, 
T380A, and G381A, which showed slower growth kinetics than wild-type virus, with 
titers approximately 10- to 15-fold lower on day four post-infection.  The third contains 
V371A and W421V, which demonstrated the most severely impaired replication at all 
time points, with yields 100- to 300-fold less than wild-type virus after four days of 
growth.  Thus, targeted mutations in the JAM-A binding surface of σ1 influence viral 
replication kinetics. 
 
Stability of the σ1H-D1 complex - In contrast to many other protein-protein complexes, in 
which the interfaces are hydrophobic in nature (71, 72), interactions between σ1H and 
D1 feature numerous salt bridges and polar interactions.  Moreover, many of the 
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observed interactions involve charged residues.  Three charged σ1H residues (Asp382, 
Glu384, and Asp423) participate directly in polar interactions with D1, and two others 
(Arg297 and Arg316) do so indirectly.  In D1, four direct contacts are mediated by 
charged residues (Arg59, Glu61, Lys63, and Lys78).  As a result, the interacting surfaces 
of both σ1H and D1 display strong electrostatic potentials (Figure IV-7A).  When 
comparing the two, the interacting surface of σ1H has a dominant electronegative 
potential in the upper jaw, whereas the lower jaw is electropositive.  The interacting 
FIGURE IV-6.  Growth of mutant reoviruses in L cells. L cells were adsorbed with virus at 
an MOI of 0.01 PFU/cell. Following incubation at room temperature for 1 h, complete 
medium was added, and cells were incubated at 37°C for 0, 24, 48, 72, or 96 h. Viral titers 
were determined by plaque assay. Data were collected from three independent experiments 
per time point per virus. Error bars indicate S. D. WT, wild-type virus.  
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FIGURE IV-7.  Stability of the σ1H-D1 complex. (A) Electrostatic potential of the surfaces of 
D1 (left) and a single σ1H subunit (right) calculated with APBS tools (89). The scale ranges 
from -3 (red) to +3 (blue) in units of kBT/ec. Boundaries of the contact areas are outlined in 
black. The other two σ1H monomers are shown as yellow ribbons. (B) Gel filtration elution 
profiles of the σ1H-D1 complex using conditions of varied pH. The σ1H, wild-type D1, and 
monomeric D1 E121A proteins were used as controls. At pH 4.5 and 4.0, the A280 of σ1H was 
multiplied by 10 to compensate for the lower concentration due to precipitation. 
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surface of D1 is complementary to that of σ1H, featuring an electropositive potential at 
the dimer interface and a more electronegative potential at the most membrane-distal part 
of the domain. 
The dominance of charge on the interacting surfaces of σ1H and D1 suggests that 
complex formation is at least partially dependent on pH or ionic strength.  To test this 
hypothesis, we used gel filtration chromatography to assess the stability of preformed 
complex following equilibration with buffered solutions of progressively lower pH.  
Purified σ1H, wild-type D1, and monomeric D1 mutant E121A (65) were used as 
controls.  Glu121 in the D1 dimer interface does not participate in complex formation 
with σ1H.  Thus, its alteration affects JAM-A dimerization but not σ1H ligation (65).  In 
accordance with our prediction, the σ1H-D1 complex was stable at pH 5.0 but 
disassembled into its components at pH 4.5 or 4.0, which approximates the pK value for 
acidic side chains (Figure IV-7B).  Similarly, wild-type D1 dissociated under conditions 
of low pH, similar to results obtained in previous studies of the murine JAM-A dimer (9). 
 
Stability of the JAM-A homodimer - The σ1H-D1 complex is readily produced in solution 
by mixing the two components.  Although JAM-A dissociates under high salt or low pH 
conditions (9), we were not able to detect monomeric species of JAM-A in the neutral 
pH, low-salt environment used for complex formation (data not shown).  However, it is 
possible that some monomeric JAM-A is present transiently in these conditions.  If so, σ1 
could trap monomeric JAM-A in a complex, which is a reasonable possibility since σ1-
JAM-A binding occurs with faster kinetics than JAM-A homophilic association in solid-
phase binding assays (52). To test this hypothesis, we incubated dimeric JAM-A D1 and 
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JAM-A D1D2 (the entire extracellular domain of JAM-A) (122) in an equimolar ratio 
and performed gel filtration experiments.  Since D1 and D1D2 dimers have molecular 
weights of 22 and 46 kDa, respectively, they can be distinguished by elution volume.  If 
JAM-A transiently dissociates into monomers, one would expect the formation of a 
dimeric species with one monomer contributed by D1 and the other by D1D2.  Such a 
species should produce a peak with an elution volume between the two observed for the 
D1 and D1D2 dimers.  No such species was observed, even after 60 min incubation, 
indicating that JAM-A does not dissociate into monomers under these conditions (Figure 
IV-8A).  Although not fully separated, the two peaks of the protein mixtures do not 
change between 5 and 60 min of incubation, indicating that the differences compared to 
the unmixed proteins are due to the limits of column resolution. Thus, we conclude that, 
at least in solution, σ1 forcibly displaces a JAM-A monomer to gain access to the JAM-A 
dimer interface. 
 
Discussion 
Implications for σ1-JAM-A complex formation - Reovirus attachment to host cells is 
mediated by interactions between σ1 protein and JAM-A. While some reovirus strains 
utilize additional co-receptors, all strains tested to date engage JAM-A (20).  JAM-A 
exists as a dimer in solution and most likely also at the cell surface, but only a monomer 
is bound by σ1 in our crystal structure.  Since the σ1-JAM-A complex can be produced 
readily in solution by mixing the two components, its formation must be 
thermodynamically favored to that of the JAM-A dimer.  The molecular basis for this 
preference is not obvious on initial inspection of the structure.  In fact, comparison of the 
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FIGURE IV-8.  Comparison of the D1 dimer and the σ1H-D1 complex. (A) Gel filtration 
chromatograms of JAM-A D1 (green), D1D2 (blue), and equimolar mixtures of both proteins 
after 5 (red) and 60 (yellow) min of incubation at 4°C. (B) Surface representations of D1, with 
key amino acids (residues forming hydrogen bonds, salt bridges, or close hydrophobic 
contacts) highlighted in orange (σ1H-D1 complex, left) or green (D1 dimer, right). (C) Ribbon 
drawings of D1, showing stick representations of key contact residue side chains.  Main-chain 
atoms of Ala81 are also depicted in stick representation. Carbon atoms are shown in orange 
(σ1H-D1 complex, left) or green (JAM-A dimer, right), oxygen atoms in red, nitrogen atoms 
in blue, and sulfur atoms in yellow. Amino acids are labeled in single-letter code. 
 
A 
B 
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surfaces buried in the two complexes reveals striking similarities.  Both surfaces are 
almost identical in size, with buried surface area values for one JAM-A molecule of 804 
Å2 and 808 Å2 for JAM-A and σ1, respectively.  Moreover, JAM-A contact surfaces for 
opposing JAM-A monomers and σ1 substantially overlap and share many residues.  
Arg59, Glu61, Lys63, Leu72, and Tyr75 serve as a footprint on β-strands C and C’ that is 
recognized by both JAM-A and σ1 (Figure IV-8B, C).  In both complexes, these residues 
form critical contacts of a similar nature (Figure IV-2 and I-5 [122]).  The JAM-A 
homodimer has additional contacts with residues on β-strands F and G on one side of this 
footprint, whereas σ1 also recognizes residues on the other side, in the adjacent C’-C” 
and C”-E loops. 
Despite these similarities, our gel filtration experiments show that σ1 disrupts the 
JAM-A dimer and engages monomeric JAM-A.  What then leads to formation of σ1-
JAM-A complexes versus JAM-A dimers?  Analysis of the electrostatic potential of the 
interacting surfaces reveals that the JAM-A binding surface of σ1 exhibits a strong 
electronegative potential (Figure IV-7A), which largely covers the loop between β-strand 
D and the 310 helix and the short F-G loop and its adjacent residues.  An accumulation of 
solvent-exposed acidic residues (Asp382, Glu384, Asp390, Glu419, and Asp423) is 
largely responsible for this potential.  In the σ1-JAM-A complex, the negatively-charged 
face of σ1 binds to an electropositive area that is not buried in the D1-D1 dimer interface 
(Figures IV-7A).  Since electrostatic interactions can be established over a larger 
distance, it is likely that the negatively-charged surface of σ1 is first attracted by JAM-A 
and makes the initial contact.  JAM-A dimer stability depends critically on salt bridges 
involving Arg59 (65, 122).  This residue might be reoriented during the initial contact of 
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σ1 with JAM-A to allow interactions with acidic σ1 residues.  This arrangement could 
then lead to destabilization and opening of the JAM-A dimer.  We note that in the σ1-
JAM-A complex, Arg59 forms a salt bridge with σ1 residue Asp382, which protrudes 
from the 310 helix in the D-E loop, at the edge of the negatively-charged face.  The 
Asp382 side chain could easily offer an alternative contact point for Arg59.  Our 
findings, including the central location of Asp382 in the σ1H-D1 binding interface, the 
lack of recovery of a D382A mutant, and reversion of the T380/D382A mutant to the 
wild-type sequence at position 382, reinforce the importance of Asp382 in viral 
attachment.  
The σ1 D-E loop is central in the binding interface, and our results suggest that 
several residues in this region in addition to Asp382 are important for efficient JAM-A 
engagement.  Mutation of either Thr380 or Gly381 to alanine leads to impaired JAM-A 
binding both on a biosensor surface and on CHO cells (Figures IV-4 and IV-5).  
Furthermore, mutation of any of the residues we chose in the σ1 D-E loop result in 
defective viral growth following infection at low MOI (Figure IV-6).  Both findings can 
be easily explained by the structure.  Mutation of Gly381 would directly affect 
interactions with JAM-A, as any side chain at this position would lead to steric clashes 
with D1 residue Tyr75.  Thr380 likely shields hydrophobic interactions from solvent 
(Figure IV-2C), a function abolished by the T380A mutation.  Moreover, the Thr380 side 
chain makes extensive contacts with other σ1H residues (Phe370, Val371, Gly424), 
helping to fasten the 310 helix to the D-E and F-G loops of σ1H.  Truncation of its side 
chain would likely perturb the structural integrity of the 310 helix.  Since this helix 
mediates several contacts to D1 (Figure IV-2B, C), alteration of its structure would 
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diminish JAM-A binding. Changes in local structure also might explain the impaired 
replication kinetics observed for the N369A mutant.  Although Asn369 does not directly 
contact D1, its location at the N-terminus of the D-E loop is strictly conserved among 
reovirus serotypes (20) and may stabilize the 310 helix. 
While complementary electrostatic forces may facilitate engagement of JAM-A 
by σ1, dependence on charge also may mediate σ1 disengagement from JAM-A once the 
virus reaches the low-pH environment of the endosome.  Our data demonstrate that the 
complex dissociates when exposed to pH 4, most likely due to protonation of acidic 
residues at the interface (Figure IV-7B).    
Charged residues are not the sole contributors to σ1-JAM-A interactions.  Val371 
and Trp421 participate in hydrophobic interactions with D1.  As the poor growth of the 
V371A and W421V viruses prohibited direct assessment of JAM-A binding capabilities, 
it was not possible to quantify the contribution of these residues to JAM-A engagement.  
However, altering the opposing residues of JAM-A, Leu72 and Tyr75, abolishes (L72A) 
or diminishes (Y75A) binding to σ1H (65), suggesting an important role for interactions 
at these positions.  Thus, the dramatic effects on viral replication observed for the V371A 
and W421V mutants are likely due to deficiencies in JAM-A binding, although it is 
possible that these mutations diminish JAM-A engagement indirectly by altering σ1 
structure. 
 
Biological context of the σ1-JAM-A interaction - To envision how σ1 interacts with 
JAM-A at the cell surface, we combined the structures of the σ1H-D1 complex, the JAM-
A extracellular domain (122), and the C-terminus of σ1 (30) with a model of the N-
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terminus of σ1 (30, 64) (Figure IV-9).  This model demonstrates that JAM-A must reach 
beyond the approaching head to access residues in the neck, which links the σ1 head and 
tail segments.  Since the sites for JAM-A are distant from each other on the σ1 trimer, it 
is conceivable that each σ1 trimer engages more than one JAM-A monomer. This 
scenario appears plausible as σ1 binding leads to separation of JAM-A dimers into 
monomers, both of which likely remain in close proximity. Thus, several molecules of 
JAM-A could form a clamp that engages σ1 by its neck and tightly adheres the virus to 
the cell, as depicted in our model (Figure IV-9). 
Since the binding JAM-A binding site in σ1 resides within the base of the head, 
flexibility within σ1 or JAM-A would appear essential to facilitate complex formation.  
The linker connecting the D1 and D2 domains of JAM-A possesses some flexibility 
(122), and residues linking D2 to the transmembrane region also may allow for some 
movement.  However, as reovirus is capable of efficiently infecting CHO cells expressing 
a JAM-A construct that lacks the D2 domain (52), it is likely that flexibility of σ1 is even 
more critical than JAM-A flexibility.  Electron microscopic images of full-length σ1 
combined with structural studies and molecular modeling indicate that σ1 has at least 
three major regions of flexibility: (i) near the N-terminus, (ii) at the midpoint of the 
molecule, where the predicted α-helical coiled-coil transitions to a triple β-spiral, and (iii) 
just below the neck of σ1, between the C-terminal two β-spiral repeats of the crystallized 
portion of T3D σ1 (30, 54, 64).  Similar to the adenovirus fiber (173), σ1 length and 
flexibility might contribute importantly to the capacity of reovirus to interact with JAM-
A, carbohydrate, and additional receptors at the cell surface. 
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FIGURE IV-9.  Full-length model of the complex between reovirus σ1 and JAM-A. A model 
of full-length σ1 extending from a schematic representation of a virion is shown as a ribbon 
drawing, with the known structure of the C-terminus (30) in tricolor and the predicted 
structure of the N-terminus in grey. A model of full-length JAM-A is shown in green as a 
ribbon drawing of the known structure of the extracellular domain (122) and a schematic 
representation of the transmembrane (TM) and intracellular domains. The model was 
produced by superimposing JAM-A (122) and the full-length model of σ1 (30) onto the σ1H-
D1 complex structure. Arrowheads indicate regions of possible flexibility. For clarity, only 
two JAM-A monomers are shown bound to σ1. 
 cytoplasmic domain 
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Serotype-specific differences - Although the σ1 sequence is the most divergent among the 
reovirus proteins, prototype and field-isolate strains from the three most prevalent 
reovirus serotypes use JAM-A as a receptor (20).  Based on sequence alignment, the 
highest degree of conservation is observed among residues in the D-E loop, which 
previously prompted us to propose that this region forms part of the JAM-A-binding site 
(20, 30).  In keeping with this prediction, residues in T3D σ1 that comprise the D-E loop 
form the upper jaw contacting JAM-A.  Val371 also is conserved and likely plays an 
important role in the interaction.  However, several T3D σ1 residues that interact with 
JAM-A are not conserved in prototype strains T1L and T2J σ1 (30).  For example, in the 
T3D σ1H-D1 complex, the carbonyl oxygen atoms of the Asp423 side chain form 
hydrogen bonds with the main-chain nitrogen atom of Ala81 in JAM-A.  In T2J σ1, 
Asp423 is replaced by alanine, which would not be capable of forming a similar bond.  In 
addition, several of the residues in the lower jaw of T3D σ1 differ among reovirus 
serotypes. In some cases, these polymorphisms are unlikely to have profound effects on 
the largely hydrophobic interactions with JAM-A that occur in this region.  However, the 
absence of a bulky proline side chain at position 377 in T1L and T2J σ1, which each have 
glycine residues at that position, could potentially alter the means by which σ1 interacts 
with JAM-A.  These observations suggest that, while the binding sites may be similar, 
σ1-JAM-A interactions may differ at an atomic level among the reovirus serotypes.  Such 
serotype-specific differences may in turn alter the affinity of the various σ1 proteins for 
JAM-A and thus influence reovirus tropism. 
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CHAPTER V 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Introduction 
Initiation of viral infection requires specific interactions of a virus with receptors 
on the host-cell surface.  A viral attachment protein often mediates the adhesion process.  
Although much progress has been made in understanding the relationships between the 
structures of viral proteins and cellular components with which they interact, much 
remains unknown about the precise nature and mechanisms of virus-receptor interactions.  
A detailed understanding of virus structure-function relationships and attachment 
strategies can direct the design of efficacious antivirals and viral vectors for therapeutic 
purposes.  The goals of my dissertation research were to elucidate features of reovirus 
attachment protein σ1 that confer functionality and define the molecular basis σ1 
interactions with JAM-A.  I characterized a novel trimerization motif, the aspartic acid 
sandwich, consisting of an unusual cluster of six aspartic acid residues located between 
residues with aromatic and hydrophobic side chains at the subunit interface of the σ1 
(Chapter II).  This motif might be important in mediating structural rearrangements in σ1.  
I systematically defined the contributions of individual residues in the JAM-A dimer 
interface to reovirus binding and JAM-A homodimer stability (Chapter III).  Residues 
with charged side chains play critical roles in stabilizing both interactions.  In addition, I 
reported the structure of a complex between σ1 and JAM-A and identified sequences in 
σ1 required for efficient JAM-A binding and reovirus infectivity (Chapter IV).  In this 
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chapter, I will discuss the broader implications of this body of work and future directions 
for this research.   
 
The aspartic acid sandwich motif 
Studies reported in Chapter II describe structural and mutational analysis of the 
aspartic acid sandwich, a novel trimerization motif that might mediate structural changes 
in σ1 during reovirus entry into target cells.  A likely scenario is that the aspartic acid 
residues act as a switch that allows full trimerization of the σ1 head only at low pH (131).  
There is evidence to suggest that σ1 exists in a partially detrimerized state ([54]  and 
Figure I-2).  While JAM-A is incapable of binding monomeric mutant σ1H-Y313A 
(Chapter II), it is possible that JAM-A still can bind partially detrimerized σ1.  The β-
barrel fold of a σ1 monomer appears to be stable, since monomeric mutant σ1H-Y313A 
has similar structural character as wild-type σ1H when assessed by CD spectroscopy 
(Chapter II).  In the crystal structure of the σ1-JAM-A complex, each JAM-A monomer 
contacts only a single σ1 monomer (Chapter IV).  Thus, if the σ1 tail is structurally intact 
and properly spaced from the head, JAM-A is likely capable of binding σ1.  Furthermore, 
partial detrimerization of the head may actually result in a higher-affinity interaction due 
to tighter packing of hydrophobic side chains in the σ1 tail against JAM-A D1 (Chapter 
IV).  Thus, it is possible that a version of σ1 that is partially detrimerized in the head 
region mediates attachment functions at the cell surface and that exposure to low pH in 
the endocytic compartment results in full trimerization of σ1. Such a conformational 
change might permit σ1 to mediate additional functions, perhaps in viral uncoating steps 
or penetration of endosomal membranes by the viral core.   
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 Clearly, we do not yet fully understand the significance of the aspartic acid 
sandwich motif in reovirus biology.  To investigate the roles of individual residues in the 
aspartic acid sandwich in reovirus attachment and entry, future studies should be directed 
toward engineering mutant viruses containing each of the eight individual σ1 point 
mutations shown in Table V-1.  Based on studies reported in Chapter II, most of these 
mutations (Y313A, Y313F, D346A, D346N, Y347A, and Y347L) are expected to 
decrease the stability of σ1 trimers, thus altering the efficiency of attachment and entry 
into target cells.  Mutations D345A and D345N could facilitate or even trigger premature 
σ1 trimer formation at neutral pH.  If the Asp345 sandwich is indeed a molecular switch, 
these two mutations will likely have severe consequences for viral attachment and cell 
entry.  In addition, D345A would render an already-formed trimer less stable.  However, 
as much remains unknown regarding the function of the aspartic acid sandwich motif, the 
viruses should be used in discovery-based research (i. e., what are the specific alterations 
in viral replication associated with aspartic acid sandwich mutations?) as well as for 
testing specific hypotheses. 
 Mutant viruses should be recovered using plasmid-based reverse genetics (78).  If 
mutant viruses are unable to be rescued easily, the pseudotyping approach described in 
Chapter IV should be employed.  So far, I have recovered Y313A, Y313F, D345A, 
D345L, D345N, and D345R mutant viruses for use in the proposed studies.  Following 
recovery of the mutant viruses, SPR should be used to assess binding to the extracellular 
domain of JAM-A (131) and sialoglycophorin (5) following incubation at high, neutral, 
and low pH.  These studies will determine whether pH-mediated conformational 
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TABLE V-1. Planned mutations at the head trimer interface and their anticipated effects. 
 
Mutation Name Anticipated result 
Tyr313→Ala Y313A Increase solvent access to Asp345, destabilize the σ1 trimer, 
decrease virus binding to JAM-A and growth in target cells 
Tyr313→Phe Y313F Slightly destabilize the trimer, but retain all hydrophobic interactions and likely the local structure, which might permit JAM-A binding 
Asp345→Asn D345N 
Allow for hydrogen bond formation between Asn345 residues, 
stabilize the interface independent of pH, permit binding but 
possibly alter growth or disassembly 
Asp345→Ala D345A Remove most of the side chain at position 345, also stabilize interface, but less so than D345N 
Asp346→Ala D346A Remove most of the side chain at position 346, prevent salt bridge interaction with Arg314, destabilize the trimer, decrease growth 
Asp346→Asn D346N Prevent hydrogen bond interaction with Arg314, destabilize the trimer, but less so than D346A 
Tyr347→Ala Y347A Increase solvent access to Asp345, destabilize the σ1 trimer, decrease virus binding to JAM-A and growth in target cells 
Tyr347→Leu Y347L Destabilize the σ1 trimer, but less so than Y347A, might permit JAM-A binding 
 
 
rearrangements enhance or inhibit receptor binding.  To assess the biological relevance of 
σ1 mutations that alter the architecture at the subunit interface, the capacity of mutant 
reoviruses to bind the cell surface, internalize, undergo disassembly in the endocytic 
compartment, and replicate in cultured cells should be determined.  Virus binding to 
HeLa cells should be assessed using flow cytometry (52).  To demonstrate specificity for 
JAM-A and sialic acid, virus binding should be assessed following incubation of cells 
with JAM-A-specific mAb J10.4 (93), A. ureafaciens neuraminidase (Sigma), or both 
(100).  To determine the capacity of mutant reoviruses to be internalized, HeLa cells 
should be adsorbed with virus particles at 4°C, warmed over a time course, stained with 
fluor-conjugated reovirus-specific antibodies, and imaged using laser-scanning confocal 
microscopy (95).  To determine the capacity of mutant reoviruses to undergo disassembly 
in the endocytic compartment, HeLa cells should be adsorbed with 35S-labeled virions at 
4°C, warmed over a time course, and lysed in the presence of protease inhibitors.  Virions 
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should be purified from cell lysates by freon extraction and resolved by SDS-PAGE and 
autoradiography to visualize viral disassembly intermediates (4).  Reovirus growth 
should be quantified by plaque assay (159).  These studies may reveal a role for the 
aspartic acid sandwich motif and provide evidence that σ1 structural rearrangements 
occur during reovirus entry.  
  
Implications for serotype-specific differences in pathogenesis 
Despite the accumulated knowledge about reovirus attachment to cell-surface 
receptors and internalization into host cells, a precise understanding of the mechanisms 
underlying the serotype-dependent differences in tropism exhibited by reovirus in the 
murine CNS remains elusive.  Since prototype and field-isolate strains of all three 
serotypes of reovirus utilize JAM-A as a receptor (6, 20), we previously thought that 
binding to JAM-A was unlikely to explain serotype-specific differences in reovirus 
pathogenesis (64).  Studies reported in Chapters III and IV defined the nature of T3D σ1-
JAM-A interactions and provide clues about JAM-A interactions with T1L and T2J 
reoviruses.  These findings permit proposal of an expanded list of σ1-dependent 
mechanisms that may contribute to serotype-specific differences in reovirus tropism and 
disease outcomes.  I envision three possibilities.  First, it is possible that differences in the 
interaction kinetics or affinity of σ1 of a particular serotype for JAM-A contribute to 
differences in tropism.  Second, the carbohydrate specificity of a particular strain of 
reovirus directs infection to specific cells or tissues.  A third possibility is that JAM-A 
may serve as a serotype-independent reovirus receptor at some sites within the host, and 
other as yet unidentified receptors may confer serotype-dependent tropism in the CNS.  
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To understand the precise contributions of σ1 to reovirus pathogenesis, these possibilities 
must be explored.     
On a cell in which little JAM-A is expressed, differences in interaction kinetics or 
affinity might determine whether or not reovirus can infect. While some residues in JAM-
A required for T3D reovirus binding appear also to be required for binding by T1L and 
T2J reoviruses, my studies have provided evidence that the binding sites in JAM-A for 
these viruses likely differ (Chapter III).  Furthermore, sequence analysis reveals that the 
residues in T3D σ1 that contact JAM-A in the structure of the complex reported in 
Chapter IV are mostly, but not entirely, conserved among reoviruses of all serotypes (20, 
30).  Thus, my studies suggest that there are differences in the interacting residues of 
T1L, T2J, and T3D σ1 and JAM-A (Chapters III and IV), which may alter their 
interactions.  To test the hypothesis that σ1 of each serotype binds JAM-A with different 
kinetics or affinity, future work should be aimed at expression and purification of the 
head domains of T1L and T2J σ1 for SPR studies.  Sequence alignments suggest that the 
domain organization and topology are similar for the σ1 proteins of prototype strains (20, 
30, 108).  Thus, it is likely that expression of sequences of T1L and T2J σ1 analogous to 
T3D σ1H and using a similar strategy will result in folded, functional protein.  However, 
expression of constructs including longer fragments of the σ1 tail or expression in 
mammalian cells are reasonable alternatives, should this strategy fail.  Interaction kinetics 
and affinities for JAM-A should be determined for each protein using SPR.  
Crystallization of the T1L and T2J σ1 head domains alone and in complex with JAM-A 
D1 should be pursued concurrently to define the structural basis of serotype-specific 
differences in interactions with JAM-A.         
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Differential carbohydrate coreceptor utilization also may contribute to serotype-
specific differences in reovirus tropism and pathogenesis.  In support of this idea, 
reovirus strains that vary in sialic acid utilization also vary in disease pathogenesis in the 
hepatobiliary system (7).  While there is some evidence that T1L binds sialic acid in 
intestinal loops (67), the exact nature of the carbohydrate coreceptors used by T1L and 
T2J remains largely undefined.  To identify carbohydrate ligands for these viruses, future 
studies should be directed toward glycan array screening of prototype strains of reovirus.  
Glycan arrays have been used to identify carbohydrates bound by influenza virus (16) 
and minute virus of mice (104) and to differentiate carbohydrates bound by influenza 
virus hemagglutinins (142, 143).  I have initiated studies with Core H of the Center for 
Functional Glycomics (CFG) at Emory University to define carbohydrate-binding 
specificities of reovirus prototype strains, T1L, T2J, and T3D (CFG_Request_1305).  
Virions will be sent to the CFG and tested for binding to printed glycan arrays that 
include 377 glycan targets.  We currently are in the process of optimizing screening 
conditions using T3D, before collecting data for T1L and T2J.  If successful in 
identifying new carbohydrate coreceptors, these studies will open a new area of research 
in the reovirus field.  
It is possible that high-affinity receptors other than JAM-A exist and contribute to 
the observed serotype-specific differences in reovirus tropism and pathogenesis.  Studies 
using JAM-A-null mice (24) are currently underway (A. A. R. Antar and T. S. Dermody, 
unpublished observations).  These studies should permit assessment of the role of JAM-A 
in reovirus pathogenesis and may serve to highlight the existence of additional receptors.  
However, these animals exhibit alterations in inflammatory and other biological 
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processes, including dendritic cell trafficking to lymph nodes, neutrophil diapedesis in 
response to injury, colonic inflammation, and mucosal permeability (24, 34, 84, 172).  
These altered phenotypes might interfere with assessment of serotype-specific differences 
in reovirus tropism and pathogenesis conferred solely by σ1.  Thus, future studies should 
be directed towards engineering JAM-A-blind reoviruses that express σ1 from prototype 
reovirus strains T1L, T2J, and T3D for studies using wild-type mice.  Since the D-E loop 
is central to the interaction of T3D σ1 with JAM-A (Chapter IV), and this region of σ1 is 
highly conserved among reoviruses of all serotypes (20, 30), the D-E loop should be the 
initial target in studies to engineer non-JAM-A-binding reoviruses.  Plasmids encoding 
T1L, T2J, and T3D σ1 for reverse genetics have been generated ([78] and T. Kobayashi 
and T. S. D., unpublished observations).  The majority of the D-E loop, including the 310 
helix, should be deleted in each construct.  This region may be replaced with alternating 
glycine and serine residues to maintain spacing between β-strands D and E.  Mutant 
viruses should be recovered using plasmid-based reverse genetics (78).  If mutant viruses 
are unable to be rescued easily, the pseudotyping approach described in Chapter IV 
should be employed.  Following verification of loss of JAM-A-binding capacity by SPR 
and flow cytometry, the recovered viruses should be used to infect newborn mice 
perorally.  Survival studies should be performed, and titers of JAM-A-blind viruses in 
specific organs should be assessed along with any associated histopathology in 
comparison to mice infected with viruses expressing wild-type parental σ1.  Should these 
viruses fail to replicate or spread from the primary site of infection, direct inoculation at 
sites of secondary replication, such as the brain, and binding and infectivity studies using 
cultures of primary cells from secondary sites of replication (112, 123, 148) should be 
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pursued.  These experiments will define the role of JAM-A in serotype-specific 
differences in reovirus pathogenesis.  If the results provide evidence for the existence of 
additional receptors, the identity of the receptors should be sought using an expression-
cloning approach (6) or by passing lysates of an appropriate cell type over columns using 
purified JAM-A-blind reoviruses as affinity ligands.       
 
Immunoglobulin superfamily members as virus receptors 
Despite an impressive variety in the structures of viral attachment proteins, many 
viruses use IgSF members as receptors (6, 12, 36, 59, 61, 94, 139, 149-151, 161).  In all 
cases described to date, the virus binds the most membrane-distal, or D1, Ig-like domain 
of the receptor.  Although the residues in the D1 domain required for engagement of 
individual viruses vary, some viruses, including adenovirus and HIV are known to make 
contacts in the same region of the D1 domain of an IgSF receptor as the σ1-binding site 
in the JAM-A D1 domain.  Thus, viruses from different families appear to share similar 
attachment strategies.    
Structural analyses have revealed striking similarities between reovirus σ1 and 
adenovirus fiber (141).  Moreover, the receptors for reovirus and adenovirus, JAM-A and 
CAR, respectively, also share many structural and functional properties.  Collectively, 
these similarities point to an evolutionary relationship in the attachment strategies used 
by these viruses (140).  A comparison of the σ1-JAM-A complex with that of the Ad12 
fiber knob in complex with the N-terminal D1 domain of human CAR reveals conserved 
features, providing additional support for common ancestry between the two viruses ([13] 
and Chapter IV) (Figure V-1).  The overall structures of both complexes are similar. 
 106 
A 
B 
FIGURE V-1.  Comparison of reovirus σ1H-JAM-A D1 and adenovirus fiber knob-CAR D1 
complexes. (A) Ribbon drawings of the complex between trimeric σ1H and monomeric JAM-
A D1, viewed along the three-fold symmetry axis (left) and from the side (right). σ1H 
monomers are shown in blue, yellow, and red; D1 is shown in green. (B) Ribbon drawings of 
the complex between trimeric Ad12 knob and monomeric CAR D1, viewed along the three-
fold symmetry axis (left) and from the side (right). Knob monomers are shown in blue, 
yellow, and red; D1 is shown in green. Modified from (13).  
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Both attachment proteins form trimers that bind three copies of the D1 domain of the 
receptor.  The combined contact area of the σ1-JAM-A complex (1622 Å2) is only 
slightly larger than the combined area of the CAR-Ad12 fiber complex of 1493 Å2.  
Similar to the D-E loop in σ1, the A-B loop, which contains several highly conserved 
contact residues, is thought to “anchor” the virus-receptor complex.  Like JAM-A, CAR 
uses the dimer interface and its top (B-C and F-G loops) to contact its viral ligand.  Also 
like JAM-A, the fiber-contacting residues of CAR are mainly located on and adjacent to 
β-strands C, C’, C’’, F and G.  However, compared to reovirus σ1, which uses sequences 
in its head and tail to bind JAM-A, the CAR-binding area in Ad12 fiber is located 
entirely on the knob and does not include parts of the shaft.  In contrast to the σ1-JAM-A 
complex, in which one JAM-A D1 domain exclusively contacts one σ1 monomer, CAR 
also has some contacts with a second subunit in the fiber knob.  Thus, the two virus-
receptor complexes share high similarity in the contact areas formed by the receptors, but 
the viral attachment proteins engage the receptors using different binding sites.   
Structures of the knob domains of Ad37 and canine adenovirus serotype 2 (CAV-
2) in complex with CAR D1 also have been solved (133).  The overall topology of the 
interactions is generally conserved among the complex structures, but the number and 
identity of specific interacting residues at the interfaces differ.  Interestingly, contacts 
between the F-G loop of Ad12 and Ad37 with the C-C’ loop of CAR are not observed in 
the CAV-2-CAR D1 complex structure. Thus, like JAM-A D1, each monomer of CAR 
D1 contacts a single monomer of CAV-2 knob, rather than interacting with two adjacent 
monomers in the knob trimer.  Furthermore, the affinities of Ad37 and CAV-2 for CAR, 
as assessed by SPR, also differ, with CAV-2 showing higher affinity for the receptor.  
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These observations provide further support for the idea that reovirus σ1 may exhibit 
serotype-specific differences in JAM-A engagement, which may in turn alter interaction 
kinetics or affinities.      
While structurally quite different from σ1, HIV attachment protein gp120 
contains β-strands and loops that are involved in receptor engagement (81).  HIV gp120 
binds the D1 domain of CD4, an IgSF member with four extracellular Ig-like domains 
(82).  Binding buries a combined area of 1544 Å2 (81), which is similar to the buried 
surface area in the σ1-JAM-A complex (Chapter IV).  However, the true contact area is 
much smaller, due to an unusual symmetry mismatch that results in occlusion of large 
cavities in the interface (81).  Binding of gp120 occurs via residues in β-strands C, C’, 
C’’, D, and the DE loop of CD4, a region that overlaps closely with the σ1-binding site in 
JAM-A ([81] and Chapter IV).  However, binding of CD4 appears to induce a 
conformational change in gp120, whereas binding to JAM-A by σ1 does not.  Similar to 
JAM-A contacts with highly conserved residues in the D-E loop of σ1, key residues in 
CD4 contact residues in loops of gp120 that are highly conserved among primate 
immunodeficiency viruses.  Contacts between CD4 and gp120 consist primarily of van 
der Waals interactions and H-bonds, whereas interactions of JAM-A with σ1 are largely 
polar and involve two salt-bridges in the “upper jaw” and hydrophobic in character in the 
“lower jaw” ([81] and Chapter IV).  Therefore, HIV binds a similar region of CD4 as 
reovirus does in JAM-A.  However, the general topology and side chain contacts that 
mediate attachment protein-receptor interactions differ in nature from those of reovirus.   
Like reovirus, feline calicivirus uses JAM-A as a receptor (96). The D1 domain of 
feline (f) JAM-A is necessary but not sufficient for virus attachment to cells (114).  
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Unlike reovirus, calicivirus requires a D2 domain for binding.  However, the requirement 
appears to be steric rather than specific, as the D2 domain of hJAM-A or CAR can 
substitute for fJAM-A D2 with only a moderate decrease in binding efficiency.  
Experiments using fJAM-A D1 point mutants indicate that residues residing in loops 
outside the dimer interface in the D1 domain of fJAM-A are required for calicivirus 
binding (114).  These findings suggest that the calicivirus binding site in fJAM-A is 
distinct from the reovirus binding site in hJAM-A.  However, it is noteworthy that the 
two fJAM-A residues required for calicivirus attachment, Asp42 and Lys43, possess 
charged side chains.  Thus, similar to reovirus, charge may play an important role in 
calicivirus binding to fJAM-A. 
 
Contributions of σ1 length and flexibility to viral attachment 
The model of σ1-JAM-A interactions at the cell surface presented in Chapter IV 
(Figure IV-7) suggests that flexibility of the attachment molecule might facilitate receptor 
engagement.  JAM-A- and sialic acid-binding sites are located in the σ1 head (6, 65, 131) 
and tail (28, 107), respectively.  A four-residue linker that connects two β-spiral repeats 
N-terminal to the σ1 head imparts flexibility between head and tail regions of the 
molecule (30).   Interdomain flexibility might facilitate receptor engagement by 
permitting structural rearrangements of σ1 that change the relative orientations of the 
receptor-binding sites, permitting concurrent interaction of the tail with sialic acid and the 
head with JAM-A.  Furthermore, the length of σ1 may contribute to receptor-binding 
capacity by appropriately spacing the receptor-binding sites to gain access to both JAM-
A and carbohydrate coreceptors on the cell surface without steric hindrance from the bulk 
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of the virus particle.  In support of these hypotheses, both flexibility and length of the 
adenovirus fiber are important mediators of efficient receptor engagement (173).  To test 
these hypotheses, future studies should be directed toward engineering reoviruses that 
contain insertions or deletions in σ1.  
Two reovirus mutants proposed to alter σ1 flexibility, F1 and F2, already have 
been engineered (Figure V-2).  These mutants contain a deletion or tandem duplication of 
flexible hinge residues Ser291-Pro294 in the β-spiral region of σ1, which is anticipated to 
decrease or increase flexibility, respectively, between the JAM-A- and SA-binding 
regions of the molecule.  Mutants that affect the length of σ1 also should be generated by 
altering the predicted α-helical and β-spiral regions of the molecule.  I propose the 
generation of 4 such mutants (Figure V-2).  In L1, the N-terminal 7 predicted β-spiral 
repeats should be deleted.  This deletion should decrease the overall length of σ1 and 
remove the predicted SA-binding site, while maintaining flexibility N-terminal to the C-
terminal β-spiral repeat of the molecule.  In L2, the central 10 heptad repeats of the tail 
should be removed.  This deletion is expected to decrease the length of σ1 by removing 
20 α-helical turns, which are predicted to account for about one-third of the length of the 
protein.  Importantly, this deletion will maintain the integrity of the receptor-binding 
sites, the N-terminal virion-insertion domain, and the region of the molecule that links the 
predicted α-helix to the predicted β-spiral region.  In L3, the majority of the predicted α-
helix and β-spiral regions of the molecule should be deleted.  This deletion will shorten 
σ1 by more than two-thirds and remove the sialic acid-binding region.  The L1, L2, and 
L3 deletions might decrease the capacity of σ1 to bind JAM-A due to steric hindrance 
from the bulk of the virion as it encounters other cell-surface structures.  In L4, the 
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predicted α-helical region of the protein should be extended by tandemly duplicating 10 
heptad repeats.  This insertion is expected to increase the length of the molecule by about 
40% without directly altering its flexibility.  It is possible that such an alteration will 
increase the capacity of the attachment protein to access receptors on the cell surface and 
thus enhance viral avidity. 
Deletion mutations should be introduced into full-length σ1 using site-directed 
mutagenesis (131), whereas insertion mutations should be engineered using SOE PCR 
FIGURE V-2.  Design of σ1 constructs differing in length and flexibility. The σ1 head is 
shown in red; the 8 β-spiral repeats are shown in orange; and the α-helical coiled coil is 
shown in blue. Amino acid positions refer to wild-type T3D σ1.  
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(28).  Mutant reoviruses should be recovered by reverse genetics (78).  If mutant viruses 
are unable to be easily rescued, a pseudotyping approach should be employed or full-
length wild-type and mutant σ1 proteins, along with outer-capsid proteins σ3 and µ1, 
should be expressed in insect cells using recombinant baculovirus and recoated onto 
reovirus core particles (27). 
 To quantify interactions of mutant forms of σ1 with JAM-A and sialic acid, SPR 
should be used to assess mutant reovirus binding to the JAM-A extracellular domain 
(131) and sialoglycophorin (5).  These experiments will provide an assessment of the 
interaction kinetics and avidity of reoviruses with wild-type and mutant forms of σ1 for 
the receptors JAM-A and sialic acid individually.  To assess the biological relevance of 
mutations that alter the flexibility and length of σ1, the capacity of mutant reoviruses to 
attach, internalize, and infect cultured cells should be determined, as described for 
reovirus mutants in the aspartic acid sandwich.  These studies will enhance an 
understanding of the structural features in σ1 that contribute to attachment and entry 
steps and provide a platform for engineering reoviruses with altered attachment 
properties for oncolytic and vaccine delivery purposes.  
 
Reovirus vector retargeting 
Significant efforts are being made to exploit viruses for medical applications, such 
as gene delivery, oncolysis, and vaccination (92, 119).  The capacity to redirect viral 
vectors to specific target cells through modification of receptor-binding capacity provides 
a powerful approach for delivery of an engineered viral payload to the appropriate target 
site.  For example, retargeting adenovirus from cells expressing CAR to cells expressing 
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JAM-A has been accomplished using a chimeric adenovirus that expresses reovirus σ1 in 
place of adenovirus fiber (100).  Replacement of the CAR-binding adenovirus fiber knob 
with a single-chain TCR molecule specific for a melanoma-associated antigen results in 
efficient killing of target tumor cells in vitro (132).  Development of a plasmid-based 
reverse genetics system for reovirus (78), coupled with the oncolytic potential of this 
virus (53, 153), underscores the importance of a precise understanding of the basis of σ1 
interactions with cellular receptors.  In Chapter IV, I reported the recovery and 
characterization of reoviruses with mutations in the JAM-A-binding site.  These studies 
provide proof-of-principle that reovirus mutants with structure-guided alterations in 
receptor-binding capacity can be engineered. This achievement represents a first step 
towards designing viruses containing modified σ1 proteins to target specific sites in the 
host based on receptor utilization. 
My findings also highlight limitations of our current reverse genetics system.  
Based on the low rescue titers of the T380A/D382A and W421V viruses, which likely 
bind poorly to JAM-A (Table IV-2), sialic acid binding alone does not appear to permit 
efficient rescue.  Optimization of expression of the enzymes that mediate transcription of 
reovirus cDNAs, a reduction in the number of plasmids, or enhancement of plasmid 
uptake in L cells might serve to increase the efficiency of rescue for all reovirus mutants.  
In the case of mutants with alterations in tropism, a pseudotyping approach using 
transient or stable expression of wild-type σ1 protein in L cells should be employed to 
enhance recovery of viruses that have been engineered to be receptor-blind or to bind 
alternative receptors.  Rescue of the W421V mutant reovirus using this strategy, 
described in Chapter IV, indicates a potential for success.  
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Future studies should be directed toward recovery of reoviruses with altered 
tropism.  A logical first step would be to substitute the reovirus σ1 head domain with the 
adenovirus fiber knob.  Reovirus σ1 and adenovirus fiber are both filamentous trimeric 
molecules that extend from icosahedral virion vertices.  The slender tail of each 
attachment molecule contains triple β-spiral repeats, while the head is composed of eight 
β-strands arranged in an identical topological order (30, 158).  These structural 
similarities suggest that substitution of the σ1 head domain with fiber knob is likely to 
result in a folded, functional, chimeric attachment molecule.  Reovirus and adenovirus 
receptors, JAM-A and CAR, respectively, each localize to tight junctions in epithelial and 
endothelial cells, contain two extracellular Ig-like domains, and form similar dimers 
(141).  Furthermore, both viruses use integrins as internalization receptors (95, 168) and 
traffic to the endocytic compartment for disassembly (60, 146).  However, the integrins 
required for efficient internalization differ between the two viruses.  Binding to cellular 
moieties may serve solely to tether the viruses to the cell surface, to initiate intracellular 
signaling required to recruit the internalization machinery, or both properties.  Reovirus 
currently is being employed in Phase I clinical trials to treat malignant gliomas (53).  The 
capacity to retarget reovirus to specific receptors that are highly expressed on tumor cells 
may enhance its efficacy as an oncolytic agent.  While CAR expression is down-
regulated in some tumors, high levels of CAR are observed in many osteosarcomas (62, 
75).  Substitution of the σ1 head with fiber knob will concurrently permit us to 
distinguish between the attachment and signaling functions of JAM-A in reovirus 
infectivity, provide clues about whether the attachment receptor used by a virus dictates 
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its internalization receptor, and determine whether reovirus can be retargeted to alternate 
receptors to enhance its therapeutic potential. 
Sequences encoding the Ad5 knob domain should be amplified by PCR and 
ligated into a plasmid encoding a reovirus S1 transcript using SOE PCR.  Recombinant 
viruses should be recovered using plasmid-based reverse genetics in the context of 
rsT3D/S4-GFP, an assembly-defective virus that encodes GFP in place of reovirus major 
outer-capsid protein σ3 (78), and amplified in σ3-expressing L cells prior to use in 
binding or single-cycle infectivity assays.  This approach diminishes biosafety concerns.  
Thus, following attachment and entry via a productive pathway, the viral core particle 
will generate transcripts, and GFP will be expressed as an indicator of viral infection.  
Infectious progeny containing chimeric attachment proteins will not assemble and thus 
not propagate.  If recovery of chimeric viruses is difficult, a pseudotyping strategy should 
be employed or additional constructs encompassing progressively longer portions of the 
fiber tail, up to but not including the virion-insertion domain should be generated.  
Binding and infectivity studies using the recovered chimeric viruses initially 
should be performed using CHO cells that express full-length JAM-A or CAR.  CHO 
cells are poorly permissive for binding and infection by both reovirus and adenovirus but 
are rendered permissive following expression of JAM-A or CAR, respectively (12, 52).  
Similar studies also may be performed using HeLa cells, which are permissive for both 
reovirus and adenovirus, following treatment with mAbs J10.4 (93) and RmcB (68), 
which block reovirus binding to JAM-A and adenovirus binding to CAR, respectively.  
Expression of GFP will indicate that the virus has been internalized via a productive 
pathway.  If viruses expressing σ1/knob chimeras are able to bind cells expressing CAR, 
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but do not express GFP following adsorption, the step in the virus life cycle that is 
blocked should be identified.  These experiments will test the exciting possibility that 
reovirus has evolved to use JAM-A both as an attachment receptor and to exploit a 
specific function of the receptor for viral replication.  The capacity of viruses expressing 
wild-type σ1 and σ1/knob chimeras to bind and infect osteosarcoma cell lines U2OS and 
SaOS2, which express high levels of CAR (75), also should be assessed, to determine 
whether knob-expressing reoviruses have the potential to be employed as highly specific 
oncolytics.   
 
Conclusions 
 My dissertation research has enhanced an understanding of features of reovirus 
attachment protein σ1 that confer functionality, defined the molecular basis σ1 
interactions with JAM-A, and provided a platform for engineering reoviruses with altered 
tropism.  This work raises several important questions that will collectively contribute to 
a general understanding of virus-receptor interactions.  First, analysis of the aspartic acid 
sandwich motif may provide new insights into the relevance of metastable 
multimerization domains and pH in nonenveloped virus attachment and entry.  Second, 
studies of JAM-A engagement by related, yet distinct ligands (the head domains of the 
three σ1 serotypes) will clarify common features of protein-protein interactions involving 
the Ig superfamily of adhesion molecules.  Third, identification of novel carbohydrate 
coreceptors and defining infection outcomes in vivo using JAM-A-blind reoviruses will 
improve an understanding of the roles of receptor specificity in viral pathogenesis.  
Finally, analysis of mutant reoviruses with alterations in topological placement, number, 
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and type of receptor-binding domains will lend general insights into the biomechanics of 
cell-surface engagement by multi-valent ligands.  Thus, knowledge gained from ongoing 
research on mechanisms of reovirus attachment should inform a more thorough 
understanding of the initial steps in viral infection, contribute new insights into the 
function of virus-receptor interactions in viral disease, and move the field towards 
targeting reovirus for oncolytic therapy and vaccine applications. 
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CHAPTER VI 
 
DETAILED METHODS OF ANALYSIS 
 
Cells, viruses, and antibodies 
Spinner-adapted murine L cells were maintained in Joklik’s minimal essential 
medium supplemented to contain 5 % fetal bovine serum, 2 mM L-glutamine, 100 
units/ml penicillin, and 100 µg/ml streptomycin.  CHO cells were maintained in Ham's F-
12 medium supplemented to contain 10 % fetal bovine serum, 2 mM L-glutamine, 100 
units/ml penicillin, and 100 µg/ml streptomycin. 
Reovirus strains T1L, T2J, and T3D are laboratory stocks originally obtained 
from Dr. Bernard Fields.  Strain T3SA- is a reassortant strain containing the S1 gene of 
T3C44, which does not bind sialic acid (29, 39), and the remaining nine genes of T1L (5).  
Reovirus strain rsT3D-σ1T249I was engineered using plasmid-based reverse genetics 
(78).  Titers of all virus stocks were determined by plaque assay using L-cell monolayers 
(159).  Reoviruses were purified by cesium chloride-gradient centrifugation from infected 
L cells as described (55).  Particle concentrations were determined by spectrophotometry 
at 260 nm using a conversion factor of 2.1 x 1012 particles/ml/A260.  Attenuated vaccinia 
virus strain rDIs-T7pol expressing T7 RNA polymerase was propagated in chick embryo 
fibroblasts (69).  
The combined T1L/T3D antiserum (167) used for detection of reovirus particles 
and viral protein products in infected cells was clarified by pre-adsorption on CHO cells.  
Alexa Fluor 488-conjugated goat anti-rabbit or goat anti-mouse IgG were obtained from 
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Molecular Probes (Invitrogen).  hJAM-A-specific monoclonal antibody J10.4 was 
provided by Dr. Charles Parkos (Emory University). 
 
Expression and purification of T3D σ1H 
 Nucleotide sequences corresponding to residues 293-455 of T3D σ1 (σ1H) were 
amplified by PCR and ligated into pGEX4T-3 (GE Healthcare) for bacterial 
transformation.  D345N and Y313A mutations were engineered in the plasmid using the 
QuikChange Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer’s 
instructions.  Escherichia coli strain BL21 (DE3) pLysS (Novagen) transformed with 
plasmids encoding GST-T3D σ1H constructs were cultured in Luria-Bertani broth, and 
protein expression was induced with 0.2 mM isopropyl-β-D-thiogalactoside (IPTG, GE 
Healthcare) at 25°C for 16 h.  Bacteria were harvested by centrifugation, solubilized in 50 
mM Tris, pH 7.8, 3 mM EDTA, 1% Triton X-100 (TX-100), 2 mM beta-mercaptoethanol 
(βME), 1 mM phenylmethylsulfonyl fluoride (PMSF), and 100 µg/ml lysozyme, and 
lysed by sonication.  The clarified supernatant was passed over a 5 ml GSTrapFF column 
(GE Healthcare), which was washed with Buffer 1 (50 mM Tris pH 7.5, 3 mM EDTA), 
Buffer 2 (20 mM MgSO4 and 10 mM ATP in Buffer 1), and Buffer 3 (1 M NaCl in 
Buffer 1).  Soluble wild-type or mutant σ1H domain was liberated from the glutathione 
resin by controlled tryptic protease treatment at 4ºC overnight and purified using MonoQ 
anion-exchange chromatography (GE Healthcare) with an increasing gradient of NaCl in 
20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.1.  
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T3D σ1H protein crystallization and data collection  
 Purified wild-type or mutant T3D σ1H was subjected to size-exclusion 
chromatography in 20 mM Tris, pH 7.5, 100 mM NaCl, and 0.01 % sodium azide and 
concentrated using Millipore 5 MWCO filters to 13.6 mg/ml, as assessed by direct 
measurement of absorbance at 260 and 280 nm using the relationship: concentration 
[mg/ml] = (1.55 × A280nm) - (0.76 × A260nm), since the T3D σ1H does not react linearly 
with either Bradford or Lowry dyes (data not shown).  Crystals of native σ1 protein were 
grown from 10-12% PEG 8K, 0.2 M magnesium sulfate, and 0.1 M sodium cacodylate, 
pH 6.9 by mixing an equal amount of protein and precipitant solution.  σ1H-D345N was 
concentrated to 8 mg/ml, and crystals were grown using the same conditions used to 
cultivate crystals of the wild-type protein, but with 20% PEG 8K.  Crystals were flash-
frozen using glycerol as cryoprotectant.  Data from native crystals were collected at the 
Brookhaven National Laboratory Synchrotron (beamline X29 features high-flux radiation 
and ADSC Quantum-315 CCD detector).  Data for σ1H-D345N crystals were collected 
at the X6S beamline of the Swiss Light Source (Villigen, Switzerland) using a MarCCD 
detector.  Both data sets were collected from single crystals and processed with HKL2000 
(116). 
 
T3D σ1H structure determination 
Crystals of wild-type σ1H belong to space group P21 (a= 83.93 Å, b= 51.38 Å, c= 
108.87 Å, β= 95.66º) and contain six molecules, forming two complete trimers, in the 
asymmetric unit.  The structure was determined by molecular replacement using the 
trimeric σ1 head domain (30) as a search model in AMORE (106).  Alternating rounds of 
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model building and refinement were performed initially using O (73) and CNS (18), 
respectively.  The programs Coot (51) and Refmac5 (23) were used to refine the model.  
σ1H-D345N also formed crystals that belong to space group P21, with very similar unit 
cell dimensions (Table II-1).  The structure of this protein was solved and refined to 1.85 
Å using Coot and Refmac5.  Atomic coordinates and structure factors have been 
deposited with the ProteinDataBank with the accession codes 2OJ5 and 2OJ6. 
 
Expression and purification of soluble JAM-A constructs 
Soluble ectodomains of wild-type and point-mutant hJAM-A constructs were 
fused to an amino-terminal GST affinity tag via a thrombin cleavage site and expressed 
and purified as described (122).  Nucleotide sequences corresponding to residues 27-233 
of wild-type hJAM-A (D1D2) were cloned by PCR, digested with Bam HI and Xho I, and 
ligated into pGEX-4T-3 (GE Healthcare) for bacterial transformation.  Point mutants of 
hJAM-A were engineered using the QuikChange Site-Directed Mutagenesis Kit.  
Sequences of primers used to engineer point mutations in hJAM-A are listed in Table III-
1.  A GST fusion with the D1 domain of hJAM-A was engineered by inserting a Xho I or 
Bam HI restriction site into the D1/D2 linker of hJAM-A in pGEX-4T-3 using site-
directed PCR mutagenesis.  Digestion with Xho I or Bam HI followed by ligation 
eliminated the D2 domain (residues 131-233) or D1 domain (residues 27-131), 
respectively, and fused the remaining domain to GST.  Escherichia coli strain BL21 
(DE3) (Novagen) transformed with plasmids encoding GST-JAM-A constructs were 
cultured in 1 L Luria-Bertani broth at 37°C with shaking.  Protein expression was induced 
with 0.2 mM IPTG (GE Healthcare) for 4-6 h.  Bacteria were harvested by centrifugation, 
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solubilized in phosphate-buffered saline (PBS) plus 1% TX-100, 2 mM βME, 1 mM 
PMSF, and 100 µg/ml lysozyme, and lysed by sonication.  The clarified supernatant was 
passed over a 5 ml GSTrapFF column (GE Healthcare), which was washed with PBS, 
PBS + 150 mM NaCl, and PBS + 0.1 % TX-100 + 100 mM NaCl .  GST-hJAM-A fusion 
proteins were liberated from the glutathione resin using 10 mM reduced glutathione in 
PBS, pH 8.0.  Soluble wild-type and point-mutant hJAM-A ectodomains were liberated 
from the glutathione resin by incubation with 100 U/ml thrombin (Sigma) at room 
temperature overnight.  
 
Expression and purification of a σ1H-D1 complex 
Sequences corresponding to residues 28-129 of wild-type human JAM-A (D1) 
were amplified from a plasmid encoding full-length JAM-A (122) and cloned into pGEX-
4T-3 (GE Healthcare) using the BamHI and XhoI restriction sites.  The D1 E121A 
mutation was engineered from this construct using the QuikChange Site-Directed 
Mutagenesis Kit.  Expression of GST-D1 fusion proteins was induced in 1 L Luria Broth 
(Sigma-Aldrich) with 0.2 mM IPTG in Escherichia coli strain BL21 (DE3) pLysS 
(Novagen) at 25°C for 16 h.  Bacteria were harvested by centrifugation, resuspended in 
50 mM Tris pH 7.5, 50 mM NaCl, 3 mM EDTA, 1% Triton X-100, 2 mM βME, 1 mM 
PMSF, and 100 µg/ml lysozyme, sonicated with 50% duty-cycle using a Branson Digital 
Sonifier 250, and centrifuged at 15,000 x g.  The clarified supernatant was passed over a 
5 ml GSTrapFF column (GE Healthcare), which was washed with  Buffer 1, Buffer 2, 
and Buffer 3.  D1 was cleaved from GST by overnight incubation with 150 units of 
thrombin (GE Healthcare) in 20 mM Tris pH 7.8, 2.5 mM CaCl2, 150 mM NaCl.  Pure 
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protein was obtained after elution with buffer.  T3D σ1H was expressed and purified as 
described (131), except that induction was achieved using 0.4 mM IPTG, and bacteria 
were lysed using a high-pressure homogenizer (Avestin EmulsiFlex).  Purified σ1H and 
D1 were mixed at a ratio of 1:1.2 and incubated at 4°C for 30 min.  Complexes were 
separated from excess D1 by gel filtration in 20 mM Tris pH 7.5, 100 mM NaCl with a 
Superdex 75 column (GE Healthcare). 
 
σ1H-D1 complex crystallization and data collection 
The σ1H-D1 complex was concentrated to 4 mg/ml according to direct 
measurement of A280 and A260 (concentration [mg/ml] = 1.55 x A280 – 0.76 x A260).  
Crystals were initially obtained by mixing equal volumes of protein and 0.1 M N-
cyclohexyl-2-aminoethanesulfonic acid (CHES), pH 9.5, 30% polyethylene glycol 3000 
(Wizard I Screen, Emerald BioSystems) at 20°C.  Larger crystals were grown upon 
replacement of polyethylene glycol 3000 with polyethylene glycol 3350 and with streak 
seeding using cat whiskers.  Crystals were flash-frozen with glycerol as cryoprotectant.  
Data were collected at the X06SA beamline of the Swiss Light Source (Villigen, 
Switzerland) using a MarCCD detector.  The crystals were extremely thin; they had to be 
exposed for 10 seconds to an unattenuated beam to yield any diffraction beyond 3.5 Å 
and suffered severe radiation damage after only a few images were taken.  We therefore 
collected data from several dozen crystals to obtain a complete data set.  A total of 286 
images were collected, and 85 of these were used to assemble the final data set.  Data 
were integrated and reduced with HKL (116). 
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Since the radiation damage led to dramatic decreases in spot intensity for many 
reflections at higher resolution, we evaluated all processed data files with an in-house 
program, calculating the signal-to-noise ratio (I/σI) according to resolution bins for each 
frame.  We then applied individual resolution cut-offs to each frame at the resolution bin 
in which I/σI dropped below 1.4.  This procedure significantly improved the overall 
quality of the data set. 
 
σ1H-D1 complex structure determination and refinement 
Crystals belong to the orthorhombic space group P21212 (a = 105.74 Å, b = 
123.78 Å, c = 131.02 Å).  The asymmetric unit consists of two σ1H trimers, each 
complexed with three D1 monomers.  The structure of the complex was determined by 
molecular replacement with PHASER in CCP4 (23) using the trimeric T3D σ1 head 
structure (131) and the monomeric D1 domain of the hJAM-A structure (122) as search 
models.  Molecular replacement solutions for two σ1H trimers in the asymmetric unit 
were readily obtained and resulted in an overall R-factor of 40.1% (30-3.2 Å).  Attempts 
to locate the D1 domains by molecular replacement yielded ambiguous results.  However, 
2Fobs-Fcalc and Fobs-Fcalc electron-density maps, calculated using phases obtained from the 
two σ1H trimers, which account for 61% of the protein atoms present in the crystal, 
clearly revealed the position and location of the six D1 domains.  Adding the D1 domains 
to the structure reduced the overall R-factor to 34.7% (30-3.2 Å). 
The structure was refined using CNS (18) and Coot (51).  Electron-density maps 
were improved using non-crystallographic symmetry averaging (77) and data sharpening 
(56) by adding an overall B-factor of -70 Å2 to the observed structure factors with CAD 
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in CCP4 (23).  Progress of the refinement was periodically evaluated by calculation of 
composite annealed omit maps (14) to confirm the electron density for several protein 
side chains.  Contact areas were calculated with AREAIMOL (23) as buried surface areas 
upon complex formation using a point density/Å2 of 10 and a solvent molecule radius of 
1.4 Å.  
 
Gel filtration chromatography 
For studies of purified hJAM-A extracellular domains (Chapter III), gel filtration 
was performed by loading approximately 0.5 mg of each protein onto a Superdex 75 
column mounted on a BioLogic HR Workstation (BIO-RAD).  Proteins were resolved in 
20 mM Tris, pH 7.5, 100 mM NaCl, 0.01% sodium azide.  Additional gel filtration 
studies of the hJAM-A extracellular domain and σ1H were performed using a Superdex 
75 column mounted on a SMART system (GE Healthcare).  σ1H (10 µg) in 20 mM 
HEPES, pH 7.1 and wild-type or mutant forms of the hJAM-A extracellular domain 
(12.74 µg) in PBS were mixed and incubated at 0°C for 40 min prior to gel filtration.  
Mixtures of proteins or individual proteins were resolved in 20 mM Tris, pH 7.5, 100 
mM NaCl.  
For studies of the σ1H-D1 complex (Chapter IV), analytical-scale gel filtration 
was performed using a SMART system (GE Healthcare) with a Superdex 75 column.  
Stability of the JAM-A homodimer was determined by incubating purified JAM-A D1 
and D1D2 (122) in a molar ratio of 1:1 in 20 mM HEPES, 100 mM NaCl, pH 7.4 at 4°C 
or 22°C for 5 or 60 min.  Effects of pH on complex stability were investigated by 
concentrating purified σ1H, wild-type D1, monomeric D1 E121A (65), and the σ1H-D1 
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complex to 10% of the original volume using Millipore 5,000 MWCO filters.  Samples 
were diluted in 20 mM citrate buffers adjusted pH 4.0, 4.5, or 5.0 or 20 mM HEPES, pH 
7.4 and re-concentrated.  This procedure was repeated five times.  Gel filtration was 
performed using the respective buffer, containing 100 mM NaCl, for each sample. 
 
GST capture assays 
Swelled, washed, glutathione-coated beads (Sigma) were incubated with 20 µg of 
purified GST or GST-hJAM-A fusion proteins and diluted in 200 µl PBS plus 1% Tween 
20 (PBST) at 4°C for 1 h. Glutathione beads with captured GST fusion proteins were 
washed twice with PBST and incubated with 10 µg purified T3D σ1 head domain in 200 
µl PBST at 4°C for 1 h.  Following two additional washes, buffer was aspirated carefully, 
and beads with bound proteins were resuspended in 30 µl sample buffer (313 mM Tris, 
pH 6.8, 4% SDS, 10% βME, 20% glycerol, 0.01% bromophenol blue).  Samples (15 
µl/lane) were loaded into wells of a SDS 4-20% continuous gradient polyacrylamide gel 
and electrophoresed at 120 V until the dye front reached the bottom of the gel.  Proteins 
were visualized by staining with Coomassie brilliant blue.  
 
Assessment of reovirus-JAM-A interactions using SPR 
A BIAcore CM5 chip (Biacore/GE Healthcare) was coated with mouse ascites 
containing monoclonal GST-specific antibody (Sigma) to ~ 1800-2000 RU of IgG by 
amine coupling.  Purified GST or wild-type or mutant GST-hJAM-A ectodomain fusion 
proteins at a concentration of 2 µM in HEPES-buffered saline (HBS), pH 7.0 were 
captured by injection across individual flow cells of an antibody-coated chip for 3 min at 
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30 µl/min using a BIAcore 2000 (Biacore/GE Healthcare).  Purified σ1H or purified 
reovirus (5 × 1012 particles/ml) was injected across the conjugated chip surface at 30 
µl/min.  Following σ1 binding, chip surfaces were regenerated with a 20 µl pulse of 10 
mM glycine, pH 2.5.  Affinity constants for σ1H binding to hJAM-A were determined 
using separate kon and koff nonlinear regression with BIAevaluation 3.0 software 
(Biacore/GE Healthcare), assuming a 1:1 Langmuir binding model (74).  Molar 
concentrations of σ1 constructs were calculated based on σ1 forming a homotrimer (30, 
131).  
 
Flow cytometric analyses of receptor expression and virus binding 
CHO cells (106) were transiently transfected with receptor-encoding plasmids 
using Lipofectamine and PLUS reagent (Invitrogen) according to the manufacturer’s 
instructions and incubated for 24 h to allow receptor expression.  Cells were detached 
from plates by incubation with 20 mM EDTA in PBS and incubated with hJAM-A-
specific monoclonal antibody J10.4 at 10 µg/ml or adsorbed with reovirus (105 
particles/cell) on ice for 1 hr.  Virus-adsorbed cells were washed with PBS containing 
0.1% bovine serum albumin (PBS/BSA) and incubated with clarified, combined 
T1L/T3D antiserum (11) at 1:1000 dilution on ice for 1 h.  Samples were washed with 
PBS/BSA and incubated with Alexa Fluor 488-conjugated goat anti-rabbit or goat anti-
mouse IgG (Invitrogen) at a 1:1000 dilution on ice for 1 hr.  Cells were washed twice 
with PBS/BSA and fixed with 4% paraformaldehyde in PBS.  Cells were analyzed for 
antibody or virus binding using a FACSCalibur (BD Biosciences) or FACSCanto II Flow 
Cytometry System (BD Biosciences).  For quantification, data were collected from three 
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independent experiments per virus and analyzed for JAM-A expression and reovirus 
binding using WinMDI ver2.8 (Scripps Research Institute). 
 
Transient transfection and infection of CHO cells 
Point mutations were engineered into full-length hJAM-A in pcDNA3.1 (122) 
using the QuikChange Site-Directed Mutagenesis Kit and the same primers used to 
engineer mutations in the hJAM-A extracellular domain in pGEX-4T-3 (Table III-1).  
CHO cells (2 x 105) were transiently transfected with receptor-encoding plasmids using 
Lipofectamine and PLUS reagent (Invitrogen) as described (122) and incubated for 24 h 
to allow receptor expression.  Cells were infected with reovirus at multiplicities of 
infection of 1 (T1L), 5 (T2J), and 10 (T3SA-) plaque forming units/cell and incubated at 
37ºC for 18-20 h.  Infected cells were processed for indirect immunofluorescence as 
described (5).  Images were captured at 200X magnification using a Zeiss Axiovert 200 
microscope.  For each experiment, three fields of view were scored from three 
independently transfected wells.  Data were collected from three independent 
experiments. 
 
 
Plasmid-based reovirus reverse genetics 
The parental S1 gene used for studies of reovirus interactions with JAM-A 
encodes a σ1 molecule that is identical to T3D σ1 with the exception of a threonine-to-
isoleucine substitution at position 249, which renders the σ1 protein resistant to 
proteolytic cleavage (78).  Substitution mutations were engineered in pBacT7-S1T3D 
T249I (78) using the QuickChange site-directed mutagenesis kit (Stratagene).  
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Reoviruses were rescued as described (78).  L cells were infected with an assembly-
defective vaccinia virus (DIs-T7 RNA pol) that hyperexpresses T7 polymerase 1 h prior 
to transfection with ten plasmids encoding RNA molecules identical to each of the 
reovirus transcripts.  Rescued viruses were recovered from cell-culture supernatants 5-6 d 
post-transfection by plaque assay.  Viruses were amplified using L-cell monolayers.  
Confirmation of mutations in the S1 gene of recombinant viruses was performed using 
the OneStep RT-PCR kit (Qiagen), gene-specific primer sets, and viral dsRNA extracted 
from infected L cells as template.  Purified PCR products were directly subjected to 
sequence analysis.  T3D σ1 protein was expressed for pseudotyping purposes by co-
transfecting 2 mg of pCAG-S1T3D during rescue.  The pCAG-S1T3D construct was 
generated by subcloning the T3D S1 open reading frame from pBacT7-S1T3D (78) into 
the EcoRI-KpnI site of pCAGMCS, which was derived by modifying the multiple-
cloning site of pCAGGS (111).  
 
Viral growth in L929 cells 
 L cells were adsorbed with virus at an MOI of 0.01 PFU/cell.  Following 
incubation at room temperature for 1 hr, complete medium was added, and cells were 
incubated at 37°C for 0, 24, 48, 72, or 96 h.  Cells were frozen (-80°C) and thawed twice, 
and viral titers were determined by plaque assay (159).  Data were collected from three 
independent experiments per time point per virus. 
 
Statistical analysis 
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Mean values were compared from at least three independent experiments using 
the unpaired Student’s t test as applied using Microsoft Excel. P values of less than 0.05 
were considered statistically significant. 
 
Preparation of figures 
Structural figures were prepared using PyMOL (38), RIBBONS (21), and GRASP 
(110).   
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Abstract Mammalian orthoreoviruses (reoviruses) serve as a tractable model system
for studies of viral pathogenesis. Reoviruses infect virtually all mammals, but cause
disease only in the very young. Prototype strains of the three reovirus serotypes differ
in pathogenesis following infection of newborn mice. Reoviruses are nonenveloped,
icosahedral particles that consist of ten segments of double-stranded RNA encap-
sidated within two protein shells, the inner core and outer capsid. High-resolution
structures of individual components of the reovirus outer capsid and a single viral
receptor have been solved and provide insight into the functions of these molecules
in viral attachment, entry, and pathogenesis. Attachment of reovirus to target cells
is mediated by the reovirus σ1 protein, a ﬁlamentous trimer that projects from the
outer capsid. Junctional adhesion molecule-A is a serotype-independent receptor for
reovirus, and sialic acid is a coreceptor for serotype 3 strains. After binding to recep-
tors on the cell surface, reovirus is internalized via receptor-mediated endocytosis.
Internalization is followed by stepwise disassembly of the viral outer capsid in the
endocytic compartment. Uncoating events, which require acidic pH and endocytic
proteases, lead to removal of major outer-capsid protein σ3, resulting in exposure of
membrane-penetration mediator μ1 and a conformational change in attachment pro-
tein σ1. After penetration of endosomes by uncoated particles, the transcriptionally
active viral core is released into the cytoplasm,where replicationproceeds.Despitema-
jor advances in deﬁning reovirus attachment and entry mechanisms, many questions
remain. Ongoing research is aimed at understanding serotype-dependent differences
in reovirus tropism, viral cell-entry pathways, the individual and corporate roles of
acidic pH and proteases in viral entry, and μ1 function in membrane penetration.
1
Introduction
Mammalian orthoreoviruses (called reoviruses here) serve as highly tractable
models for studies of viral pathogenesis. Reoviruses are nonenveloped, icosa-
hedral viruses that contain a genome of ten double-stranded (ds) RNA gene
segments. There are three reovirus serotypes, which can be differentiated by
the capacity of anti-reovirus antisera to neutralize viral infectivity and in-
hibit hemagglutination [120, 126]. The three serotypes are each represented
by a prototype strain isolated from a human host: type 1 Lang (T1L), type 2
Jones (T2J), and type 3 Dearing (T3D). Reoviruses have a wide geographic
distribution, and virtually all mammals, including humans, serve as hosts for
infection [146]. However, reovirus is rarely associated with disease, except in
the very young [89, 142].
Newborn mice are exquisitely sensitive to reovirus infection and have
been used as the preferred experimental system for studies of reovirus patho-
genesis [151]. Following oral or intramuscular inoculation of newborn mice,
strains of serotype 1 and serotype 3 reoviruses invade the central nervous sys-
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tem (CNS), yet by different routes and with distinct pathologic consequences.
Serotype 1 reovirus spreads to the CNS hematogenously and infects ependy-
mal cells [147, 155], resulting in hydrocephalus [153]. In contrast, serotype 3
reovirus spreads to the CNS by neural routes and infects neurons [99, 147,
155], causing lethal encephalitis [142, 153]. Studies using T1L x T3D reassor-
tant viruses have shown that the pathways of viral spread [147] and tropism
for neural tissues [45, 155] segregate with the viral S1 gene, which encodes
attachment protein σ1 [83, 154]. T1L x T3D reassortant viruses also were used
to demonstrate that serotype-speciﬁc differences in virus binding to primary
cultures of ependymal cells and neurons are determined by the S1 gene [45,
141]. These studies suggest that σ1 dictates the CNS cell types that serve as
targets for reovirus infection, presumably by its capacity to bind to receptors
expressed by speciﬁc CNS cells.
In addition to conferring viral attachment, engagement of reovirus re-
ceptors also induces postbinding signaling events that may inﬂuence dis-
ease pathogenesis. Reovirus induces apoptosis in cultured cells [32, 36, 119,
148] and in vivo [38, 109]. Strain T3D induces apoptosis to a greater extent
than strain T1L in murine L929 (L) cells [148], Madin-Darby canine kidney
cells [119], and human HeLa cells [34]. Differences in the capacity of these
strains to induce apoptosis are determined primarily by the S1 gene [34, 119,
148], suggesting a critical role for receptor-linked signaling in the apoptotic
response elicited by reovirus. However, viral disassembly steps that occur
following cell attachment are also required for the induction of apoptosis by
reovirus [35].
Following attachment to host cells, reovirus particles must penetrate cell
membranes and uncoat to activate the viral transcription machinery. Mech-
anisms underlying these events are dependent on receptor-mediated endo-
cytosis, host-cell proteases resident in the endocytic pathway, and a novel
membrane penetration process that requires stepwise disassembly of the vi-
ral outer capsid. The σ3 protein is the outermost capsid component and acts
as a protective cap for the μ1 protein, which facilitates membrane penetra-
tion. Following removal of σ3 by endocytic proteases [50, 68], μ1 undergoes
a conformational rearrangement to facilitate entry of the core particle into
the cytoplasm [26].
Here we review mechanisms of reovirus attachment and cell entry. Studies
of these reovirus replication steps have been signiﬁcantly advanced by the
availability of high-resolution structures of the viral outer-capsid proteins
and at least one of the viral receptors. This work, coupled with biochemical
andgenetic analysesof the reovirus attachment andentryprocess, has allowed
an enhanced understanding of how viral protein structure and function relate
to viral disease.
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2
Structure and Function of Reovirus Attachment Protein σ1
2.1
Structure of the σ1 Trimer
Reovirus particles are approximately 850 Å in diameter [104]. The ten seg-
ments of dsRNA that compose the reovirus genome are encapsidated within
two concentric protein shells, the outer capsid and inner core. Together, the
outer capsid and core are composed of eight structural proteins. The bulk
of the outer capsid consists of the tightly associated μ1 and σ3 proteins [86].
In addition, there are turrets at each of the 12 icosahedral vertices of the
virion formed by the pentameric λ2 protein, from which the viral attachment
protein, σ1, extends [8, 29, 47, 60, 61].
The σ1 protein is a ﬁbrous, trimeric molecule about 480 Å in length
with distinct head-and-tail morphology [60, 61] (Fig. 1). Discrete regions
of the molecule mediate binding to cell-surface receptors. Sequences in the
N-terminal σ1 tail bind to carbohydrate, which is known to be sialic acid in
either α2,3 or α2,6 linkages for serotype 3 reoviruses [29, 30, 43, 64, 116].
The C-terminal σ1 head binds to junctional adhesion molecule-A (JAM-A,
previously called JAM1) [8]. The σ1 tail partially inserts into the virion,
while the head projects away from the virion surface [46, 61]. Insertion of the
trimeric σ1 protein into a pentameric λ2 base results in an unusual symmetry
mismatch. Such symmetry mismatches often produce interactions of limited
strength or speciﬁcity and indicate a strong potential to undergo structural
rearrangement.
Structural analysis of the C-terminal half of T3D σ1 (residues 246–455) re-
veals a trimeric structure, inwhicheachmonomer is composedofa slender tail
and a compact head [31] (Fig. 2). The C-terminal residues that form the head
domain (310–455) consist of two Greek-key motifs that fold into a β-barrel.
Loops connecting the individual strands of the β-barrel are short with the ex-
ception of the loop that connects β-strandsD and E, which contains a 310 helix
(Fig. 2). N-terminal residues in the crystallized fragment form a portion of
the tail, residues 246–309, which consists of three β-spiral repeats. Each repeat
is composed of two short β-strands connected by a four-residue β-turn that
has either a proline or a glycine residue at its third position [31]. A surface-
exposed, variable loop links successive repeats, and trimerization generates
an unusual triple β-spiral motif that has been observed in only one other
molecule todate, theadenovirusattachmentprotein,ﬁber [150].Theσ1 trimer
features a distinct bend between the three-fold axes of the head and tail do-
mains. Although this bend ismost likely introduced by crystal packing forces,
it indicates that the σ1 trimer possesses a high degree of ﬂexibility. The region
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Fig. 1 Structure of reovirus σ1. Left: Computer-processed electron micrograph of σ1
showing regions of ﬂexibility and approximate molecular dimensions. Image adapted
fromFraser et al. [60].Right: Full-lengthmodel of reovirusσ1 generated by adding ﬁve
β-spiral repeats, followed by a trimeric coiled coil formed by elongating an existing
coiled-coil structure [156], to the N-terminus of the crystallized fragment of σ1 [31].
Regions of the molecule that interact with JAM-A and sialic acid, and approximate
molecular dimensions are indicated. This model was prepared using RIBBONS [22]
of ﬂexibility is located between the second and third β-spiral repeats in the tail
and corresponds to a four-residue insertion, aminoacids 291–294 [31] (Fig. 2).
Sequence analysis has facilitated the development of amodel of full-length
σ1 [31]. The σ1 tail is thought to contain an N-terminal α-helical coiled-coil
followed by eight β-spiral repeats (Fig. 1). Sequences predicted to form the
α-helical coiled coil are required for trimer stability [29, 84, 138, 159]. Electron
microscopic (EM) images of full-length σ1 show ﬂexibility at three regions
of the molecule, a region near the N-terminus, a region that correlates with
the transition from the predicted α-helical coiled-coil to the triple β-spiral,
and a region that corresponds to the insertion between β-spiral repeats 2
and 3 of the crystallized portion of T3D σ1 [31, 60] (Fig. 1). These regions
of ﬂexibility could facilitate interactions with receptors or enable structural
rearrangements during viral assembly or disassembly (see also Sect. 1.9).
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Fig. 2A–C Crystal structure of reovirus σ1. A Ribbon drawing of the σ1 trimer with σ1
monomers shown in red, orange, and blue. Each monomer consists of a head domain
formed by a compact β-barrel and a ﬁbrous tail with three β-spiral repeats.B Enlarged
view of the σ1 head domain monomer. The two Greek-key motifs, shown in red and
orange, form a compact, cylindrical β-sheet that contains eight β-strands (A–H). The
head domain also contains two short helices, shown in blue: one 310 and one α-helix.
C Schematic view of the β-strand arrangement in the σ1 head domain. Colors are as
in B. (Image adapted from Chappell et. al [31])
2.2
Interactions of σ1 with Sialic Acid
Reoviruses exhibit the capacity to agglutinate erythrocytes of several mam-
malian species [85]. For serotype 3 reoviruses, hemagglutination is mediated
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by interactions of the σ1 protein with terminal α-linked sialic acid residues
on several glycosylated erythrocyte proteins such as glycophorin A [65, 115].
The carbohydrate receptors for other serotypes of reovirus have not been
well characterized. Sialic acid binding is required for reovirus attachment
and infection of certain cell types, including murine erythroleukemia (MEL)
cells [30, 122]. Although not all serotype 3 strains are capable of binding to
sialic acid, the majority bind to this carbohydrate and produce hemaggluti-
nation. Sequence polymorphism within the σ1 tail determines the capacity
of ﬁeld-isolate reovirus strains to bind to sialic acid and infect MEL cells [42,
122]. Furthermore, non-sialic acid-binding serotype 3 variants canbe adapted
to growth in MEL cells during serial passage. These variants have gained the
capacity to bind to sialic acid and contain sequence changes within a discrete
region of the σ1 tail (residues 198–204) predicted to form a β-spiral [30].
Residues in this vicinity may form part of a sialic acid-binding site [31, 135].
Experiments using expressed σ1 truncation mutants and chimeric molecules
derived from T1L and T3D σ1 proteins have conﬁrmed that the sialic acid-
binding domain of serotype 3 σ1 is contained within this predicted β-spiral
region of the σ1 tail [29] (Fig. 1).
Serotype 1 reoviruses also appear to bind to sialic acid in some contexts.
T1L, but not T3D, binds to the apical surface of microfold (M) cells, but
not to enterocytes, in tissue sections of rabbit Peyer’s patches [71]. Binding
is inhibited by preincubation of the tissue sections with neuraminidase or
with lectins that speciﬁcally recognize α2–3-linked sialic acid. The capacity
of T1L to bind to the apical surface of M cells was shown to segregate with
the S1 gene using reassortant genetics and with reovirus particles recoated
with recombinant σ1 protein. The interaction between T1L σ1 and sialic acid
is especially intriguing as serotype 1 reoviruses are incapable of infecting
MEL cells, a property dependent on sialic acid binding that segregates with
the S1 gene [123], and are insensitive to the growth-inhibitory effects of
neuraminidase treatment of L cells [107].
2.3
Interactions of σ1 with JAM-A
Substantial evidence has accumulated to suggest that the σ1 head also binds
to receptors on the cell surface [11, 49, 107, 145]. Neutralization-resistant
variants of T3D selected using σ1-speciﬁcmonoclonal antibody 9BG5 contain
mutations in the σ1 head that segregate genetically with alterations in neural
tropism [11, 75, 133, 134]. This ﬁnding suggests a role for the σ1 head in
receptor binding. Truncated forms of σ1 containing only the head domain are
capable of speciﬁc cell interactions [48, 49]. Concordantly, proteolysis of T3D
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virions leads to release of a C-terminal receptor-binding fragment of σ1 and
a resultant loss in infectivity [107]. These ﬁndings indicate that the σ1 head
promotes receptor interactions that are distinct from interactions with sialic
acid mediated by the σ1 tail.
A ﬂow cytometry-based expression-cloning approach was employed to
identify a receptor bound by the σ1 head [8]. A non-sialic acid-binding
strain of reovirus that contains a serotype 3 σ1 was used as an afﬁnity
ligand to avoid the potential complication of isolating heavily glycosylated
molecules that might not interact speciﬁcally with σ1. A neural precursor cell
(NT2) cDNA library was selectively enriched for cDNAs that confer binding
of ﬂuoresceinated virions to transfected cells. Four clones were identiﬁed
that conferred virus binding. Each encoded JAM-A, a member of the im-
munoglobulin superfamily postulated to regulate formation of intercellular
tight junctions [87, 92, 158]. Three lines of evidence support the contention
that JAM-A is a functional reovirus receptor [8]. First, JAM-A-speciﬁc mono-
clonal antibodies inhibit reovirus binding and infection. Second, expression
of JAM-A in nonpermissive cells allows reovirus growth. Third and most
convincingly, the σ1 protein binds directly to JAM-A with an apparent KD of
approximately 6×10–8 M. Together, these ﬁndings indicate that JAM-A serves
as a receptor for the σ1 head. Surprisingly, JAM-A serves as a receptor for
both prototype and ﬁeld-isolate strains of all three reovirus serotypes [8,
165]. Therefore, utilization of JAM-A as a receptor does not appear to explain
the serotype-dependent differences in reovirus tropism observed in the CNS.
Variation in the afﬁnity of σ1 for JAM-A among reoviruses or interactions
with receptors other than JAM-A, possibly including carbohydrate-based
coreceptors, may inﬂuence reovirus pathogenesis.
3
Structure of the JAM-A Ectodomain
Reovirus receptor JAM-A is an important component of barriers known as
the zonula occludens or tight junctions that form between endothelial and
epithelial cells [87, 92, 114]. Tight junctions constitute a semipermeable bar-
rier to the transport of water and solutes between cells, help to establish
distinct apical and basolateral regions in polarized epithelia, and serve as
critical sites for vesicle targeting and signaling [5, 164]. Tight junctions are
composed of complex networks of interacting ﬁbrils that encircle the lateral
portion of a polarized epithelial cell toward its apical end and seal the para-
cellular space. Occludin and members of the claudin family are concentrated
in the ﬁbrils andmake important contributions to tight junction barrier func-
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tion [144]. JAM-A interacts with several proteins. The extracellular domain
of JAM-A interacts with the leukocyte function-associated antigen-1 (LFA-1,
integrin αLβ2) [113]. Cytosolic proteins known to bind to tight junction
components, including zonula occludens (ZO)-1 [13, 53], AF-6 [53], multi-
PDZ-domain protein 1 (MUPP1) [70, 149], and partitioning-defective protein
(PAR)-3 [54, 72], interact with the JAM-A cytoplasmic tail in a PDZ-domain-
dependent manner. JAM-A appears to inﬂuence the migration of leukocytes
across endothelial and epithelial barriers during the course of an inﬂam-
matory response [39, 82], although mechanisms by which JAM-A regulates
transendothelial migration are not known.
The capacity of reovirus to interact with tight junctions via JAM-A may
make important contributions to the pathogenesis of reovirus infection. Re-
ovirus gains access to the basolateral surface of intestinal cells by transport
throughMcells [162], whichwould allow virus exposure to the area of highest
JAM-A expression. It is also possible that transient disruptions of the tight
junction barrier, such as those that occur during migration of immune and
inﬂammatory cells, permit reovirus access to JAM-A from the intestinal lu-
men. In addition to reovirus, several other viruses bind to receptors expressed
at regions of cell–cell contact [132]. Like JAM-A, the coxsackievirus and ade-
novirus receptor CAR [14] is expressed at tight junctions [33], and nectins,
which serve as receptors for herpes simplex virus [67, 152], are expressed
at adherens junctions [140, 163]. Interestingly, each of these viruses is capa-
ble of i (TJ)nfecting both epithelial surfaces and neurons in some types of
hosts. Reovirus interactions with JAM-A may induce tight junction dysregu-
lation, enhancing viral shedding and transmission. After spreading from the
intestine, reovirus interactions with JAM-A may lead to a destabilization of
tight junctions in CNS endothelium, which could promote breakdown of the
blood–brain barrier and permit cerebral edema and neural inﬂammation,
conditions evident in reovirus encephalitis [151].
JAM-Aisamemberofa familyof relatedproteins.Theproteinsmost closely
related to JAM-A are JAM-B (JAM2) and JAM-C (JAM3), which share 44%and
32% amino acid identity with JAM-A, respectively [2, 37, 55]. Each protein
consists of two extracellular immunoglobulin-like domains, a short trans-
membrane region, and a cytoplasmic tail containing a PDZ-domain-binding
motif [14, 92, 131, 158]. Crystal structures are available for the extracellular
regions of the human and murine homologues of JAM-A [80, 117] (Fig. 3),
which both serve as reovirus receptors [8]. Unlike JAM-A, JAM-B and JAM-C
do not serve as receptors for reovirus [117, 165].
JAM-Acrystallizes as ahomodimer inwhichmonomers engage inan“arm-
wrestling grip” via the membrane-distal, or D1, domain [80, 117] (Fig. 3A,
B). This dimeric structure is maintained by a highly unusual interface that is
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Fig. 3A–C Crystal structure of the hJAM-A extracellular domain. A, B Ribbon draw-
ings of the hJAM-A dimer, with one monomer shown in orange and the other in blue.
Two orthogonal views are displayed. Disulﬁde bonds are shown in green. C View of
the interface between two hJAM-A monomers. The interface is formed by residues on
the GFCC’ faces of two membrane-distal (D1) domains. The view is along a crystallo-
graphic dyad. Hydrogen bonds and salt bridges are represented by broken cylinders.
Amino acids are labeled in single-letter code. (Image from Prota et. al [117])
rich in charged residues [117] (Fig. 3C). The principal means of association
between JAM-A monomers involves four salt bridges at the center of the
interface. These interactions are mediated by the side chains of Arg59, Glu61,
Lys63, and Glu121, all of which are buried and solvent-inaccessible [117].
Protein–protein contacts areoftenmediatedbyhydrophobicorpolar residues,
whereas charged amino acids are more typically found at solvent-exposed
areas. Although formation of salt bridges is generally viewed as energetically
favorable, the stability of these interactions depends very much on the nature
of the surrounding environment. Apolar surroundings increase the energy
gained by salt bridge formation, whereas highly polar surroundings or low
pH values decrease the stability of these contacts. Of note, JAM-A dimers can
dissociate intomonomers under conditions ofmoderately high ionic strength
or when exposed to low pH [12]. This dynamic nature of the JAM-A interface
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may facilitate efﬁcient binding of the viral attachment protein [59]. Sequence
alignments show that most of the residues mediating dimer formation are
conserved in JAM-B and JAM-C, which has led to the suggestion that these
two molecules form similar dimeric structures [80, 117].
4
Model of σ1-JAM-A Interactions
Although structural data for a σ1-JAM-A complex are not yet available, ex-
perimental results suggest that σ1 engages monomeric JAM-A. Chemical
cross-linking of the JAM-A dimer diminishes the capacity of reovirus to bind
to JAM-A in vitro and on cells and negates the competitive effects of soluble
JAM-Aon reovirus attachment [59]. These observations suggest that the virus
cannot interactwith a covalently linkeddimer, but can recognize amonomeric
version of the receptor. Sequences required for reovirus binding have been
deﬁned in part by mutating several solvent-accessible residues covering most
of the JAM-A D1 surface. Residues selected for this analysis are conserved
in human and murine homologues of JAM-A, which both serve as reovirus
receptors [8, 117]. Assaying the mutant constructs for the capacity to bind to
reovirus in vitro identiﬁed residues Ser57 and Tyr75 as especially important
for efﬁcient reovirus attachment [59]. Tyr75 is located at the JAM-A dimer
interface and forms a hydrogen bondwith Glu114 [117] (Fig. 3C). Thus, Tyr75
would not be accessible to ligand in the context of dimeric JAM-A. Ser57 is
located close to Tyr75, at the edge of the JAM-A dimer interface. Together,
these results provide strong evidence that reovirus σ1 engages a monomeric
form of JAM-A, most likely via residues located at or in the vicinity of the
JAM-A dimer interface.
Structural observations and sequence analysis also support a model of
the σ1-JAM-A interaction in which σ1 engages monomeric JAM-A via the
dimer interface. The JAM-A dimer interface is concave and composed of
four β-strands (C’, C, F, and G). The structure of the monomeric reovirus
σ1 head domain features a solvent-exposed surface that is similarly concave
and also composed of four β-strands (B, A, D, and G). In fact, the concave
β-sheets C’CFG of JAM-A and BADG of σ1 are so similar that they can be
superimposed with low rootmean square deviations [136]. Sequence analysis
of prototype strains of the three reovirus serotypes, which each use JAM-
A as a receptor [165], identiﬁes a cluster of conserved residues at the lower
edge of the BADG sheet of σ1, including several residues that form the loop
connecting β-strandsD and E (Fig. 2) [31]. Therefore, it is possible that the σ1
surface mimics features of the JAM-A dimer interface and engages JAM-A in
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a manner similar to that used to form JAM-A dimers. Structural analysis of a
σ1-JAM-A complex is ongoing to test this hypothesis.
5
Adhesion-Strengthening Mechanism
of Stable Reovirus Attachment to Cells
Monoreassortant viruses containing the σ1-encoding S1 gene of either non-
sialic acid-binding strain T3C44 (T3SA–) or sialic acid-binding strain T3C44-
MA (T3SA+) in a T1L background have been used to study the contribution of
sialic acid to stable reovirus attachment to cells [7]. T3SA– and T3SA+ vary by
a single amino acid residue at position 204 (leucine for T3SA– and proline for
T3SA+), which correlates with the capacity to bind to sialic acid [30]. T3SA+
binds to sialic acid with an apparent KD of approximately 5×10–9 M, while
T3SA– displays no speciﬁc interaction with this carbohydrate [7]. While the
steady-state avidity of these strains for L cells, as determined by competition
binding assays, is nearly equivalent (KD ~3×10–11 M), the avidity of T3SA+
for HeLa cells is ﬁvefold higher than that of T3SA– [7]. Kinetic assessments of
binding indicate that the capacity to engage sialic acid functions primarily to
increase the kon value of virus attachment to HeLa cells.
The enhanced infectivity of T3SA+ ismediatedby the interactionofσ1with
cell-surface sialic acid, since preincubation of virus with sialyllactose (SLL)
dramatically reduces the efﬁciency of T3SA+ infection, yet has no effect on
T3SA– infectivity [7]. However, sialic acid-mediated enhancement of T3SA+
infection occurs only during the initial phases of virus–cell interaction, since
SLLdoesnot inhibit productive bindingofT3SA+ after theﬁrst 30minof virus
adsorption. In contrast, Fab fragments of a monoclonal antibody directed to
the σ1 head (9BG5) neutralize T3SA+ infection efﬁciently, even when added
at late times during adsorption [7].
Results of the binding studies performed using T3SA+ and T3SA– suggest
that reovirus attaches to cells using an adhesion-strengthening mechanism,
in which initial low-afﬁnity binding to sialic acid facilitates secondary higher-
afﬁnity binding to JAM-A (Fig. 4A). For sialic acid-binding reovirus strains,
the initial interaction between the virus and the host cell is likely mediated by
sialic acid because of the high surface concentration of this carbohydrate. By
virtueof its rapidassociation rate, virusbinding to sialic acidwouldadhere the
virion to the cell surface, thereby enabling it to diffuse laterally until it encoun-
ters JAM-A. Such lateral diffusion has been reported for inﬂuenza virus [127]
and phage T4 [161]. After attachment, interactions between reovirus and
additional proteins on the cell surface may be required for internalization.
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Fig. 4A, B Stepwise disassembly of reovirus. A Schematic of the reovirus disassembly
steps. (a) Following attachment to cell-surface carbohydrate (α-linked sialic acid [SA]
for type 3 reoviruses) and junctional adhesion molecule-A (JAM-A), reovirus virions
enter cells by receptor-mediated endocytosis (b). Within an endocytic compartment,
the viral outer-capsid undergoes acid-dependent proteolysis. (c) The ﬁrst disassembly
intermediate is the ISVP, which is characterized by loss of σ3 and cleavage of μ1C into
particle-associated fragments δ and ϕ. (d) The ISVP then undergoes further confor-
mational changes to form the ISVP*. The ISVP* is characterized by conformational
rearrangements of the μ1 fragments to expose hydrophobic residues, release of μ1N,
and loss of attachment protein σ1. (e) The μ1 cleavage fragments mediate penetration
through the endosomal membrane releasing the transcriptionally active core into the
cytoplasm. B Structure of reovirus virions, ISVPs, and cores. Surface-shaded repre-
sentations of cryo-EM image reconstructions of reovirus are shown, as viewed along
a twofold axis of symmetry. Density, representingσ1, can bee seen extending from tur-
rets of λ2 at the icosahedral axes of virions and ISVPs. Cores lack σ1. (Image adapted
from Dryden et. al [46])
6
Overview of Entry Steps
Following attachment to cell-surface receptors, reovirus virions are deliv-
ered into the endocytic pathway (Fig. 4A). Although conclusive evidence
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for the mechanism of internalization is lacking, current data support a role
for clathrin-dependent endocytosis in reovirus cell entry. Thin-section EM
images show virions in structures that appear to be clathrin-coated pits on
the cell surface and in clathrin-coated vesicles in the cytoplasm [17, 18, 122,
139], suggesting clathrin-dependent uptake. This ﬁnding was conﬁrmed by
using video ﬂuorescence microscopy in which reovirus virions and clathrin
were observed to colocalize during internalization [56]. While these results
are interesting, the involvement of clathrin-dependent uptake in functional
reovirus entry (i.e., leading to productive reovirus infection) has not been
demonstrated.
Vesicles containing internalized reovirus virions are transported via mi-
crotubules [66] and accumulate in late endosomes [17, 18, 66, 122, 139]. In
the endocytic compartment, reovirus virions undergo stepwise disassembly
forming sequential disassembly intermediates, the ﬁrst of which is the in-
fectious subvirion particle (ISVP) (Fig. 4). ISVPs are characterized by the
loss of outer-capsid protein σ3, a conformational change in attachment pro-
tein σ1, and cleavage of outer-capsid protein μ1 to form particle-associated
fragments, δ and ϕ. Following further processing, ISVP-like particles (called
ISVP*s) penetrate through the endosomal membrane, leading to release of
transcriptionally active core particles, which lack μ1 and σ1, into the cyto-
plasm. Thus, the disassembly process consists of a highly coordinated series
of events that are dependent on host cell functions that act upon discrete
components of the viral outer capsid.
7
Cellular Factors That Facilitate Reovirus Disassembly
7.1
Reovirus Disassembly in Some Cell Types
Requires Acidic pH and Endocytic Proteases
Treatment of murine L cells [21, 90, 139] or rat insulinoma cells [21, 90,
139] with the weak base ammonium chloride (AC), which raises the pH of
endosomes and lysosomes [95, 111], blocks growthof reoviruswhen infection
is initiated with virions. However, ISVPs generated in vitro by treatment of
virions with chymotrypsin or trypsin can infect AC-treated cells [139]. This
ﬁnding indicates that the block to reovirus growth mediated by AC occurs
following internalization but prior to disassembly. Concordantly, treatment of
L cells with inhibitors of vacuolar proton ATPase activity, such as baﬁlomycin
A1 and concanamycin A, blocks infection by virions but not by ISVPs [91].
Thus, acidic pH is required for reovirus disassembly in some types of cells.
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Pharmacologic treatments also have been used to demonstrate an im-
portant function for endocytic proteases in reovirus disassembly. Treatment
of L cells with E64, an inhibitor of cysteine proteases [6], blocks growth of
reovirus virions. Similar to ﬁndings made in studies using acidiﬁcation in-
hibitors, ISVPs generated in vitro can infect E64-treated cells [3, 25, 52, 73],
suggesting that one or more endocytic cysteine proteases can catalyze reo-
virus disassembly. However, pepstatin A, an inhibitor of aspartyl proteases,
is incapable of blocking reovirus infection and uncoating in multiple cell
types [81]. Moreover, in vitro treatment of reovirus virions with cathepsin D,
an aspartyl protease, does not lead to generation of ISVPs [81]. Thus, aspartyl
proteases appear to be incapable of mediating virion-to-ISVP conversion.
Proteolytic enzymes are required for reovirus infection when mice are
infected by the peroral route [10, 15]. Virions are converted to ISVPs in
the intestinal lumen by the resident proteases chymotrypsin and trypsin.
ISVPs produced in this fashion infect intestinal M cells to gain entry into the
host [1]. ISVPs generated by chymotrypsin or trypsin in vitro or in the gut
lumen [10, 15] are similar to ISVPs generated in the endocytic compartment
of cells [4, 51].
7.2
Studies of Persistent Reovirus Infections Provide Clues
About the Identity of Proteases That Catalyze Disassembly
Support for a critical role of cysteine proteases in reovirus disassembly comes
from studies of persistent reovirus infections in cultured cells. Although usu-
ally cytolytic, reoviruses are capable of establishing persistent infections in
many types of cells in culture [41]. These cultures are maintained by hori-
zontal transmission of virus from cell to cell and can be cured of persistent
infection by passage in the presence of anti-reovirus serum. Cured (LX) cells
and the viruses isolated from persistently infected L-cell cultures (PI viruses)
harbor mutations that affect viral disassembly [41].
Parental L cells support growth of reovirus after infection by virions or in
vitro generated ISVPs. In contrast, LX cells do not support growth of reovirus
after infection by virions of wild-type virus but do so after infection by PI
virus virions or wild-type ISVPs [4, 44] (Fig. 5A). Since LX cells allow growth
of wild-type reovirus only when infection is initiated by ISVPs, these cells
are altered in the capacity to support steps in viral replication leading to
ISVP formation. L cells and LX cells do not differ in the capacity to bind
or internalize virions or distribute them to a perinuclear compartment [4].
Intravesicular pH is equivalent in both cell types, and virions colocalize with
an acid-sensitive ﬂuorophore in both L cells and LX cells. However, LX cells
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Fig. 5A, B Growth of wild-type and PI viruses in parental L cells and mutant LX
cells in the presence and absence of inhibitors of reovirus disassembly. A Growth of
T3D virions, PI 3–1 virions, and T3D ISVPs in L cells and LX cells. Monolayers of cells
(5×105) were adsorbedwith the viral particles shown at anMOI of 2 PFUper cell. After
1 h, the inoculum was removed, fresh medium was added, and cells were incubated
at 37 °C for 24 h. Cells were frozen and thawed twice, and viral titers in cell lysates
were determined by plaque assay. The results are presented as the mean viral titers for
two independent experiments. (Figure adapted from Wilson et al. [160] and Dermody
et al. [44])BGrowth of wild-type and PI viruses in the presence and absence of AC and
E64. Monolayers of L cells (5×105) were adsorbed with T3D or the PI viruses shown
at an MOI of 2 PFU per cell. After 1 h, the inoculum was removed, fresh medium was
added (with or without 10 mM AC or 100 μM E64), and cells were incubated at 37 °C
for either 0 or 24 h. Cells were frozen and thawed twice, and viral titers in cell lysates
were determined by plaque assay. The results are presented as the mean viral yields
(viral titer at 24 h divided by that at 0 h) for two independent experiments. (Figure
adapted from Wetzel et al. [157] and Baer and Dermody [3])
do not support the proteolytic disassembly of the viral outer-capsid following
internalization into the endocytic pathway [4, 51], suggesting a defect in
proteolytic activity in LX cells.
The major cysteine proteases in the endocytic compartment of ﬁbroblasts
like L cells are cathepsins B, H, and L, with cathepsin L being the most abun-
dant in several cell types [6, 16, 62, 69, 78]. These enzymes are ﬁrst produced
as inactive proenzyme precursors that are processed to yield single-chain
intermediates that are subsequently cleaved in lysosomes to form two-chain
mature forms consisting of heavy and light chains [63, 88, 93, 121, 125, 128].
In LX cells, only the precursor form of cathepsin L is found [4]. The mature,
double-chain form of cathepsin B is found in these cells; however, the enzyme
is inactive [51]. Neither cathepsin B nor cathepsin L is genetically altered in
LX cells, indicating an extrinsic block to the function of these enzymes.Mixed
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lysates of L cells and LX cells lack activity of both cathepsin B and cathep-
sin L [51], suggesting the presence of an inhibitor of cathepsin function in
LX cells. These ﬁndings suggest that a mutation in LX cells selected during
persistent reovirus infection alters the activity of cathepsin B and cathepsin L,
suggesting a critical function for these enzymes in reovirus disassembly in ﬁ-
broblasts. Consistent with a role for cysteine proteases in reovirus uncoating,
treatment of virions with either cathepsin B or cathepsin L in vitro results
in the formation of particles that have biochemical and growth properties
similar to ISVPs generated by treatment of virions with chymotrypsin or
trypsin [4, 50].
7.3
Proteases That Mediate Disassembly Vary Depending on Cell Type
The involvement of cathepsin B and cathepsin L in the disassembly of reo-
virus virions in ﬁbroblasts was conﬁrmed in studies using pharmacologic
inhibitors (Fig. 6) and genetically deﬁcient cell lines [50]. Infection of either
L cells treated with the cathepsin L inhibitor A-Phe-Tyr(t-Bu)-diazomethyl
ketone or cathepsin L-deﬁcientmouse embryo ﬁbroblasts results in inefﬁcient
proteolytic disassembly and decreased viral yields. In contrast, both L cells
treated with the cathepsin B inhibitor CA-074Me and cathepsin B-deﬁcient
mouse embryo ﬁbroblasts support reovirus disassembly and growth. How-
ever, removal of both cathepsin B and cathepsin L activity completely abro-
gates disassembly andgrowthof reovirus. Concordantly, cathepsinLmediates
reovirus disassembly more efﬁciently than cathepsin B in vitro [50]. These
results demonstrate that either cathepsin L or cathepsin B is required for
reovirus entry into murine ﬁbroblasts and indicate that cathepsin L is the
primary mediator of reovirus disassembly in these cells.
Proteases other than cathepsin B and cathepsin L also are capable of ISVP
formation. In P388D cells, a macrophage-like cell line, cathepsin S mediates
uncoatingof somestrainsof reovirus [68]. Like cathepsinsBandL, cathepsinS
is a cysteineprotease required forprocessing internalizedantigensbyantigen-
presenting cells [98, 101, 118]. The role of cathepsin S in reovirus disassembly
is important because during enteric infection, primary replication is thought
to occur in mononuclear cells of Peyer’s patches [58, 99].
8
Outer-Capsid Protein σ3 Regulates Reovirus Disassembly
The ﬁst step in the disassembly of reovirus virions is the proteolytic removal
of outer-capsid protein σ3. The σ3 protein is a major outer-capsid component
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Fig. 6A–C Effect of cathepsin B inhibitor CA-074Me (BI) and cathepsin L inhibitor Z-
Phe-Tyr(t-Bu)-diazomethyl ketone (LI) on growth and disassembly of reovirus strains
T1L and T3D in L cells. A Monolayers of L cells (4×105) were preincubated for 1 h
in medium supplemented with BI, LI, or both BI and LI at the concentrations shown
in μM. The medium was removed, and cells were adsorbed with each virus strain at
an MOI of 2 PFU per cell. After 1 h, the inoculum was removed, fresh medium with
or without BI and LI was added, and cells were incubated for 24 h. Viral titers in
cell lysates were determined by plaque assay. The results are presented as the mean
viral yield, calculated by dividing titer at 24 h by that at 0 h, for three independent
experiments. Error bars indicate standard deviations. UT, untreated. B Monolayers of
L cells (1×107) were preincubated for 1 h inmedium supplemented to contain 0–10 μM
BI or LI. The medium was removed, and cells were adsorbed with puriﬁed 35S-labeled
T1Lvirions at 10,000particles per cell.After incubationat 4°C for 1h, the inoculumwas
removed, fresh medium with or without BI or LI was added, and cells were incubated
at 37°C for either 0 or 3 h. Viral particles in cell lysates were subjected to SDS-PAGE.
Concentrations of BI and LI (μM) are shown at the top. UT, untreated. Viral proteins
are labeled on the right. C Quantitation of σ2 and σ3 band intensities. The densities
of bands corresponding to the σ2 and σ3 proteins were determined, and the results
are expressed as the mean σ3/σ2 ratios for three independent experiments. Error bars
indicate standard deviations. (Figure and legend modiﬁed from Ebert et al. [50])
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that protects the virion from degradation in the environment [105] and forms
a protective cap for the μ1 protein [46]. The latter function is especially
important during entry as μ1 is thought to be responsible for penetration of
ISVPs into the cytoplasm. By capping the μ1 protein, σ3 controls the timing of
penetration: if too early, the resulting particle may not be primed to initiate
transcription; if too late, the particle may be proteolytically degraded in the
lysosome before it gains access to the cytoplasm where transcription occurs.
Theσ3protein contains two largedomains separatedbyaﬂexiblehinge [46,
112] (Fig. 7). The N-terminus of σ3 is in the smaller, virion-proximal lobe,
and the C-terminus is in the larger, virion-distal lobe. These domains are
not discrete in primary sequence as the peptide chain passes back and forth
between the two lobes. A σ3-speciﬁc monoclonal antibody that inhibits the
σ1-mediated property of sialic acid binding engages the very tip of the virion-
distal lobe [102].
Studies of PI viruses have shed light on mechanisms of σ3 cleavage during
reovirus disassembly. In contrast towild-type reoviruses, PI viruses can infect
cells treated with either AC [4, 44, 157] or E64 [3] (Fig. 5B). In most cases,
growth of PI viruses in the presence of AC or E64 segregates with the S4 gene
segment [3, 157], which encodes σ3 [96, 100]. Moreover, passage of wild-type
reovirus in the presence of E64 selects E64-resistant viruses (D-EA viruses)
that contain mutations in the σ3-encoding S4 gene [52]. Therefore, mutations
in σ3 protein confer the capacity of variant reoviruses to grow in the presence
of pharmacologic inhibitors of reovirus disassembly.
All PI viruses analyzed to date have a mutation of Tyr354 to His near the
C-terminus of σ3 [3, 157]. This mutation is also selected in D-EA viruses [52].
PI and D-EA viruses exhibit altered kinetics of disassembly with degradation
of σ3 and cleavage of μ1 occurring much more rapidly both in vitro and
in cells [52, 157]. Image reconstructions of cryo-EM images of virions of PI
viruses indicate that the Tyr354 to His mutation confers an alteration in σ3
structure at the hinge region between the two lobes [160]. These ﬁndings
suggest that the C-terminus of σ3 regulates susceptibility of the protein to
cleavage.
The σ3 C-terminus also has been shown to dictate strain-speciﬁc differ-
ences in the susceptibility of σ3 to proteolytic attack [73, 74]. The σ3 protein
of strain T1L is cleaved more rapidly than that of T3D. Analysis of ISVPs re-
coated with chimeric σ3 proteins generated from T1L and T3D revealed that
the C-terminus is primarily responsible for the rate of σ3 proteolysis. More-
over, sequence polymorphisms at residues 344, 347, and 353 in σ3 contribute
to this effect [74].
Treatment of reovirus virions in vitro with either cathepsin B or cathep-
sin L leads to an initial cleavage of σ3 at a terminus [50]. Given that sequence
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Fig. 7A–C Cathepsin L cleavage sites in T1L σ3. A The primary amino acid sequence
of σ3 from amino acids 241 to 255 is shown. The arrows highlight cathepsin L cleavage
sites identiﬁed by N-terminal sequencing of σ3 cleavage products following treatment
of reovirus T1L with cathepsin L in vitro. B Cathepsin L cleavage sites are highlighted
in the crystal structure of σ3. A ribbondiagramof the crystal structure of T3Dσ3 [112]
is displayed. The cathepsin L cleavage sites in T1L are depicted in blue between amino
acids 243 and 244 and between 250 and 251. Surrounding residues, from amino acids
241 to 253, are shown in yellow. The C-terminal residues of σ3, from amino acids
340 to 365, are colored red. Amino acid 354, which is a site altered in PI and D-EA
viruses, is colored green. The virion-distal end of σ3 is at the top of the ﬁgure, and
the virion-proximal end and N-terminus are at the bottom. C An enlarged view of the
boxed region of σ3 indicated in panel B is shown using the same color scheme. Amino
acids 243, 244, 250, 251, and 354 are depicted in ball-and-stick representation. (Figure
and legend modiﬁed from Ebert et al. [50])
polymorphisms in the C-terminus determine susceptibility to proteolysis,
the initial cleavage of σ3 probably occurs in this region. During proteolysis
by cathepsin L, subsequent cleavages occur between residues 243–244 and
250–251 [50] (Fig. 7A). These cleavage sites are physically located near the C-
terminus in the σ3 crystal structure [112] (Fig. 7C). Because of this proximity,
the small end fragment released following initial cathepsin L cleavage likely
exposes the other two sites, rendering them sensitive to subsequent cleavage
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events. The C-terminus therefore appears to act as a safety latch that con-
trols access to internal, proteolytically sensitive sites in σ3. Because reovirus
disassembly in some cell types is an acid-dependent process, the safety latch
might be primed for movement at acidic pH. In viruses with mutations near
the C-terminus, such as PI and D-EA viruses, the safety latch may be altered
by structural rearrangements.
9
Conformational Changes in σ1
The disassembly of reovirus virions to ISVPs is accompanied by a dramatic
conformational change inσ1.EMimagesofnegatively stained reovirusvirions
and ISVPs reveal ﬁlamentous projections extending up to 400 Å from the
surface of ISVPs but not virions [61]. These images suggest that σ1 adopts
a compact form in the virion and a more extended one in the ISVP. Cryo-EM
image reconstructions of virions of reovirus prototype strains and cores of
T1L each lack a discernible density corresponding to σ1 at the icosahedral
vertices [46, 97]. However, in cryo-EM image reconstructions of T1L ISVPs,
discontinuous density is observed for σ1 extending approximately 100 Å
from each vertex (Fig. 4B). Presumably, the full length of σ1 is not visible
in reovirus particles because icosahedral averaging was employed for the
cryo-EM image reconstructions. The trimeric σ1 protein is positioned at an
icosahedral ﬁvefold axis; therefore, it does not obey icosahedral symmetry.
Moreover, σ1 possesses structural ﬂexibility, which also may preclude its
visualization by this technique.
The ﬂexibility of σ1 has been observed in EM images of negatively stained
σ1 isolated from virions, which show bending in individual ﬁbers at speciﬁc
regions within the molecule [60] (Fig. 1) and in the crystal structure of the
C-terminal half of T3D σ1 [31] (Fig. 2). In addition, a highly unusual cluster
of conserved aspartic acid residues is found at the trimer interface at the base
of the σ1 head [31] (Fig. 8). These residues may be important for triggering
conformational changes in the low pH environment of the endocytic path-
way. Acid-dependent conformational changes in the attachment proteins of
enveloped viruses, such as inﬂuenza virus and tick-borne encephalitis virus,
are well-documented [20, 137]. A four-residue linker that connects β-spiral
repeats 2 and 3 of the crystallized fragment of σ1, which are just N-terminal to
the σ1 head, confers ﬂexibility between the head and tail regions [31] (Fig. 2).
Despite the importance of σ1 in mediating attachment to host cells, the con-
formational changes that occur in σ1 during the viral entry and uncoating
steps and their signiﬁcance at present are poorly understood.
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Fig. 8A, B The σ1 head trimer interface. A View into the head trimer interface. Two
monomers are shown as surface representations and the third monomer is shown as
a blue ribbon. Surface residues that are within 4 Å of residues in the third monomer
are shown in red (residues conserved in T1L, T2J, and T3D σ1) and yellow (residues
unique to T3D σ1). The contact area involving conserved residues Val344, Asp345,
and Asp346 is boxed, and this region is shown in more detail in B. B View along
the trimer axis, centered at conserved residues Asp345 and Asp346 (yellow) located
at the base of the σ1 head. Residues Tyr313, Arg314, and Tyr347 engage in contacts
with the two aspartic acids. The side chains of Asp345 are likely to be protonated to
avoid an accumulation of negative charge at the interface. Hydrogen bonds involving
protonated Asp345 are indicated. Oxygen and nitrogen atoms of side chains are shown
as red and blue spheres, respectively. The Asp346 main chain amides also are shown as
blue spheres. (Image from Chappell et al. [31])
Mutations found in PI viruses provide additional evidence of a role for σ1
in viral entry independent of its function in receptor binding. All mutations
identiﬁed to date in PI virus σ1 protein are found in the tail region of σ1 and
alter the stability of σ1 oligomers [159]. Several mutations also are found in
the region of σ1 responsible for anchoring the protein into the virion surface.
Thus, mutations selected during persistent infection suggest that oligomer-
ization and σ1-capsid interactions are important for viral disassembly and
growth.
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Outer-Capsid Protein μ1 Mediates Membrane Penetration
Insight intomechanismsemployedbyreovirus topenetrate into thecytoplasm
ﬁrst came from studies of ISVPs generated in vitro. ISVPs, but not intact
virions, release 51Cr from preloaded L cells [17], lyse red blood cells in the
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presence of cesium ions [25, 27, 73], and form ion-permeant channels in
planar phospholipid bilayers [143]. ISVPs also facilitate entry into cells of the
toxin alpha-sarcin in the presence of inhibitors of reovirus uncoating [26, 91,
110]. These observations suggest that ISVPs are the immediate precursor to
the disassembly intermediate that facilitates delivery of the core particle into
the cytoplasm.
Following formation of ISVPs in endosomes, transcriptionally active core
particles, which lack both σ1 and μ1, are released into the cytoplasm. The
mechanism of penetration and the shedding of these outer-capsid proteins
has been the focus of recent work, which has led to the identiﬁcation of an
additional intermediateparticle formedsubsequent to the ISVP, the ISVP*[24,
26, 110] (Fig. 4A).
Most of the μ1 protein on mature virions is autocatalytically cleaved near
the N-terminus to generate two fragments, μ1N and μ1C [106, 130] (Fig. 9).
This cleavage is not required for virion assembly [110] and may occur phys-
iologically during the transition from the ISVP to the ISVP* [108]. In ISVPs,
μ1C is further cleaved by either endocytic [50, 139] or intestinal [15] proteases
to form fragments δ and ϕ, which remain particle-associated [103]. However,
the role of this cleavage in viral penetration is not understood, as core parti-
cles recoated with mutant forms of μ1 incapable of δ/ϕ cleavage can establish
productive infection [27]. In addition, μ1 is not cleaved at the δ/ϕ junction
in ISVPs generated in the presence of alkyl sulfate detergents (dpSVPs), yet
dpSVPs are infectious [25].
Transformation from the ISVP to the ISVP* in vitro is triggered by dif-
ferential cationic concentration or interactions with membranes [24, 26]. In
contrast to ISVPs, ISVP*s lackσ1 andhave analtered conformerof μ1 inwhich
internal hydrophobic residues are exposed. ISVP*s are capable of membrane
penetration and transcription initiation [24, 26]. The conformational change
in μ1 may be the driving force for both the loss of σ1 and the initiation of
transcription [86]. Mechanisms underlying these events are unknown, but
it is possible that μ1 rearrangement induces a conformational change in λ2,
the pentameric turret that anchors σ1, causing σ1 release. A μ1-induced con-
formational change in λ2 may also activate the transcriptional machinery
through interactions with either or both of the core proteins λ1 and σ2.
Cleavage of intact μ1 to form μ1N and μ1C is required for the generation
of the ISVP* [108, 110]. Particles recoated with mutant forms of μ1 inca-
pable of μ1N/μ1C cleavage can facilitate each of the entry steps, including μ1
conformational changes and transcription initiationbut are deﬁcient inmem-
brane penetration [110]. In addition to σ1, the N-terminal μ1 fragment μ1N
is released from the ISVP* [26]. The function of the released μ1 fragment in
membrane penetration is not understood. However, the presence of a myris-
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Fig. 9A–C The μ1 protein. A The μ1 trimer shown without bound σ3. One μ1 subunit
is colored by domain (domain I, light and dark blue [μ1N, μ1C]; domain II, light
and dark green [μ1N, μ1C]; domain III, red; domain IV, yellow); the other two μ1
subunits are shown in gray. The β-octyl glucoside in the colored subunit is in yellow;
the sulfate ion is shown in green and red. The σ3 binding site is indicated by an arrow.
BRibbondiagramof an isolatedμ1 subunit. Colors are as inA.CDomain segmentation
of the amino acid sequence as determined from the three-dimensional structure.
Domain color code as in A. The central domain II contains domains I and III as
inserts, and domain III similarly contains domain IV. (Figure and legend modiﬁed
from Liemann et al. [86])
toyl group at the N-terminus of μ1N suggests that this fragment interacts with
membranes and that the released μ1N may form a membrane-penetration
complex.
High-resolution structural analysis of μ1 has led to the development of
amodel for its role inmembranepenetration (Figs. 9, 10). Theprotein consists
of four domains: domains 1–3 are primarily α-helical while domain 4, which
sits atop the molecule, is a jelly-roll β-barrel [86] (Fig. 9). Three μ1 subunits
assemble into an oblong homotrimer, which is bound by the lower lobes of
three σ3 subunits. This arrangement gives rise to a heterohexameric complex
in which each σ3 subunit interacts intimately with two different μ1 subunits
(Fig. 10). The μ1 proteins serve as the principalmeans of capsid association by
mediating contacts between different heterohexamers [86]. The σ3 proteins
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Fig. 10 Structure of the μ13σ33 heterohexamer. A A μ13σ33 complex, viewed from
the side. The bottom of the complex would contact σ2 proteins on the surface of
the reovirus core. Three σ3 proteins (shown in gray) bind to the upper part of the
underlying trimer of μ1 (shown in yellow, red, and blue). The three μ1 chains are
wound tightly around each other. Each σ3 contacts two μ1 proteins. B Enlarged view
of the lower portion of the trimer, with the blue monomer removed for clarity. In
this view, it is evident that the protein has undergone autocatalytic cleavage between
residues 42 and 43. (Figure and legend modiﬁed from Liemann et al. [86])
do not contribute to the formation of this network but project outward, away
from the virion surface. The C-terminal lobe of each σ3 protein is therefore
easily accessible to proteases. The autocatalytic cleavage site that yields μ1N
and μ1C is located between residues 42 and 43, at the center of the trimer
near the base of the protein (Fig. 10). This site is buried in μ1 and distant
from residues that interact with σ3. The crystallized protein has undergone
cleavage at this position, resulting in separation of residues 42 and 43. The
δ/ϕ cleavage site is located in domain 3.
There are amphipathic helices and other hydrophobic residues in the cen-
ter of μ1, including the myristoylated Gly2 at the N-terminus [86]. Cleavage
of μ1 to μ1N and μ1C does not appear to result in conformational rearrange-
ments, but this cleavage, along with the loss of σ3, may render the μ1 trimer
metastable. Since the μ1N/μ1C cleavage sites in the threemonomers lie next to
each other, cleavage may soften this area of the molecule by altering protein–
protein contacts and allow an inﬂux of solvent into an area at the center of the
trimer structure.When the steric hindrance imposedbyσ3 is released, μ1may
then undergo the conformational alterations necessary to allow membrane
penetration.
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The conformational changes in μ1 that accompany viral disassembly are
thought to expose internal hydrophobic residues and release μ1N from the
particle [24, 26, 110]. Massive rearrangements are necessary to expose the
hydrophobic residues and myristoylated N-terminus [86]. The cleavage of μ1
to form μ1N and μ1C is necessary for productive infection [110]. However,
it is not clear whether membrane penetration is accomplished by soluble
or particle-associated μ1N, perhaps acting in concert with other regions of
the molecule. For example, an anion-binding site in domain 4 lies on the
outermost, solvent-exposed surface of the ISVP [86]. This site may bind to
phospholipid head groups bringing the virus particle into proximity with the
endosomalmembrane. This association alsomight trigger rearrangements in
μ1, revealing the myristoylated μ1N and the internal hydrophobic residues.
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Conclusions and Future Directions
Despite the accumulated knowledge about reovirus attachment to cell-surface
receptors and internalization into host cells, a precise understanding of the
mechanisms underlying the serotype-dependent differences in tropism ex-
hibited by reovirus in the murine CNS remains elusive. Since prototype and
ﬁeld-isolate strains of all three serotypes of reovirus utilize JAM-A as a re-
ceptor [8, 165], more work is required to determine the basis for serotype-
dependentdifferences in reovirusdisease.Weenvision fourpossibilities. First,
JAM-A may serve as a serotype-independent reovirus receptor at some sites
within the host, and other as yet unidentiﬁed receptors may confer serotype-
dependent tropism in the CNS. Studies using JAM-A-null mice [23] should
permit assessment of the role of JAM-A in reovirus pathogenesis and may
serve to highlight the existence of additional receptors. Second, it is possi-
ble that the carbohydrate speciﬁcity of a particular strain of reovirus directs
infection to speciﬁc cells or tissues. In support of this idea, reovirus strains
that vary in sialic acid utilization have also been shown to vary in disease
pathogenesis in the hepatobiliary system [9]. A third possibility is that re-
ovirus requires independent receptors for attachment and internalization. It
has not been deﬁnitively demonstrated that JAM-A alone can mediate inter-
nalization into host cells. Therefore, it is possible that virus is tethered to the
cell surface through interactions with carbohydrate and JAM-A, but only the
strains or serotypes that are capable of interactions with an internalization
receptor, which may be expressed in a cell- or tissue-speciﬁc manner, achieve
entry. Finally, differences in receptor utilization and internalization pathways
might inﬂuence disease pathogenesis by virtue of activating different types
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of signaling networks. Reovirus strains T1L and T3D differ in the capacity to
induce apoptosis [36, 119, 148], a property that has been linked to receptor
binding and disassembly [8, 34, 35]. Studies of reovirus-induced myocarditis
provide support for the hypothesis that postattachment signaling plays a role
in disease production. Treatment of reovirus-infected mice with a calpain
inhibitor dramatically reduces myocardial injury and apoptotic myocardial
cell death [38]. Additional studies are required to conﬁrm an association of
apoptosis with reovirus-induced disease. However, it appears that the role
of reovirus receptors in disease pathogenesis is more complex than simply
mediating the virus-docking event.
Tropism of reovirus in the host may also be inﬂuenced by postattachment
entry steps. All available evidence suggests that reovirus virions are inter-
nalized by clathrin-mediated endocytosis. However, inhibition of clathrin-
mediated uptake by treatment of cells with hypertonic sucrose or dominant-
negative Eps15 has only a modest effect on virus entry [56]. This observation
suggests that reovirus is capable of using more than a single entry pathway,
a situation observed for other viruses. Inﬂuenza virus utilizes both clathrin-
mediated and clathrin- and caveolin-independent uptake pathways [94, 124,
129], and human papillomaviruses use different pathways of entry depend-
ing on the viral type [19]. Additional studies of reovirus entry pathways are
required to dissect the functional mechanisms used by reovirus to internalize
into cells. If cell-speciﬁc entry pathways are elucidated, then the type of uptake
mechanism may inﬂuence target cell selection in the host.
Tissue-speciﬁc expression of endocytic proteases might serve as an ad-
ditional determinant of reovirus tropism. Cathepsin B and cathepsin L are
required for reovirus uncoating in ﬁbroblasts [50], whereas cathepsin S is
required in macrophage-like P388D cells [68]. Interestingly, not all reovirus
strains infect P388D cells [68], suggesting that different strains use different
enzymes for uncoating in different cell types. While cathepsins B and L are
ubiquitously expressed, cathepsin S displays a more restricted and regulated
expression pattern with increased levels in tissues and cells of the immune
system (reviewed in [28]). It is noteworthy that inﬂuenza virus [76, 77] and
rotavirus [40, 57] display tropismpartly on thebasis of expressionof proteases
required for viral entry. Studies of reovirus pathogenesis using mice deﬁcient
in various proteases should clarify the role of these enzymes in viral tropism
and disease.
The role of acidic pH in reovirus disassembly is unclear. Viruses with a His
at residue 354 inσ3 can grow in the presence ofAC [157]. This ﬁnding suggests
that the altered conformationofσ3-His354 imparts an increased susceptibility
to cleavage, allowing proteases enhanced access to internal cleavage sites.
Thus, σ3-His354 may mimic a pH-dependent conformational intermediate
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in the uncoating pathway. However, cathepsin B and cathepsin L require
acidic pH for activity. Therefore, it is possible that the requirement for acidic
pH during viral entry and disassembly serves to provide the appropriate
conditions for the action of these enzymes. AC does not alter reovirus growth
inP388Dcells inwhichdisassembly is catalyzedbycathepsinS [68], anenzyme
that does not require acidic pH [79].However, yields of reovirus in P388Dcells
are substantially less after infection by virions than by ISVPs [68], suggesting
that entry into these cells is not optimally efﬁcient. The role of acidic pH in
internalization and disassembly may be better understood through studies of
AC-resistant viral variants currently ongoing in our laboratory [166].
The massive rearrangements of μ1 during disassembly and membrane
penetration are of considerable interest. The trigger for these conformational
changes is not known, nor is it understood whether the process is simply
dependent on the removal of σ3 or on other factors as yet unidentiﬁed. In
addition, it is not apparent whether the N-terminal myristoylated fragment
of μ1 must be released from the virion to mediate membrane penetration
or whether the entire particle in some way contributes to membrane rup-
ture. Ongoing studies in this area will likely contribute general insights into
nonenveloped virus penetration and establish how viral assembly is precisely
coordinated to prime the particle for the stepwise disassembly process.
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Reovirus attachment protein 1 mediates engagement of
receptors on the surface of target cells and undergoes dramatic
conformational rearrangements during viral disassembly in the
endocytic pathway. The 1 protein is a filamentous, trimeric
molecule with a globular -barrel head domain. An unusual
cluster of aspartic acid residues sandwiched between hydropho-
bic tyrosines is located at the 1 subunit interface. A 1.75-A˚
structure of the 1 head domain now reveals two water mole-
cules at the subunit interface that are held strictly in position
and interact with neighboring residues. Structural and bio-
chemical analyses of mutants affecting the aspartic acid sand-
wich indicate that these residues and the corresponding che-
lated water molecules act as a plug to block the free flow of
solvent and stabilize the trimer. This arrangement of residues at
the 1 head trimer interface illustrates a new protein design
motif that may confer conformational mobility during cell
entry.
Mammalian orthoreoviruses (reoviruses)5 attach to cells by
specific binding to both carbohydrate and proteinaceous recep-
tors. For serotype 3 reoviruses, viral attachment is a multistep
process initiated by low affinity binding to sialic acid followed
by high affinity binding to junctional adhesion molecule-A
(JAM-A) (1, 2). These steps are mediated by discrete receptor-
binding domains in the attachment protein, 1 (3), a fiber-like
molecule with head-and-tail morphology (4–6). Strain type 3
Dearing (T3D) 1 has distinct binding sites for its receptors:
the head domain binds to JAM-A with high affinity (2),
whereas a region in the tail has been implicated in binding to
sialic acid (1, 3, 7).
Viral attachment to the cell surface by 1 leads to internal-
ization of the virus by receptor-mediated endocytosis that is
likely clathrin-dependent (8–10). Within endosomes, virions
undergo acid-dependent, proteolytic disassembly to form
infectious subvirion particles (8, 11). Infectious subvirion par-
ticles penetrate endosomal membranes and release transcrip-
tionally active cores into the cytoplasm (12–14). Accumulating
evidence suggests that 1 undergoes dramatic conformational
changes during viral disassembly and that these changes facili-
tate key steps in the cell entry process (4, 15, 16).
We previously determined the structure of the C-terminal
half of1, which comprises the head domain plus a short region
of the tail (6). This structure provided clues about the interac-
tion of the head domainwith its receptor JAM-A and the nature
of trimer contacts. The head domain contains a water-filled
cavity formed by three eight-stranded -barrels, one donated
by each monomer. The tail region consists of three -spiral
repeats. One of the most remarkable features of the 1 struc-
ture is a cluster of aspartic acid residues at the base of the head
domain (6). Molecular dynamics studies suggest that these res-
idues are likely to play a role in mediating conformational
changes in 1 (17). However, at 2.6 Å resolution, the structure
did not allow precise placement of water molecules and visual-
ization of contacts between amino acids with sufficient accu-
racy to explain how such a unique arrangement of amino acids
is compatible with a higher order structure.
In this study, we determined a high resolution structure of a
fragment of T3D 1 that comprises the head domain and a
single -spiral repeat of the tail. The structure has been refined
to a resolution of 1.75 Å, allowing us to discernwith high clarity
details of the subunit interface in the vicinity of the aspartic acid
cluster. Furthermore, we have analyzed two 1 mutants with
alterations in the vicinity of the subunit interface to determine
the effects on receptor binding capacity and trimer stability.
Our studies suggest that the aspartic acid cluster serves as a
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molecular switch that, depending on the microenvironment,
can stabilize or destabilize the formation of a trimeric structure.
EXPERIMENTAL PROCEDURES
Protein Expression, Purification, and Analysis—A cDNA
encoding residues 293–455 of T3D 1 was amplified by PCR
and introduced into pGEX4T-3 (GE Healthcare). Mutations
were engineered using site-directed PCR with appropriate
mutagenic primers. Expression was induced with 0.2 mM IPTG
in Escherichia coli strain BL21(DE3) pLys-S cells (Novagen) at
25 °C. Bacteria were centrifuged to form a pellet, solubilized in
50 mM Tris (pH 7.8), 3 mM EDTA, 1% Triton X-100, 2 mM
-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, and
100 g/ml lysozyme, submitted to 50% duty-cycle sonication
pulses using a Branson Sonifier 450, and centrifuged at
15,000  g. The soluble fraction was purified using a 5-ml
GSTrapFF column (GE Healthcare) and eluted with 30 mM
reduced glutathione, 2 mM -mercaptoethanol, 3 mM EDTA,
and 50 mM Tris (pH 8.05). Controlled tryptic protease treat-
ment was performed overnight at 4 °C to remove the glutathi-
one S-transferase (GST) tag. The sample was equilibrated using
PD-10 desalting columns and purified further using Mono Q
anion-exchange chromatography (GE Healthcare) with an
increasing gradient of NaCl in 20 mM HEPES (pH 7.1). The
1-Y313A mutant protein was cleaved with thrombin on-col-
umn and further purified by gel filtration using a Superdex 75
column (GEHealthcare). Human JAM-A (hJAM-A), expressed
as a GST fusion protein, was purified as described (18). Analyt-
ical scale gel filtration was performed using a Superdex 75 col-
umn mounted on a SMART system (GE Healthcare) in 20 mM
Tris (pH 7.5), 100 mM NaCl.
Protein Crystallization and Data Collection—Purified T3D
1 head domain was subjected to size-exclusion chromatogra-
phy in 20 mM Tris (pH 7.5), 100 mM NaCl, and 0.01% sodium
azide and concentrated usingMillipore 5MWCO filters to 13.6
mg/ml, as assessed by directmeasurement of absorbance at 260
and 280 nm using the relationship: c[mg/ml]  (1.55 
A280 nm)  (0.76  A260 nm), since the T3D 1 head domain
does not react linearly with either Bradford or Lowry dyes (data
not shown). Crystals of native 1 protein were grown from
10–12% polyethylene glycol 8000, 0.2 M magnesium sulfate,
and 0.1 M sodium cacodylate (pH 6.9) by mixing an equal
amount of protein and precipitant solution. 1-D345N was
concentrated to 8 mg/ml, and crystals were grown using the
same conditions used to cultivate crystals of the wild-type pro-
tein but with 20% polyethylene glycol 8000. Crystals were flash-
frozen using glycerol as cryoprotectant. Data from wild-type
crystals were collected at the Brookhaven National Laboratory
Synchrotron (beamline X29 features high flux radiation and
ADSCQuantum-315 CCD detector). Data for 1-D345N crys-
tals were collected at the X6S beamline of the Swiss Light
Source (Villigen, Switzerland) using a MarCCD detector. Both
data sets were collected from single crystals and processed with
HKL2000 (19).
Structure Determination—Crystals of wild-type 1 belong to
space group P21 (a 83.93 Å, b 51.38 Å, c 108.87 Å, 
95.66°) and contain six molecules, forming two complete tri-
mers, in the asymmetric unit. The structure was determined by
molecular replacement using the trimeric 1 head domain (6)
as a search model in AMoRe (20). Alternating rounds of model
building and refinementwere performed initially using the pro-
grams O (21) and CNS (22), respectively. The programs Coot
(23) and Refmac5 (24) were then used to refine the model.
1-D345N also formed crystals that belong to space group P21,
with very similar unit cell dimensions (Table 1). The structure
of this protein was solved and refined to 1.85 Å using Coot and
Refmac5. Structure factors and coordinates have been depos-
ited with the Protein Data Bank with accession codes 2OJ5 and
2OJ6 for the wild-type and mutant proteins, respectively.
Surface PlasmonResonance—ABIAcoreCM5 chip (Pharma-
cia Biosensor AB) was coated with mouse ascites containing
monoclonal anti-GST antibody (Sigma) to 10,000 RU protein
(2000RUantibody) by amine coupling. PurifiedGSTorGST-
hJAM-A ectodomain fusion protein at a concentration of 2 M
in HEPES-buffered saline (pH 7.0) were captured by injection
across individual flow cells of an antibody-coated CM5 chip for
3min at 30l/min using a BIAcore 2000 (Pharmacia Biosensor
AB). Purified T3D1 head domainwas injected across the con-
jugated chip surface at 30 l/min. Following 1 binding, chip
surfaces were regenerated with a 20-l pulse of 10 mM glycine
(pH 2.5). Affinity constants for 1 binding to hJAM-A were
determined using separate kon and koff nonlinear regression
with BIAevaluation 3.0 software (Pharmacia Biosensor AB),
assuming a 1:1 Langmuir binding model (25).
RESULTS
Purification of the1Head—Thepreviously crystallizedT3D
1 protein (6) contained a flexible linker between the C-termi-
nal two-spiral repeats of the tail. This flexibility likely contrib-
uted to the observed diffraction limit of 2.6 Å for these crystals.
To obtain better diffracting crystals of T3D 1, we designed a
modified construct containing the entire head domain and only
the C-terminal -spiral repeat of the tail (residues 293–455).
We also tested an additional construct comprising only the
head domain (residues 309–455), but it did not yield soluble
and trimeric protein, suggesting that the C-terminal -spiral
contributes to trimer formation. The protein was produced
with a cleavable N-terminal GST tag and purified via sequential
glutathione affinity chromatography and anion exchange chro-
matography. Subsequent gel filtration showed that the protein
elutes at an apparent molecular weight of45 kDa, consistent
with a trimer (see Fig. 4A). N-terminal sequencing confirmed
that the product released following protease treatment was the
1 head domain with two additional amino acids from the pro-
tease recognition sequence (data not shown).
Binding of the 1 Head Domain to JAM-A—To determine
whether the purified protein folds natively, we quantitatively
assessed the capacity of the 1 head domain to bind to
JAM-A using surface plasmon resonance. The JAM-A
ectodomain, expressed and purified as a GST fusion protein
(18), was captured on a biosensor surface with a GST-spe-
cific antibody. When injected across the biosensor surface,
purified 1 head bound saturably and reversibly to the GST-
JAM-A ectodomain but not to GST alone (Fig. 1A). Kinetic
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analysis of the 1-GST-JAM-A interaction using BIAevalu-
ation 3.0 software indicated aKD of7 109 M, a value that
approximates the KD determined for a larger fragment of 1
(2). These results indicate that the purified 1 head domain
is functional and that the JAM-A-binding domain of 1 lies
within residues 293–455.
Overall Structure of the1HeadDomainat 1.75ÅResolution—
Diffraction data were collected at the National Synchrotron
Light Source (Brookhaven National Laboratory) using crystals
of the purified 1 head domain. The structure was solved by
molecular replacement using the previously determined lower
resolution structure of a C-terminal
fragment of 1 (6) and refined to
1.75 Å (Table 1). An omit map for a
portion of the refined structure cal-
culated without model bias (supple-
mental Fig. 1) demonstrates that the
model is accurate. Concordantly,
bothworking and freeR-factors (38)
are very low (Table 1), indicating
that the structure is well refined and
of high quality. A total of six mono-
mers, arranged into two almost
identical trimers, are present in the
asymmetric unit of the crystals. A
ribbon tracing of one trimer is
shown in Fig. 1B. Each 1monomer
is composed of an eight-stranded
-barrel. The overall conformation
of the monomers is very similar, with the exception of two lon-
ger and presumably flexible loops: the G-H loop at the top of
eachmonomer and the D-E loop at its base.With the exception
of His-388, all 1 residues occupy allowed regions in the Ram-
achandran diagram (24). However, since the density corre-
sponding to His-388 is unambiguous, it appears that a salt
bridge to Glu-348 fixes its side chain in its observed conforma-
tion. Asp-345 is located in the generously allowed region of the
Ramachandran diagram; it forms, together with Asp-346, a
-hairpin between -strands B and C (supplemental Fig. 1).
The dihedral angles classify this region as a type II -hairpin
(26).
Contacts in the 1 Trimer—Trimer formation buries from
solvent an area of 2292 Å2 per monomer. Residues in the tail
account for about 25% of this area, primarily through hydro-
phobic interactions between the strands of the -spiral. The
three -barrel domains that form the head engage in a more
complex pattern of interactions.Multiple contacts between the
subunits at the outer edges of each monomer result in binding
surfaces that extend from the base of the head to its top (Fig.
2A). However, a large cavity exists at the center of the trimer,
and this cavity is surrounded by smaller regions that lack inter-
subunit contacts (Fig. 2A). The central cavity measures15 Å
in height and 10 Å in width and contains a large number of
orderedwatermolecules that are connected to the exterior sur-
face through channels at the top of the trimer (Fig. 2B). The
cavity probably also containsmany less well orderedwatermol-
ecules, which are not visible in our electron density maps.
Dimensions of the channels leading toward the cavity suggest
that water molecules can flow freely to the top of the trimer. In
contrast, the bottom of the cavity is sealed by the three Tyr-347
side chains.
The Aspartic Acid Sandwich—An unusual cluster of aspartic
acid residues lies just below the water-filled cavity. Each mon-
omer contributes two aspartic acid residues, Asp-345 and Asp-
346, to this cluster, giving rise to a total of six aspartic acid side
chains that are arranged in close proximity. Asp-345 and Asp-
346 are located at the very tip of a -hairpin between -strands
B and C (Fig. 3,A and B). -Hairpins are small structural motifs
stabilized by a defined backbone hydrogen bond pattern (27).
FIGURE1.Functional andstructural characterizationof the1headdomain.A, T3D1headbinding to the
JAM-A ectodomain. Purified 1 head domain at 300 nM (red), 30 nM (yellow), and 3 nM (green) concentrations
was injected over a biosensor surface coatedwith either GST or GST-JAM-A. Binding of1 head domain to GST
was set as the base line (gray). Binding is measured in resonance units (RU). The calculated affinity for binding
to GST-JAM-A, expressed as apparent KD, is approximately 7 10
9
M. B, high resolution structure of the 1
head. Shown is a ribbon tracing of the trimer, with the three chains drawn in red, orange, and blue. Termini are
labeled in one monomer with N (N terminus) and C (C terminus). Bwas prepared using RIBBONS (36).
TABLE 1
Data collection and refinement statistics for the wild-type1 and
1-D345N crystal structures
Data set Wild-type 1 1-D345N
Diffraction dataa
Space group P21 P21
Unit cell dimensions (Å) a 83.9 a 84.0
b 51.4 b 51.6
c 108.9 c 108.9
Angles (°)  95.7  95.6
Resolution range (Å) 30-1.75 30-1.85
Completeness (%) 96.7 (86.7) 98.7 (97.9)
Total reflections 300,167 347,405
Redundancy (%) 3.3 (2.6) 4.4 (4.0)
Rmerge (%)b 9.3 (42.7) 9.6 (41.6)
I/I 15.7 (2.3) 6.5 (1.4)
Refinement statistics
Rcryst (%); work setc 22.8 (30.3) 17.5 (23.0)
Rcryst (%); free setc 27.4 (38.1) 22.4 (27.3)
Overall B-factor (Å2) 15.7 17.2
Root mean square deviation
bond lengths (Å)
0.008 0.012
Root mean square deviation
bond angles (°)
0.963 1.202
Number of water molecules 1166 953
Ramachandran plot:d
Most favorable regions 88.5% 87.9%
Additional allowed regions 10.0% 10.5%
Generously allowed regions 1.0% 1.5%
Disallowed regions 0.5% 0.0%
a Data sets were collected at 100 K and a wavelength of 1.1 Å (wild-type) and 1.0 Å
(D345N). Values in parentheses refer to the outermost resolution shell (1.75–1.81
Å for wild-type 1 and 1.85–1.92 Å for D345N).
bRmergehklI I/hklI , where I is the intensity of a reflection hkl, and I is the
average over symmetry-related observations of hkl.
c RcrysthklFobs Fcalc/hklFobs, where Fobs and Fcalc are observed and calculated
structure factors, respectively. Free set (38) contains 10% of the data.
d Calculated with PROCHECK (24).
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The hairpins of the three monomers face each other, with the
side chains of Asp-345 making key contacts. The aspartic acids
are partitioned between two layers that each contain three tyro-
sine residues, Tyr-347 at the top and Tyr-313 at the bottom
(Fig. 3, C and D).
Each Asp-346 side chain forms a salt bridge with Arg-314
from a neighboring monomer, but the Asp-345 side chains are
not engaged in any ionic interactions (with other residues or
with cations) that would negate their negative charges. The
accumulation of three negative charges in such a hydrophobic
environment would be highly unfavorable. Although hydrogen
atoms cannot be seen in our electron density maps even at the
high resolution obtained (1.75 Å), the location and orientation
of the carboxyl groups strongly suggests that they are proto-
nated. A protonated state of Asp-345 is also suggested by
molecular dynamics studies of 1 (17). Each protonated car-
boxylate forms two hydrogen bonds. One of these involves the
hydrogen atomof theAsp-345 carboxyl group and the carbonyl
oxygen of a neighboring Asp-346 residue; a second is formed
between the carbonyl oxygen and the backbone amide group of
Asp-346 in a neighboring monomer. Since these two hydrogen
bonds occur three times, and since there are few other hydro-
gen bonds involved in head trimerization, the aspartic acid
sandwich likely makes a major contribution to trimer stability.
The cluster of aspartic acids is sandwiched between
hydrophobic residues that block access of solvent molecules
to the carboxylate groups. One side of this sandwich (the “top”
in Fig. 3D) is formed by Val-344 and Tyr-347, the other (the
“bottom” in Fig. 3D) is formed by Tyr-313 and Met-309. Two
well ordered water molecules located directly on the 3-fold axis
are also present in this arrangement of amino acids. These
water molecules interact with Tyr-313 and Asp-345, respec-
tively, and they are held in place by an extensive hydrogen bond
network. Buried water molecules can sometimes be exchanged
without major unfolding. However, residues in the immediate
vicinity of the two water molecules have temperature factors
that are among the lowest of the entire structure (supplemental
Fig. 2), suggesting that thermal mobility is low in this area.
Thus, it is unlikely that the water molecules can be exchanged.
Purification and Characterization of 1 Y313A—To explore
potential conformational changes of1, we generated substitu-
tions of two key residues of the cluster, Tyr-313 (Y313A) and
Asp-345 (D345N). The mutant proteins were analyzed for
receptor binding properties and the capacity to form trimers.
We reasoned that substitution of Tyr-313 with a smaller amino
acid might allow influx of water molecules to the aspartic acid
cluster, thereby causing the trimer to undergo structural
changes triggered by charged Asp-345 side chains. The
1-Y313A mutant protein was expressed as a GST fusion in
bacteria, purified by glutathione affinity, proteolytically cleaved
from the GST tag on-column, and further purified using gel
filtration. Purified 1-Y313A is soluble and elutes as a mono-
mer by gel filtration chromatography (Fig. 4A). Treatment of
1-Y313Awith each of three different cross-linking reagents of
various lengths (11.4 to 16.1 Å) failed to alter the chromato-
graphic mobility of the mutant protein (data not shown).
1-Y313A was incapable of binding to JAM-A by either gel
filtration (data not shown) or surface plasmon resonance (Fig.
4B), indicating that a trimeric form of 1 is required for JAM-A
engagement. Circular dichroism spectra of 1-Y313A show a
secondary structure content similar to that of wild-type 1,
suggesting that 1-Y313A is folded properly (data not shown).
Thus, our results indicate that residue Tyr313 is required for
trimerization and that the trimeric form of 1 is essential for
receptor binding.
Characterization and Structure Analysis of 1 D345N—To
determine whether structural and functional changes occur
upon replacement of Asp-345 with asparagine, we engi-
neered a D345N mutation in the wild-type T3D 1 head
construct. We anticipated that hydrogen bonds might form
between the asparagine residues, stabilizing the trimer inter-
face in much the same manner as accomplished by the pro-
tonated Asp-345 side chains. The mutant protein was puri-
FIGURE 2. Architecture of the 1 head subunit interface. A, contacts
between subunits in the T3D1 trimer. Three views, each differing by 90°, are
shown.Onemonomer is shownas ablack ribbon, and its contact areawith the
other two monomers is represented as a molecular surface. Residues dis-
cussed in the text are labeled. The contact area was calculated using
AREAIMOL (24) as the solvent-accessible areadifferencebetween the trimeric
andmonomeric forms of themolecule. The difference values range from1Å2
(dark blue) to 52Å2 (red). Regionswith a high area difference have low solvent
accessibility in the trimer and thus represent areaswith high affinity intersub-
unit contacts. Surfaceswith an area difference of less than 1Å2 are not shown.
Calculationswere performed using a point density/Å2 of 1 and a solventmol-
ecule radius of 1.4 Å. B, solvent structure at the1 head interface. Twomono-
mers are shown as a surface representation; the third monomer has been
removed to allowa view into the trimer interface.Orderedwatermolecules at
the interface are represented with spheres. The waters shown in blue fill most
of the central cavity between the monomers and can leave the cavity via
channels leading to the topand the sidesof the trimer (arrows). The twowater
molecules shown in red are located near the Asp-345 side chains. These
waters are solvent-inaccessible. This figure was generated using PyMOL (37).
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fied using the strategy employed
for purification of the wild-type
T3D 1 head domain. The
1-D345N mutant forms trimers
at neutral pH (Fig. 4A) and binds
to JAM-A with an affinity similar
to that of wild-type 1 (Fig. 4B).
Thus, 1-D345N is biochemically
and functionally indistinguishable
from the wild-type protein.
To test whether the D345N
mutation in the T3D 1 head
domain alters the conformation of
the aspartic acid sandwich, we
determined the structure of
1-D345N. Themutant protein was
crystallized using conditions similar
to those employed to crystallize the
wild-type protein. We collected a
complete data set from the
1-D345N crystals to 1.85 Å and
solved the structure by molecular
replacement using thewildtype pro-
tein structure as a model (Table 1).
The 1-D345N mutant crystallized
as a trimer with a structure that is
nearly identical to that of the wild-
type T3D 1 head domain (Fig. 1B).
At the subunit interface, the two
water molecules observed just
above and below residues 345 are
at almost exactly the same posi-
tion in 1-D345N (Fig. 5). The
amino groups of Asn-345 form the
same hydrogen bond pattern as
the hydroxyl group of protonated
Asp-345. Thus, the mutant structure provides evidence that
in trimeric, wild-type 1 all Asp-345 residues must be
protonated.
DISCUSSION
Formation of 1 Trimers—Although a C-terminal fragment of
1 has been crystallized (6), further characterization at an atomic
level of resolution has enhanced an understanding of its trimeric
nature. Interactions that form the trimer are highly complex. The
base of the trimer is held firmly together by hydrophobic interac-
tions, a standard means of inducing the formation of oligomeric
structures. In contrast, contacts at the center and top of the trimer
involve interrupted surfaces, cavities filled with water molecules,
trapped individual water molecules, very few hydrophobic con-
tacts, andprotonatedsidechains that formhydrogenbonds.These
types of interactions are unusual for protein-protein contacts.We
think that the1 head is designed to exist as bothmonomeric and
trimeric species. In fact, themutation of only one residue, Y313A,
results in soluble, folded protein that is entirely monomeric. A
single substitution at the base of the trimer therefore suffices to
completely abolish trimer formation, indicating that the lower
affinity contacts at the center and top of the 1 head are not suffi-
cient for stabilization of the trimer.
Comparison of deduced amino acid sequences of1 proteins
from prototype and field-isolate reovirus strains reveals that
Asp-345 and Asp-346 are highly conserved (6, 28). Addition-
ally, hydrophobic residues that form the top and bottom of the
aspartic acid sandwich show a high degree of conservation.
Phenyl ring-containing side chains are found at positions 313
and 347 in a 1 sequence alignment. For example, strain type 1
Lang contains phenylalanine and tryptophan residues, and
strain type 2 Jones contains tyrosine and tryptophan residues at
positions corresponding to Tyr-313 and Tyr-347 in T3D 1.
Furthermore, a hydrophobic residue (isoleucine, leucine,
methionine, or valine) is found at position 309, and a valine is
absolutely conserved at position 344. The striking level of
sequence conservation at these positions suggests that the
aspartic acid sandwich serves an essential function in reovirus
replication.
Engagement of JAM-A—Our analysis shows that the
1-Y313A mutant is soluble and monomeric. Furthermore,
since its CD spectrum is similar to that of wild-type 1,
1-Y313A appears to be properly folded. However, the mutant
FIGURE 3. An aspartic acid sandwich at the 1 head trimer interface. A, ball-and-stick view of the type II
-hairpin on which Asp-345 is located. Residues 342–349 are shown. Oxygen atoms are shown in red, and
nitrogen atoms are shown in blue. Main-chain hydrogen bonds are represented with black dotted lines. Letters
B andC refer to-strands in the1head.B, arrangementof-hairpins and theaspartic acid cluster as seen from
the top of the molecule. The view is along the 3-fold axis. The -strands are depicted as arrows, and -strands
of one monomer are labeled. Side chains of Asp-345 and Asp-346 are shown in ball-and-stick representa-
tion. C, schematic view of the aspartic acid cluster, shown in the same orientation as that in B. Residues
that interact with Asp-345 are shown in orange (monomer A), green (monomer B), and blue (monomer C).
Hydrogen bonds are shown as dotted lines.W1 andW2 represent the two water molecules trapped inside
the cluster.D, ball-and-stick representation of the aspartic acid cluster and surrounding residues. The view
is perpendicular to the 3-fold axis. Residues discussed in the text are labeled in one monomer. The two
trapped water molecules are represented with red spheres. The color code is the same as that used in C.
This figure was prepared using RIBBONS (36).
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protein does not bind to JAM-A. Themost likely interpretation
of these findings is that a trimeric form of 1 is required for
engagement of JAM-A. We envision two possible explanations
for these results. First, the JAM-A binding site may extend
across more than one monomer. Second, the surface structure
of the JAM-A-binding region may be stable only in the context
of a trimer. We think it unlikely that JAM-A makes a direct
contact with Tyr-313 or with residues in close proximity. Tyr-
313 is not exposed to solvent in the trimeric wild-type protein
andwould be unlikely to encounter JAM-A at its position in the
head trimer interior.
The structure of1 is closely related to that of the adenovirus
attachment protein, fiber (6). Moreover, the receptors for reo-
virus and adenovirus, JAM-A and coxsackievirus and adenovi-
rus receptor, respectively, also share significant structural and
functional homology and may engage their viral ligands in a
similar manner (29). We note that the adenovirus fiber knob
binds to its receptor coxsackievirus and adenovirus receptor via
contacts between two knob subunits and a single receptor mol-
ecule. If this mode of binding is conserved in 1, it would be
affected by alterations at the trimer interface.
We observed a single magnesium ion adjacent to residues
Asp-365 andGlu-419 at the center of the concave surface of the
1head (data not shown). This surface of1mimics the JAM-A
dimer interface and has been proposed to participate in inter-
actions with JAM-A (29, 30). The side chains of Asp-365 and
Glu-419 are exposed to solvent and exist in close spatial prox-
imity to side chains of Arg-427 and Arg-429. These residues
would be positioned to engage in salt-bridge interactions with
charged residues in the receptor. In support of this idea, our
preliminary analysis of point mutants of JAM-A suggests that
acidic and basic residues in the JAM-A dimer interface are
required for high-affinity interactions with 1.6
A Unique Cluster of Aspartic Acid Residues at the Head Tri-
mer Interface—The structure of 1 reveals a unique cluster of
solvent-inaccessible, conserved aspartic acid residues at the
head trimer interface. A key aspect of these residues is that they
are located at the very tip of a -hairpin. As judged by its tem-
perature factors (supplemental Fig. 2), the-hairpin is rigid and
possesses limited mobility. Three lines of evidence support the
conclusion that the side chains of Asp-345 must be protonated
6 K. M. Guglielmi and T. S. Dermody, unpublished observations.
FIGURE4.Functional analysisof1mutants.A, gel filtrationof T3D1head
mutants. Purified wild-type T3D 1 head (blue), 1-D345N (red), and
1-Y313A (yellow) constructs were applied to a Superdex 75 gel filtration
column (GE Healthcare) in 20 mM Tris (pH 7.5), 100 mM NaCl. The D345N
mutant elutes at the same time as the wild-type protein, indicating that it
forms a trimer, whereas the Y313A mutant shows a significantly smaller
molecular weight that corresponds to monomeric protein. B, binding of T3D
1 headmutants to the JAM-A ectodomain. Purified point mutants of the 1
head domain at 300 nM (red), 30 nM (yellow), and 3 nM (green) concentrations
were injected across a biosensor surface coated with either GST or GST-
JAM-A. Binding of1 headpointmutants toGSTwas set as the base line (gray
line). Binding ismeasured in resonance units (RU). The identity of themutants
is indicated. The calculated affinity for binding of 1-D345N to GST-JAM-A,
expressed as apparent KD, is approximately 1 10
8
M.
FIGURE 5. Structure of1-D345N. Superposition of wild-type T3D 1 and
1-D345N at the aspartic acid cluster. Ribbon drawings of the wild-type
and 1-D345N backbones are shown in gray, oxygen atoms are shown in
red, and nitrogen atoms are shown in blue. The Asn-345 side chains of
1-D345N (green) show the same conformation as those of wild-type 1
(yellow). The water molecules above and below the cluster also occupy
virtually identical positions in both molecules. This figure was generated
using PyMOL (37).
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to allow formation of the trimer. First, molecular dynamics
studies show that the introduction of negative charges at the
Asp-345 side chains destabilizes the trimer, causing partial sep-
aration of the three chains at the base of the 1 head (17).
Second, the mutant 1-D345N protein assembles into a tri-
meric structure that is indistinguishable from that of the wild-
type protein. Remarkably, the arrangement of water molecules
in the vicinity of residue 345 in both the wild-type and mutant
structures is identical. Since the asparagine side chain is an
excellent mimic for a protonated aspartic acid but not for a
charged aspartate, the structural similarities between the two
proteins argue strongly that thewild-type protein contains pro-
tonated Asp-345 residues. Third, substitution of a residue that
shields Asp-345 from solvent, Y313A, results in monomeric
protein. It is likely that mutation of Tyr-313 renders Asp-345
solvent-accessible, causing it to lose its proton at neutral pH.
We performed gel-filtration experiments using purified 1
head domain under conditions of low, neutral, and high pH
(data not shown). The 1 head
eluted as a trimer under all condi-
tions tested. These results provide
additional evidence that the aspartic
acids are protonated and inaccessi-
ble to solvent in the assembled
trimer.
The hypothesis that Asp-345 in
1 is protonated is also supported
by the finding of a similar cluster of
aspartic acids in the G protein of
vesicular stomatitis virus (VSV)
(31). Although the global architec-
ture of VSV G differs substantially
from reovirus 1, VSV G also forms
a trimer that features three aspartic
acids that face each other at the tri-
mer interface. The location and ori-
entation of the aspartic acid clusters
in VSV G and 1 are in fact surpris-
ingly similar (Fig. 6). In both cases,
hydrogen bonds are thought to
mediate interactions between pro-
tonated aspartic acid side chains.
These hydrogen bonds lie in a plane
that is perpendicular to the trimer
axes, and deprotonation would lead
to destabilization of the trimer. In
both molecules, the aspartic acids
emanate from well ordered back-
bone structures with low mobility
(an -helix in VSV G and a -hair-
pin in 1). Most interestingly, both
clusters contain trapped water mol-
ecules that form hydrogen bonds
with the protonated carboxylate
groups.
What are the implications of the
aspartic acid cluster for 1 function
in viral attachment and cell entry?
Both VSV and reovirus enter cells via the endosomal pathway
and thus encounter a low pH environment during the entry
process. The VSVG structure has been interpreted as a low-pH
conformer of the molecule (31). In keeping with this conclu-
sion, it is possible that the 1 structure reported here also rep-
resents a form of the protein found at low pH. Both VSV G and
reovirus 1 were crystallized at close-to-neutral pH, but the
conditions used for crystallization are far from physiologic in
both cases and may easily create an environment that favors
protonated aspartic acids. Thus, the aspartic acid cluster
may act as a molecular switch that disfavors trimerization
when charged but favors trimerization when the protein
encounters a low pH environment that allows it to be proto-
nated. Because the aspartic acids project from rigid structural
motifs, they may prevent trimerization in environments that
favor deprotonation.
Conformational changes of viral proteins in response to
ligand binding or exposure to acidic pH are well documented
FIGURE 6. Comparison of aspartic acid clusters in reovirus 1 and VSV G. Views into the aspartic acid
clusters of1 (A) and VSVG (B). In both cases, the view is along the 3-fold axis. Ribbon drawings of the complete
trimers are shownon the left in each case todepict the locationof the clusters (red circles).Ribbon tracingsof the
backbones are shown ingray, carbonatomsof aspartic acid residuesAsp-268 (VSVG) andAsp-345andAsp-346
(1) are shown in orange, and oxygen atoms are shown in red. Hydrogen bonds are represented with dotted
lines. This figure was generated using PyMOL (37).
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(32–34). These changes allow viruses to expose previously hid-
den epitopes for ligand binding andmembrane penetration. For
example, the influenza virus hemagglutinin undergoes a mas-
sive rearrangement upon exposure to acidic pH. This confor-
mational change is enabled by prior proteolytic cleavage and
leads to the formation of -helical coiled-coil structures that
expose a hydrophobic fusion peptide. Importantly, the hemag-
glutinin structure at neutral pH represents ametastable formof
the protein, as the low pH conformer, once formed, is stable
even at neutral pH (35). The conspicuous location ofAsp-345 at
the 1 trimer interface suggests that the aspartic acid cluster
serves a similar function to mediate a structural transition
between a form of the protein that is at least partially detrimer-
ized in the head region and a fully trimerized molecule (as seen
in the crystal structure here). Based on our current data, it
appears that the fully trimerized protein is the energetically
favored form. Placed in the context of the entire virion, such a
conformational change might facilitate events during reovirus
entry subsequent to viral attachment, such as internalization
into the endocytic pathway and proteolytic disassembly to form
infectious subvirion particles.
Acknowledgments—We thank the members of our laboratories for
many useful discussions while conducting this research.
REFERENCES
1. Barton, E. S., Connolly, J. L., Forrest, J. C., Chappell, J. D., and Dermody,
T. S. (2001) J. Biol. Chem. 276, 2200–2211
2. Barton, E. S., Forrest, J. C., Connolly, J. L., Chappell, J. D., Liu, Y., Schnell,
F., Nusrat, A., Parkos, C. A., and Dermody, T. S. (2001)Cell 104, 441–451
3. Chappell, J. D., Duong, J. L., Wright, B. W., and Dermody, T. S. (2000)
J. Virol. 74, 8472–8479
4. Furlong, D. B., Nibert, M. L., and Fields, B. N. (1988) J. Virol. 62, 246–256
5. Fraser, R. D. B., Furlong, D. B., Trus, B. L., Nibert, M. L., Fields, B. N., and
Steven, A. C. (1990) J. Virol. 64, 2990–3000
6. Chappell, J. D., Prota, A., Dermody, T. S., and Stehle, T. (2002)EMBO J.21,
1–11
7. Chappell, J. D., Gunn, V. L., Wetzel, J. D., Baer, G. S., and Dermody, T. S.
(1997) J. Virol. 71, 1834–1841
8. Sturzenbecker, L. J., Nibert, M. L., Furlong, D. B., and Fields, B. N. (1987)
J. Virol. 61, 2351–2361
9. Baer, G. S., Ebert, D. H., Chung, C. J., Erickson, A. H., and Dermody, T. S.
(1999) J. Virol. 73, 9532–9543
10. Ehrlich, M., Boll, W., Van Oijen, A., Hariharan, R., Chandran, K., Nibert,
M. L., and Kirchhausen, T. (2004) Cell 118, 591–605
11. Baer, G. S., and Dermody, T. S. (1997) J. Virol. 71, 4921–4928
12. Chandran, K., Farsetta, D. L., and Nibert, M. L. (2002) J. Virol. 76,
9920–9933
13. Chandran, K., Parker, J. S., Ehrlich, M., Kirchhausen, T., and Nibert, M. L.
(2003) J. Virol. 77, 13361–13375
14. Odegard, A. L., Chandran, K., Zhang, X., Parker, J. S., Baker, T. S., and
Nibert, M. L. (2004) J. Virol. 78, 8732–8745
15. Dryden, K. A., Wang, G., Yeager, M., Nibert, M. L., Coombs, K. M., Fur-
long, D. B., Fields, B.N., andBaker, T. S. (1993) J. Cell Biol. 122, 1023–1041
16. Nibert, M. L., Chappell, J. D., and Dermody, T. S. (1995) J. Virol. 69,
5057–5067
17. Cavalli, A., Prota, A. E., Stehle, T., Dermody, T. S., Recanatini, M., Folkers,
G., and Scapozza, L. (2004) Biophys. J. 86, 3423–3431
18. Prota, A. E., Campbell, J. A., Schelling, P., Forrest, J. C., Peters, T. R.,
Watson, M. J., Aurrand-Lions, M., Imhof, B., Dermody, T. S., and Stehle,
T. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 5366–5371
19. Otwinowski, Z., and Minor, W. (1997)Methods Enzymol. 276, 307–326
20. Navaza, J. (1994) Acta Crystallogr. Sect. A 50, 157–163
21. Jones, T. A., Zhou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta
Crystallogr. Sect. A 47, 110–119
22. Bru¨nger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P.,
Grosse-Kunstleve, R.W., Jiang, J. S., Kuszewski, J., Nilges,M., Pannu,N. S.,
Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta
Crystallogr. Sect. D Biol. Crystallogr. 54, 905–921
23. Emsley, P., and Cowtan, K. (2004) Acta Crystallogr. Sect. D Biol. Crystal-
logr. 60, 2126–2132
24. Collaborative Computational Project, Number 4 (1994) Acta Crystallogr.
Sect. D Biol. Crystallogr. 50, 760–763
25. Karlsson, R., and Falt, A. (1997) J. Immunol. Methods 200, 121–133
26. Sibanda, B. L., and Thornton, J. M. (1991)Methods Enzymol. 202, 59–82
27. Blanco, F., Ramı´rez-Alvarado, M., and Serrano, L. (1998) Curr. Opin.
Struct. Biol. 8, 107–111
28. Campbell, J. A., Shelling, P.,Wetzel, J. D., Johnson, E. M.,Wilson, G. A. R.,
Forrest, J. C., Aurrand-Lions, M., Imhof, B., Stehle, T., and Dermody, T. S.
(2005) J. Virol. 79, 7967–7978
29. Stehle, T., and Dermody, T. S. (2004) Viral Immunol. 17, 129–143
30. Forrest, J. C., Campbell, J. A., Schelling, P., Stehle, T., and Dermody, T. S.
(2003) J. Biol. Chem. 278, 48434–48444
31. Roche, S., Bressanelli, S., Rey, F. A., and Gaudin, Y. (2006) Science 313,
187–191
32. Bullough, P. A., Hughson, F. M., Skehel, J. J., and Wiley, D. C. (1994)
Nature 371, 37–43
33. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., and Hen-
drickson, W. A. (1998) Nature 393, 648–659
34. Chen, B., Vogan, E. M., Gong, H., Skehel, J. J., Wiley, D. C., and Harrison,
S. C. (2005) Nature 433, 834–841
35. Chen, J., Wharton, S. A., Weissenhorn, W., Calder, L. J., Hughson, F. M.,
Skehel, J. J., and Wiley, D. C. (1995) Proc. Natl. Acad. Sci. U. S. A. 92,
12205–12209
36. Carson, M. (1987) J. Mol. Graph. 5, 103–106
37. DeLano, W. L. (2002) The PyMOL Molecular Graphics System, DeLano
Scientific, San Carlos, CA
38. Bru¨nger, A. T. (1992) Nature 355, 472–475
The Reovirus1 Aspartic Acid Sandwich
APRIL 13, 2007•VOLUME 282•NUMBER 15 JOURNAL OF BIOLOGICAL CHEMISTRY 11589
 179 
APPENDIX C 
 
REOVIRUS BINDING DETERMINANTS IN JUNCTIONAL ADHESION 
MOLECULE-A 
 
Kristen M. Guglielmi, Eva Kirchner, Geoffrey H. Holm, Thilo Stehle, and Terence S. 
Dermody 
 
Journal of Biological Chemistry. 282(24):17930-17940;2007 
 
Reovirus Binding Determinants in Junctional
Adhesion Molecule-A*□S
Received for publication,March 13, 2007, and in revised form, April 23, 2007 Published, JBC Papers in Press, April 23, 2007, DOI 10.1074/jbc.M702180200
Kristen M. Guglielmi‡§, Eva Kirchner¶, Geoffrey H. Holm§, Thilo Stehle§¶, and Terence S. Dermody‡§1
From the Departments of ‡Microbiology and Immunology, Pediatrics, and the §Elizabeth B. Lamb Center for Pediatric Research,
Vanderbilt University School of Medicine, Nashville, Tennessee 37232 and the ¶Interfakulta¨res Institut fu¨r Biochemie, Universita¨t
Tu¨bingen, Hoppe-Seyler-Strasse 4, D-72076 Tu¨bingen, Germany
Junctional adhesion molecule-A (JAM-A) serves as a sero-
type-independent receptor for mammalian orthoreoviruses
(reoviruses). The membrane-distal immunoglobulin-like D1
domain of JAM-A is required for homodimerization and bind-
ing to reovirus attachment protein 1. We employed a struc-
ture-guided mutational analysis of the JAM-A dimer interface
to identify determinants of reovirus binding. We purified
mutant JAM-A ectodomains for solution-phase and surface
plasmon resonancebinding studies and expressedmutant forms
of full-length JAM-A in Chinese hamster ovary cells to assess
reovirus binding and infectivity. Mutation of residues in the
JAM-A dimer interface that participate in salt-bridge or hydro-
gen-bond interactions with apposing JAM-A monomers abol-
ishes the capacity of JAM-A to form dimers. JAM-A mutants
incapable of dimer formation form complexes with the1 head
that are indistinguishable fromwild-type JAM-A-1 head com-
plexes, indicating that 1 binds to JAM-Amonomers. Residues
Glu61 and Lys63 of -strand C and Leu72 of -strand C in the
dimer interface are required for efficient JAM-A engagement of
strain type 3 Dearing 1. Mutation of neighboring residues
alters the kinetics of the 1-JAM-A binding interaction. Proto-
type reovirus strains type 1 Lang and type 2 Jones share similar,
although not identical, binding requirements with type 3 Dear-
ing. These results indicate that reovirus engages JAM-A mono-
mers via residues found mainly on -strands C and C of the
dimer interface and raise the possibility that the distinct disease
phenotypes produced in mice following infection with different
strains of reovirus are in part attributable to differences in con-
tacts with JAM-A.
Mammalian orthoreoviruses (reoviruses)2 are nonenvel-
oped, icosahedral viruses that contain a genome of 10 double-
stranded RNAgene segments encapsulatedwithin two concen-
tric protein shells (1). Reoviruses infect a broad range of
mammalian hosts, including humans, but cause disease primar-
ily in the very young (2). The three reovirus serotypes, each
represented by a prototype strain, type 1 Lang (T1L), type 2
Jones (T2J), and type 3 Dearing (T3D), differ mainly in the
sequence of the viral attachment protein, 1 (3, 4). Following
oral or intramuscular inoculation of newbornmice, strains T1L
and T3D invade the central nervous system, yet these viruses
use different routes and produce distinct pathologic conse-
quences. T1L spreads to the central nervous system hematog-
enously and infects ependymal cells (5, 6), resulting in hydro-
cephalus (7). In contrast, T3D reovirus spreads to the central
nervous system by neural routes and infects neurons (5, 6, 8),
causing lethal encephalitis (7, 9). Pathways of viral spread (5)
and tropism for neural tissues (6, 10) segregate with the viral S1
gene, which encodes the 1 protein (11, 12). Collectively, these
studies suggest that the1 protein determines the central nerv-
ous system cell types that serve as targets for reovirus infection,
presumably through specific receptor binding.
Reovirus attachment protein 1 is a filamentous, trimeric
molecule 480 Å in length with distinct head-and-tail mor-
phology (13, 14). Reovirus 1 shares striking structural similar-
ities with the adenovirus attachment protein, fiber (15). Each is
a trimer with a tail that partially inserts into the virion at the
icosahedral vertices and a head that projects away from the virion
surface. Both1 and fiber possess an uncommon triple-spiral
fold in the tail and an 8-stranded -barrel structure that com-
poses the head. Discrete regions of reovirus1mediate binding
to cell-surface receptors. Sequences in the N-terminal tail bind
carbohydrate (16–18), whereas the C-terminal head binds
junctional adhesion molecule-A (JAM-A) (19, 20).
JAM-A is a member of the immunoglobulin (Ig) superfamily
postulated to regulate formation of intercellular tight junctions
(21–23). JAM-A contains two extracellular Ig-like domains, a
short transmembrane region, and a cytoplasmic tail possessing
a PDZ domain-binding motif (21, 22). Crystal structures of the
extracellular region of human (h) JAM-A (24) and murine (m)
JAM-A (25) reveal two concatenated Ig-like domains (D1 and
D2) (Fig. 1A). Twomonomers form a symmetrical dimer with a
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large interface between apposing D1 domains. The JAM-A
dimer interface is concave and primarily composed of four
-strands (C, C, F, and G). The intermolecular interface is
stabilized by four pairs of salt-bridges as well as hydrophobic
interactions and two hydrogen bonds (Fig. 1B). Remarkably,
JAM-A serves as a receptor for prototype and field-isolate
strains of all three reovirus serotypes (19, 26).
JAM-A belongs to a structurally related family of cell-adhe-
sion molecules. The most closely related of these proteins to
JAM-A are JAM-B and JAM-C (27–29), neither of which serves
as a receptor for reovirus (24, 26). Although structural informa-
tion is not available for JAM-B and JAM-C, sequence analysis
suggests that homophilic contacts are conserved between JAM
family members (24). The coxsackievirus and adenovirus
receptor (CAR) also contains two extracellular Ig-like domains
that form similar dimers via the GFCC interface. Moreover,
intermolecular interactions in CAR also include some contacts
between charged residues (30, 31).
Chinese hamster ovary (CHO) cells transfected with plas-
mids encoding chimeric CAR-JAM-A receptor constructs or
JAM-A domain-deletion mutants provide evidence that the
N-terminal D1 domain of JAM-A is required for reovirus
attachment and infection (32). Reovirus binding to JAM-A
occurs more rapidly than homotypic JAM-A association and is
competed by excess JAM-A in vitro and on cells (32). Chemical
cross-linking of JAM-A diminishes the capacity of reovirus to
bind JAM-A in vitro and on cells and negates the competitive
effects of soluble JAM-A on reovirus attachment (32). These
findings suggest that reovirus binds to monomeric JAM-A by
engaging the dimer interface to effect stable cell attachment.
However, the precise nature of 1-JAM-A interactions is not
understood.Moreover, as all reovirus serotypes bind to JAM-A,
it is not apparent how JAM-A binding contributes to the
serotype-dependent differences in reovirus tropism in the
murine central nervous system.
In this study, we performed a systematic mutagenic analysis
of the dimer interface of the D1 domain of JAM-A. We engi-
neered point mutations in the dimer-contributing surface of
the extracellular domain of JAM-A, purified the resultant
mutants, and characterized effects of the mutations on JAM-A
homodimerization and binding to the purified1 head domain.
In complementary experiments, we tested the capacity of CHO
cells expressing full-length JAM-A point mutants to support
binding and infection by prototype strains from each of the
three reovirus serotypes. Our results indicate that reovirus T3D
1 engages JAM-Avia residues in-strandsC andCwithin the
dimer interface and that JAM-A binding requirements differ
significantly among the reovirus serotypes. These findings
enhance an understanding of reovirus-receptor interactions
and suggest that the nature of JAM-A contacts contributes to
differences in pathogenesis among reovirus serotypes.
EXPERIMENTAL PROCEDURES
Cells, Viruses, and Antibodies—Spinner-adapted murine
L929 cells were cultured as described (33). CHO cells were
maintained in Ham’s F-12 medium supplemented to contain
10% fetal bovine serum, 2 mM L-glutamine, 100 units/ml peni-
cillin, and 100 g/ml streptomycin. Reovirus strains T1L, T2J,
and T3D are laboratory stocks. Strain T3SA is a reassortant
strain containing the S1 gene of T3C44, which does not bind
sialic acid (17, 34), and the remaining nine genes of T1L (33).
FIGURE 1. Structure and location of residues in the JAM-A D1 domain.
A, ribbon drawing of the hJAM-A dimer, with one monomer shown in yellow
and the other in green. B, view of the interface between two hJAM-A mono-
mers. The interface is formedby residueson theGFCC facesof twoD1domains.
The view is along a crystallographic dyad. Oxygen atoms are shown in red,
nitrogen in blue, and sulfur in purple. Hydrogen bonds and salt-bridges are
representedbydashed lines.Aminoacidsare labeled insingle-lettercode.C, view
of the GFCC -sheet that composes the dimer interface of one JAM-A mon-
omer, labeled as in B. Side chains are shown for residues that were altered in
this study. This figure was generated using PyMOL (54).
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Reoviruses were purified by cesium chloride gradient centrifu-
gation from infected L929 cells as described (13). Particle con-
centrations were determined by spectrophotometry at 260 nm
using a conversion factor of 2.1  1012 particles/ml/A260.
hJAM-A-specific monoclonal antibody J10.4 was provided by
Dr. Charles Parkos (Emory University).
Protein Expression and Purification—The C-terminal head
domain of T3D 1 was purified as described (20). Soluble
ectodomains of wild-type and point mutant hJAM-A con-
structs were fused to an amino-terminal GST affinity tag via a
thrombin cleavage site and purified as described (24). Nucleo-
tide sequences corresponding to residues 27–233 of wild-type
hJAM-A were cloned by PCR, digested with BamHI and XhoI,
and ligated into pGEX-4T-3 (GE Healthcare) for bacterial
transformation. Point mutants of hJAM-A were engineered
using the QuikChange Site-directed Mutagenesis Kit (Strat-
agene), as per the manufacturer’s instructions. Sequences of
primers used to engineer point mutations in hJAM-A are listed
in supplemental Table 1. A GST fusion with the D1 domain of
hJAM-A was engineered by inserting a XhoI or BamHI restric-
tion site into the D1/D2 linker of hJAM-A in pGEX-4T-3 using
site-directed PCRmutagenesis. Digestion with XhoI or BamHI
followed by ligation eliminated the D2 domain (residues 131–
233) or D1 domain (residues 27–131), respectively, and fused
the remaining domain to GST. Bacteria transformed with plas-
mids encoding GST-JAM-A constructs were cultured in Luria-
Bertani broth at 37 °Cwith shaking, and protein expressionwas
induced with 0.2 mM isopropyl -D-thiogalactoside (GE
Healthcare) at 25 °C. Bacteria were harvested by centrifugation,
solubilized in phosphate-buffered saline (PBS) plus 1% Triton
X-100, 2 mM -mercaptoethanol, 1 mM phenylmethylsulfonyl
fluoride, and 100 g/ml lysozyme, and lysed by sonication.
GST-hJAM-A proteins were purified from bacterial lysates by
glutathione affinity chromatography. Soluble wild-type and
point-mutant hJAM-A ectodomains were liberated from the
glutathione resin by incubation with 20 units/ml thrombin
(Sigma) at room temperature overnight.
Gel Filtration Chromatography—Gel filtration of purified
hJAM-A extracellular domains was performed by loading0.5
mg of each protein onto a Superdex 75 column mounted on a
BioLogic HRWork station (Bio-Rad). Proteins were resolved in
20 mM Tris (pH 7.5), 100 mM NaCl, 0.01% sodium azide. Gel
filtration of the hJAM-A extracellular domain and the 1 head
domain was performed using a Superdex 75 column mounted
on a SMART analytical chromatography system (GE Health-
care). The 1 head (10 g) in 20 mMHEPES (pH 7.1) and wild-
type or mutant forms of the hJAM-A extracellular domain
(12.74 g) in PBS were mixed and incubated at 0 °C for 40 min
prior to gel filtration. Mixtures of proteins or individual pro-
teins were resolved in 20 mM Tris (pH 7.5), 100 mM NaCl.
GST Capture Assays—Swelled, washed, glutathione-coated
beads (Sigma) were incubated with 20 g of purified GST or
GST-hJAM-A fusion proteins and diluted in 200l of PBS plus
1% Tween 20 at 4 °C for 1 h. Glutathione beads with captured
GST fusion proteins were washed twice with PBS plus 1%
Tween 20 and incubated with 10 g of purified T3D 1 head
domain in 200 l of PBS plus 1% Tween 20 at 4 °C for 1 h,
followed by two additional washes. After the final wash, buffer
was aspirated carefully, and beads with bound proteins were
resuspended in 30l of sample buffer (313mMTris (pH6.8), 4%
SDS, 10%-mercaptoethanol, 20% glycerol, 0.01% bromphenol
blue). Samples (15l/lane)were loaded intowells of a SDS4–20%
continuous gradient polyacrylamide gel and electrophoresed at
120 V until the dye front reached the bottom of the gel. Proteins
were visualized by staining with Coomassie Brilliant Blue.
Assessment of 1-JAM-A Interactions Using Surface Plasmon
Resonance (SPR)—A BIAcore CM5 chip (Pharmacia Biosensor
AB) was coated with mouse ascites containing monoclonal
GST-specific antibody (Sigma) to 1800 resonance units of
IgG by amine coupling. Purified GST or wild-type or mutant
GST-hJAM-A ectodomain fusion proteins at a concentration
of 2 M in HEPES-buffered saline (pH 7.0) were captured by
injection across individual flow cells of an antibody-coated chip
for 3 min at 30 l/min using a BIAcore 2000 (GE Healthcare).
Purified T3D 1 head domain was injected across the conju-
gated chip surface at 30 l/min. Following 1 binding, chip
surfaces were regenerated with a 20-l pulse of 10 mM glycine
(pH2.5). Affinity constants for1 binding to hJAM-Awere deter-
mined using separate kon and koff nonlinear regression with
BIAevaluation 3.0 software (GEHealthcare), assuming a 1:1 Lang-
muir binding model (35). Molar concentrations of 1 constructs
were calculated based on 1 forming a homotrimer (20, 36).
Flow Cytometric Analysis of Receptor Expression and Virus
Binding—CHO cells (106) were transiently transfected with
receptor-encoding plasmids using Lipofectamine and PLUS
reagent (Invitrogen) according to the manufacturer’s instruc-
tions and incubated for 24 h to allow receptor expression. Cells
were detached from plates by incubation with 20 mM EDTA in
PBS and incubatedwith hJAM-A-specificmonoclonal antibody
J10.4 at 10 g/ml or incubated with reovirus T1L, T2J, or
T3SA (105 particles/cell) on ice for 1 h. Virus-adsorbed cells
were washed with PBS containing 0.1% bovine serum albumin
and incubated with clarified, combined T1L/T3D antiserum
(37) at 1:1000 dilution on ice for 1 h. Samples were washed with
PBS containing 0.1% bovine serum albumin and incubatedwith
Alexa 488-conjugated goat anti-rabbit or goat anti-mouse IgG
(Invitrogen) at a 1:1000 dilution on ice for 1 h. Cells were
washed twice with PBS containing 0.1% bovine serum albumin
and fixed with 4% paraformaldehyde in PBS. Cells were ana-
lyzed for antibody or virus binding using a FACSCalibur flow
cytometer (BD Biosciences).
Transient Transfection and Infection of CHO Cells—Point
mutations were engineered into full-length hJAM-A in
pcDNA3.1 (24) using the QuikChange Site-directed Mutagen-
esis Kit (Stratagene) and the same primers used to engineer
mutations in the hJAM-A extracellular domain in pGEX-4T-3
(supplemental Table 1). CHO cells (2  105) were transiently
transfected with receptor-encoding plasmids using Lipo-
fectamine and PLUS reagent (Invitrogen) and incubated for
24 h to allow receptor expression. Cells were infected with reo-
virus at multiplicities of infection of 1 (T1L), 5 (T2J), and 10
(T3SA) plaque forming units/cell and incubated at 37 °C for
18–20 h. Infected cells were processed for indirect immunoflu-
orescence as described (33). Images were captured at 200
magnification using a Zeiss Axiovert 200 microscope. For each
experiment, three fields of view were scored from three inde-
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pendently transfected wells. Mean values from three independ-
ent experiments were compared using the unpaired Student’s t
test as applied using Microsoft Excel. p values of less than 0.05
were considered statistically significant.
RESULTS
Analysis of 1 Head Binding to GST-JAM-A—For studies of
1-JAM-A interactions, we purified an N-terminal GST fusion
with the extracellular region of JAM-A (GST-JAM-A) (24).
Bacteria were transfected with plasmids encoding GST-
JAM-A, harvested by centrifugation, and lysed by sonication.
GST-JAM-A constructs were purified from bacterial lysates
using glutathione affinity chromatography (32). To determine
whether GST-JAM-A is capable of binding 1, we captured
GST-JAM-A on the surface of a biosensor chip via a covalently
linked GST-specific antibody. We then injected a purified
C-terminal fragment of T3D 1 at three different concentra-
tions and detected association with GST-JAM-A by SPR (Fig.
2A). The injected fragment of 1 incorporates residues 293 to
455, which comprise the globular -barrel head domain and
one -spiral repeat of the tail and is referred to as the 1 head
(20). The 1 head did not show any specific binding to the
GST-specific antibody or to GST captured on the biosensor
surface (data not shown). However, the 1 head bound GST-
JAM-A with an affinity of2.4 109 M, which approximates
previous calculations of 1 affinity for JAM-A (19, 20). To
determine whether the isolated D1 Ig-like domain of JAM-A is
capable of 1 engagement, we expressed and purified only the
D1 or D2 Ig-like domains of JAM-A with an N-terminal GST
tag. We assessed the capacity of the fusion proteins to bind the
1 head using the SPR strategy employed for GST-JAM-A.
Whereas the 1 head bound GST-D1 with an affinity similar to
GST-JAM-A, GST-D2 was incapable of capturing the 1 head
(Fig. 2B and data not shown). In accordance with data obtained
using chimeric receptormolecules (32), these data indicate that
themembrane distal D1 domain of JAM-A is sufficient for high
affinity interactions with 1.
Generation and Characterization of JAM-A Dimer Interface
Point Mutants—To identify specific residues in the D1 domain
required for1 binding, we generated individual alanine substitu-
tions of residues with surface-exposed side chains in the JAM-A
dimer interface (Fig. 1C). Twogroupsof residueswere targeted for
mutagenesis: (i) those that form direct protein-protein intersub-
unit contacts:Arg59,Glu61,Lys63,Leu72,Tyr75,Met110, andGlu121,
and (ii) those that make indirect contacts: Asp65, Thr70, Asn76,
FIGURE 2. Characterization of the 1 head domain binding to GST-
JAM-A. A, binding of the 1 head domain to GST-JAM-A. Purified 1 head
domain, at concentrations of 167 (red), 16.7 (yellow), or 1.67 nM (green), was
injected for 5min across a biosensor surface onwhichGST fused to the JAM-A
ectodomain previously had been captured. Buffer alone was injected for 6.7
min. The baseline is 167 nM 1 head domain binding to GST (gray). The KD of
1 head binding to GST-JAM-A is2.4 109 M. B, binding of the 1 head
domain to GST-JAM-A Ig-like domains. Purified1 head domain, at a concen-
tration of 167 nM, was injected for 5 min across a biosensor surface on which
GST-JAM-A fusion proteins previously had been captured. Buffer alone was
injected for 6.7min. The resultant traces showbinding toGST-JAM-A (yellow),
GST-D1 (red), and GST-D2 (green). The baseline is 167 nM 1 head domain
binding to GST (gray). Binding is expressed in resonance units (RU).
FIGURE 3. Precipitation of the1 head domain with purified GST-JAM-A
point mutants. Glutathione-agarose was incubated with buffer alone (NP),
GST, orGST fused to the JAM-AD1,D2, entire extracellular domain (JAM-A), or
point mutants shown at 4 °C for 1 h. The glutathione-agarose was pelleted,
washed, and incubatedwithpurified T3D1headat 4 °C for an additional 1 h.
The glutathione-agarose was washed, pelleted, resuspended in SDS sample
buffer, and boiled. Samples were resolved by SDS-PAGE and stained with
Coomassie Brilliant Blue to visualize captured proteins. Input T3D 1 head
alsowas resolved followingboiling in SDS samplebuffer.Molecularmasses of
protein standards in kDa are indicated on the left. Proteins are labeled on the
right.
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Thr106, Thr108, Ser112, and Lys123. GST-JAM-A point mutants
were purified by glutathione affinity chromatography and used in
GSTprecipitationassays to identifymutations that ablate1bind-
ing. In these experiments, glutathione-coated beads bound GST
fusion proteins, which in turn were used to capture the 1 head
domain.Asanticipated, the1headwasboundefficientlybyGST-
JAM-A and GST-D1 but not detectably by beads alone, GST, or
GST-D2 (Fig. 3). The majority of JAM-A dimer interface point
mutants were capable of binding the 1 head. However, mutants
E61A, K63A, L72A, and N76A were incapable of binding the 1
head as detected by Coomassie Blue staining or immunoblotting,
despite similar capture of the GST-JAM-Amutants on the beads
(Fig. 3 and data not shown). Residues Leu72 and Asn76 are located
on -strand C and the CC loop, respectively (Fig. 1C). Leu72
participates in ahydrophobic interactionwithTyr119 onanappos-
ing JAM-A monomer. Residues Glu61 and Lys63 are located on
-strandCandparticipate in salt-bridge interactions that stabilize
JAM-A dimers. These data suggest that the 1 head engages
JAM-A via residues near the top of (as oriented in Fig. 1C) and
within the dimer interface.
Kinetics of 1 Head Binding to GST-JAM-A Dimer Interface
Point Mutants—To quantitatively assess the effects of muta-
tions in the JAM-A dimer interface on interactions with 1,
GST-JAM-A point mutants were captured on a biosensor sur-
face and tested for1 binding by SPR. Based on the kinetics and
affinity of the interaction with 1, the majority of JAM-A
mutants clustered into one of four groups. The first group (I)
includes point mutants that display binding kinetics similar to
wild-type (Fig. 4A and Table 1). Group I includes mutants of
Thr70 in -strand C and nearby residue Thr106 in -strand F,
which do not contribute to intersubunit interactions at the
JAM-A dimer interface. The second group of GST-JAM-A
mutants (II) exhibited faster association kinetics thanwild-type
JAM-A by5–10-fold, resulting in higher calculated affinities
for 1 than wild-type JAM-A (Fig. 4B and Table 1). Initially
upon injection of wash buffer, much of the 1 was removed
from these mutants. However, specifically bound 1 protein
exhibited a similar off-rate to wild-type GST-JAM-A. Group II
includes mutants T108A, M110A, and E121A. Thr108, Met110,
FIGURE 4. Binding of the 1 head to GST-JAM-A point mutants. Purified 1 head domain, at a concentration of 167 nM, was injected for 5 min across a
biosensor surface on which GST-JAM-A fusion proteins, as indicated, had been captured. Buffer alone was injected for 6.7 min. The resultant traces show
binding to GST-JAM-A and GST-JAM-A point mutants, as indicated. The resultant sensograms are grouped based on binding kinetics: A, kon and koff similar to
wild-type JAM-A; B, faster kon than wild-type JAM-A; C, faster kon and koff than wild-type; and D, no specific binding. The baseline is 167 nM 1 head domain
binding to GST (gray). Binding is expressed in resonance units (RU).
TABLE 1
Kinetics of purified1 head binding to GST-JAM-A point mutants
Association and dissociation rates and dissociation constants were calculated using
BIAevaluation 3.0 software.Mutants are grouped as in Fig. 4. Group IVmutants did
not display specific binding.
Group JAM-Amutant
Association
rate
Dissociation
rate
Dissociation
constant
1/ms 1/s M
I Wild-type 8.9 104 2.5 104 2.8 109
D1 8.9 104 3.1 104 3.5 109
T70A 7.1 104 9.9 104 1.4 108
T106A 7.8 104 4.5 104 5.8 109
II T108A 4.1 105 6.1 104 1.5 109
M110A 6.5 105 3.5 104 5.4 1010
E121A 5.7 105 8.5 104 1.5 109
III R59A 3.8 105 8.4 103 2.2 108
Y75A 5.0 105 7.0 103 1.4 108
N76A 7.3 104 3.5 103 4.7 108
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and Glu121 all are located within the dimer interface in proxim-
ity to one another on -strands F and G (Fig. 1C). Glu121 par-
ticipates in salt-bridge interactions that stabilize the dimer
interface (24). Met110 participates in a hydrophobic interaction
withMet110 on an apposing JAM-Amonomer. The third group
(III) includes GST-JAM-A mutants R59A, Y75A, and N76A
(Fig. 4C), which exhibited a faster 1 on-rate than wild-type
JAM-A but also a faster off-rate, resulting in affinities similar to
wild-type. The N76A mutant exhibited a slower on-rate and a
lower level of 1 binding, relative to the other mutants in this
group, and binding returned to baseline levels over severalmin-
utes of wash buffer injection. This result agrees with results
obtained in the GST precipitation assay, in which the N76A
mutant of JAM-A was incapable of capturing the 1 head
domain (Fig. 3). Arg59, Tyr75, and Asn76 are located on
-strands C and C in the dimer interface (Fig. 1C). The final
group of JAM-Apointmutants includes E61A,K63A, andL72A
(Fig. 4D), which showed very low levels of 1 binding above
background. Upon injection of wash buffer, the binding signal
returned to baseline levels immediately, indicating that the
observed binding was not specific.We were unable to find suit-
able binding models for the interaction of these mutants with
the 1 head using BIAevaluation software (data not shown).
These results also are in accord with results obtained in the
GSTprecipitation assay (Fig. 3), inwhich no1headwas bound
detectably by the E61A, K63A, or L72A GST-JAM-A point
mutants. These data reinforce the importance of Glu61, Lys63,
and Leu72 as mediators of 1-JAM-A interactions and suggest
that these residues serve as contact points for the 1 head.
Oligomeric State of JAM-A Point Mutants—Because two res-
idues that participate in salt-bridge interactions at the JAM-A
dimer interface are required for efficient 1 binding, we asked
whether mutation of these residues or other residues in the
dimer interface alters the capacity of JAM-A to formdimers. To
answer this question, the extracellular domains of wild-type
and selected JAM-A point mutants were released from the
immobilized GST tag by thrombin cleavage and further purified
using gel filtration. The extracellular domain of wild-type JAM-A
eluted as a single peak, with an apparent molecular mass of48
kDa, indicating that it forms a dimer (Table 2 and data not shown)
(24). Likewise, alanine substitutions of Ser112 and Lys123, which
participate in indirect contacts at the intersubunit interface,donot
alter the oligomeric state of JAM-A
(Table 2). In sharp contrast, JAM-A
extracellular domains with alanine
substitutionsofArg59,Glu61, Lys63, or
Glu121, which form salt-bridges
across thedimer interface, or position
Tyr75, which forms a hydrogen bond
with Glu114 from an apposing mono-
mer, eluted from the column as a sin-
gle species with an apparent molecu-
lar mass of 30 kDa. This elution
peak likely represents solely mono-
meric JAM-A. These data indicate
that each salt-bridge pair and Tyr75
individually is required for stabiliza-
tion of JAM-A dimers.
To determine whether 1
engages monomeric or dimeric
forms of the JAM-A extracellular
domain, we assessed binding of the
1 head to the JAM-A extracellular
domain in solution using gel-filtra-
tion chromatography. Incubation of
purified wild-type JAM-A and the
1 head in a 3:1 molar ratio (three
JAM-A monomers to one 1 tri-
mer), results in formation of a
higher molecular weight complex
that contains both JAM-A and the
1 head (Fig. 5A and data not
FIGURE 5. Characterization of 1 head/JAM-A extracellular domain mixtures using gel filtration chro-
matography. Purified T3D1 head andwild-type JAM-A (A) or JAM-A pointmutants S112A (B), E121A (C), and
E61A (D) were mixed in a 3:1 molar ratio and incubated on ice for 40 min. The mixtures (yellow) or individual
purifiedproteins (red andblue)were applied to a Superdex 75gel-filtration column, andproteins in the column
fractions were detected by A280. Dimeric forms of wild-type JAM-A and S112A elute earlier than monomeric
forms E121A and E61A. Wild-type JAM-A, S112A, and E121A each form a complex with 1 that elutes from the
columnat approximately the same time, thuswith similar apparentmolecularweight, for eachproteinmixture.
TABLE 2
Characterization of selected point mutants of the JAM-A dimer
interface by gel filtration
Apparent molecular masses were calculated by graphing Ve  Vo against the log10
Mr of protein standards, performing linear regression, and back-calculating, based
on elution time.
JAM-A
mutant
Apparent
molecular mass
Apparent
oligomeric state 1 Binding
kDa
Wild-type 46.1 Dimeric 
R59A 32.5 Monomeric 
E61A 32.5 Monomeric 
K63A 33.8 Monomeric 
Y75A 27.8 Monomeric 
S112A 49.8 Dimeric 
E121A 30.0 Monomeric 
K123A 46.1 Dimeric 
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shown). Similar findings weremade following incubation of the
extracellular domain of dimeric JAM-A mutant S112A or the
monomeric mutant E121A with the 1 head (Fig. 5, A–C). In
both cases, a complex was formed that eluted from the size-
exclusion column at the same volume as the complex observed
following incubation of wild-type JAM-A with the 1 head. As
expected, monomeric JAM-A point mutant E61A does not
form a detectable complex when incubated with the 1 head
(Fig. 5D). Becausemutant forms of JAM-A that are incapable of
forming dimers retain the capacity to interact with 1, we con-
clude that the1 head can engagemonomeric forms of JAM-A.
Reovirus Binding and Infectivity of CHO Cells Expressing
Mutant Forms of JAM-A—To determine the capacity of reovi-
rus to bind JAM-Amutants in cell culture, we transiently trans-
fected CHO cells, which are poorly permissive for reovirus
infection (26, 32), with plasmids encoding wild-type (24) or
mutant forms of full-length JAM-A. Transfected cells were
incubated for 24 h to allow receptor expression and adsorbed
with reovirus virions. Surface expression of JAM-A and reovi-
rus binding were assessed by flow cytometry (Fig. 6).Wild-type
JAM-A and each of the JAM-A mutants were expressed at the
surface of transfected cells at approximately equivalent levels,
providing confidence that the mutant constructs are properly
folded. Virions of T3SA, a non-sialic acid-binding reovirus
strain with a serotype 3 1 identical in sequence to T3D in the
1 head domain (33), bound poorly to vector-transfected CHO
cells, whereas specific binding to CHO cells expressing wild-
type JAM-Awas observed.We usedT3SA rather thanT3D in
these studies to diminish background binding to cells due to
interactions with carbohydrate. T3SA binding approximated
JAM-A expression at the surface of CHO cells expressing the
majority of the point mutants. However, T3SA binding to
cells expressing the K63A or L72A mutants was diminished,
and no binding above background was observed with cells
expressing the E61A mutant form of JAM-A. These results
closely mimic the binding of the T3D 1 head to JAM-A
mutants in theGSTprecipitation and SPR assays (Figs. 2 and 3).
Interestingly, mutation of Glu61 to aspartate or Lys63 to argi-
nine was not associated with the binding defects observed for
the E61A and K63A mutants (Fig. 6), indicating that the acidic
or basic properties of these residues are important for reovirus
engagement.
To compare JAM-A binding determinants for reoviruses of
the three serotypes, we assessed binding of virions of strains
T1L and T2J to CHO cells expressing wild-type and mutant
forms of JAM-A by flow cytometry. Because no serotype 1 or 2
reoviruses incapable of binding carbohydrate have been iso-
lated, we used prototype strains T1L and T2J to represent sero-
types 1 and 2. Similar to T3SA, each virus bound poorly to
vector-transfected cells, whereas T1L and T2J binding to cells
expressing wild-type JAM-A approximated JAM-A expression
(Fig. 7). In contrast to T3SA, T1L and T2J showed approxi-
mately wild-type binding to CHO cells expressing each of the
JAM-A pointmutants (data not shown). To determine whether
T1L and T2J might share similar binding determinants with
T3D and T3SA but with less stringency, we constructed dou-
ble pointmutants R59A/E61A and E61A/K63A.As anticipated,
T3SA showed no specific binding to CHO cells expressing
either of the JAM-A double point mutants (Fig. 7). Although
not with the same magnitude as T3SA, both T1L and T2J
showed diminished binding toCHOcells expressing the double
FIGURE 6. Reovirus T3SA binding to CHO cells expressing JAM-A
mutants. CHO cells (106) were transiently transfected with plasmids encod-
ing the indicated receptor constructs. Following incubation for 24 h topermit
receptor expression, cellswere lifted fromplates using EDTAand stainedwith
hJAM-A-specific monoclonal antibody J10.4 or adsorbed with reovirus
T3SA (105 particles/cell). Cell-surface expression of receptor constructs and
virus binding was assessed by flow cytometry.
FIGURE 7. Reovirus T1L, T2J, and T3SA binding to CHO cells expressing
JAM-A mutants. CHO cells (106) were transiently transfected with plasmids
encoding the indicated receptor constructs. Following incubation for 24 h to
permit receptor expression, cells were lifted from plates using EDTA and
stained with hJAM-A-specific monoclonal antibody J10.4 or adsorbed with
reovirus T1L, T2J, or T3SA (105 particles/cell). Cell-surface expression of
receptor constructs and virus binding was assessed by flow cytometry.
Reovirus Binding Determinants in JAM-A
17936 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 282•NUMBER 24•JUNE 15, 2007
point mutants, with T1L exhibiting highly impaired binding to
CHO cells expressing the R59A/E61A JAM-A mutant.
To assess the functional significance of mutations in JAM-A
that alter reovirus binding,we quantified infectivity ofT1L,T2J,
and T3SA following adsorption to CHO cells expressing full-
length wild-type or mutant forms of JAM-A by indirect immu-
nofluorescence (33). Infectivity of T3SA was significantly
decreased (50%) following infection of CHO cells expressing
the E61A and K63A mutants in comparison to cells expressing
wild-type JAM-A (Fig. 8). Consistent with the flow cytometry
experiments (Fig. 7), conservation of charge at residues Glu61
and Lys63 by substituting aspartate and arginine, respectively,
rescued the infectivity defect. T3SA infectivity was decreased
almost to the level of background following adsorption to CHO
cells expressing the double point mutants R59A/E61A and
E61A/K63A. As predicted by the binding results, T1L also
showed a striking loss of infectivity in cells expressing the
R59A/E61A JAM-A mutant and a slight decrease in infectivity
in cells expressing the K63A or E61A/K63A mutants. T2J
showed only a very modest decrease in infectivity, less than
25%, in CHO cells expressing the R59A mutant or either of the
two double point mutants, in accordance with the flow cytom-
etry results. Taken together, these data reinforce the validity of
results obtained from binding assays using the T3D 1 head
domain and suggest that T1L, T2J, and T3SA engage JAM-A
using non-identical residues.
DISCUSSION
The goal of this study was to identify reovirus binding deter-
minants in JAM-A. We generated alanine substitutions of res-
idues with solvent-exposed side chains in the JAM-A dimer
interface in the context of a GST-JAM-A fusion. Analysis of the
point mutants using GST precipitation assays and SPR experi-
ments led to the identification of Glu61, Lys63, and Leu72 that
individually are required for efficient binding of the T3D 1
head. Glu61 and Lys63 have charged side chains and participate
in salt-bridge contacts that stabilize the JAM-A dimer interface
(24). Leu72 is located in proximity to Glu61 and Lys63 and par-
ticipates in hydrophobic interactions with Tyr119 from the
apposing JAM-Amonomer (24). SPR findings were concordant
with these results and indicate that mutation of specific resi-
dues in the JAM-Adimer interface can enhance or diminish the
rate of association and dissociation of the T3D 1 head. Specif-
ically, T108A, M110A, and E121A mutations enhanced associ-
ation of 1, leading to higher calculated binding affinities in
comparison to wild-type JAM-A. On the other hand, R59A and
Y75A displayed faster association with the 1 head but also
faster dissociation. The same charged residues required for
JAM-A-1 interactions in biochemical assays, Glu61 and Lys63,
also are required for serotype 3 1 interactions with JAM-A in
cultured cells.
Gel-filtration chromatography of purified, mutant JAM-A
extracellular domains revealed that mutation to alanine of any
residue in the JAM-A dimer interface that contributes to salt-
FIGURE8.Reovirus infectionofCHOcellsexpressingJAM-Amutants.CHO
cells (2  105) were transiently transfected with empty vector (pcDNA) or
plasmids encoding mutant forms of JAM-A. Following incubation for 24 h to
permit receptor expression, cellswere adsorbedwith reovirus at amultiplicity
of infection of 1 (T1L), 5 (T2J), or 10 (T3SA) plaque-formingunits/cell at room
temperature for 1 h. Cells were washed with PBS, incubated in complete
mediumat 37 °C for 20 h, and stained for reovirus antigen. Infected cells were
identified by indirect immunofluorescence and quantified by counting cells
exhibiting cytoplasmic staining in three confluent fields of viewper experiment.
The results are expressedas themean fluorescent focusunits (FFU) per fieldof
view for triplicate experiments. Error bars indicate S.D. *, p 0.05 in compar-
ison to cells expressing wild-type JAM-A.
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bridge interactions as well as one residue, Tyr75, whichmakes a
hydrogen-bond contact with Glu114 (24), abolishes the capacity
of JAM-A to form dimers in solution at neutral pH. These data
indicate that each salt-bridge interaction and the Tyr75–Glu114
hydrogen-bond interaction are essential mediators of JAM-A
dimer stabilization. Both monomeric and dimeric point
mutants of JAM-A are capable of binding the 1 head. Because
residues required for 1 head binding are found within the
dimer interface, we hypothesize that a monomeric form of
JAM-A is the relevant 1 binding partner. Based on elution
profiles, it is formally possible that the1-JAM-Acomplex con-
tains dimeric JAM-A and monomeric 1. However, we think it
unlikely that dimeric JAM-A is in the complexes, because the
monomeric E121Amutant of JAM-A forms complexes with 1
that are indistinguishable by gel filtration fromwild-type JAM-
A-1 complexes. It also is unlikely thatmonomeric1 interacts
with JAM-A, as a 1 point mutant that is incapable of trimer
formation is incapable of binding JAM-A (20).
Our data support a model of reovirus-JAM-A interactions in
which the T3D 1 head domain directly engages the dimer
interface of JAM-A via critical contacts with Glu61 and Lys63 in
-strandC andLeu72 in-strandC and additional, less-critical
contacts with nearby residues Arg59, Tyr75, and Asn76 (Figs. 1C
and 9). In thismodel,1 is anticipated to bindwith high affinity
only to JAM-A monomers. Comparisons of the hJAM-A and
mJAM-A crystal structures suggest that small movements of
one JAM-A monomer with respect to the apposing monomer
can occur in a physiologic context (24). We envision two pos-
sible scenarios to explain how 1 accesses monomeric forms of
JAM-A. In the first, small movements of JAM-A monomers
with respect to one another might provide 1 the opportunity
to interact weakly with residues closer to the solvent-exposed
regions of the JAM-A dimer interface, such as Arg59, Tyr75, and
Asn76, as the dimer shifts slightly to amore open conformation.
This interaction could potentially orient 1 to access the dimer
interface, where interactions that lead to high-affinity binding
occur. In support of this model, mutation of Arg59, Tyr75, or
Asn76 to alanine leads to reduced levels of binding and faster
association and dissociation kinetics between JAM-A and the
1 head, whereas mutation of Glu61, Lys63, or Leu72 to alanine
ablates 1 binding altogether. In the second, reovirus might
exploit an equilibrium between monomeric and dimeric forms
of JAM-A at the cell surface to engage the dimer interface of
JAM-A monomers.
Our binding and infectivity data from CHO cells transfected
with JAM-A mutants highlight differences in JAM-A engage-
ment among the reovirus serotypes. Residues Arg59 and Glu61
are required for efficient T1L binding and infectivity, but only
when both residues are altered simultaneously, whereas a small
infectivity diminishment is observed when Lys63 is altered. In
contrast, binding and infectivity of JAM-A-expressing CHO
cells by reovirus strain T3SA requires residuesGlu61 or Lys63,
with some additional contribution from Arg59. In a previous
study, T1L virions showed diminished binding to JAM-A
mutants S57K and Y75A in a plate-based binding assay (32).
These two residues are located in proximity toGlu61, with Ser57
residing at the NH2 terminus of -strand C (24). Thus, it
appears that T1L utilizes a binding site that overlaps with, but is
not identical to, the serotype 3 binding site. Based on our bind-
ing and infectivity studies with CHO cells, it does not appear
that T2J shares contact points with serotype 1 or 3 reoviruses.
T2J showed a slight decrease in binding to CHO cells trans-
fected with JAM-A double point mutants R59A/E61A and
E61A/K63A, but infectivity was not significantly diminished in
these cells. These findings constitute the first evidence that dif-
ferent serotypes of reovirus engage JAM-A at distinct sites or
via different contact residues and, therefore, potentially with
different specificities and affinities.Of note, differences in affin-
ity for the primary cellular receptor -dystroglycan have been
shown tomediate strain-specific differences in tropism for lym-
phocytic choriomeningitis virus (38). It is possible that a similar
mechanism contributes to serotype-dependent differences in
reovirus pathogenesis. For example, a reovirus serotype that
has a higher affinity for JAM-A might be capable of infecting
cells that express JAM-A at a low level, whereas a reovirus sero-
type with a lower affinity for the receptor may not. Instead, the
tropism of a reovirus with a lower affinity for JAM-A might be
more dependent on the carbohydrate binding specificity of the
virus or engagement of unidentified receptors on cells express-
ing low levels of JAM-A.
Although our data suggest non-identical binding sites in
JAM-A for different serotypes or strains of reovirus, we find it
noteworthy that both T1L and T2J are capable of agglutinating
human erythrocytes (39), presumably via carbohydrate engage-
ment, whereas T3SA is unable to bind sialic acid or aggluti-
nate mammalian erythrocytes (33, 34). Reovirus utilizes an
adhesion-strengthening mechanism of attachment to host
cells, inwhich initial low affinity interactionswith carbohydrate
are thought to tether the virus to the cell surface where it can
diffuse laterally until it encounters and engages JAM-A in a high
affinity interaction (19, 33). Therefore, it is possible that
engagement of carbohydrates on the surface of CHO cells by
T1L and T2J reovirus provides an advantage in the capacity of
these viruses to encounter JAM-A mutants. The proximity to
JAM-A afforded by carbohydrate binding, combined with avid-
FIGURE 9. Predicted serotype 3 reovirus binding region in JAM-A. View of
the JAM-A D1 domain dimer. One monomer is oriented as in Fig. 1C and is
shown as a space-filling representation. The apposing monomer is shown as
a red ribbon drawing. Residues Glu61, Lys63, and Leu72 (dark green) are
required for efficient serotype 3 reovirus engagement of JAM-A and are pro-
posed to serve as critical contacts for T3D1. Residues Arg59, Tyr75, andAsn76
(light green) are proposed to serve as additional contacts. This figure was
generated using PyMOL (54).
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ity effects, might lead to detectable binding by T1L and T2J but
undetectable binding by T3SA to some JAM-A mutants
expressed at the cell surface.
Whereas the precise nature of 1-JAM-A interactions will
not be known until the structure of the attachment protein
bound to the receptor is available, data generated in this study
allow some speculation about the nature of these interactions.
Because JAM-A serves as a receptor for all serotypes of reovirus
(19, 26), we previously hypothesized that conserved residues in
1 might contribute to 1-JAM-A interactions (26, 36). While
possible, our data suggest that different serotypes of reovirus
engage JAM-A via distinct but perhaps overlapping residues, a
result that has led us to extend our search for the JAM-A bind-
ing site in 1. Residues at positions 61 and 63 of JAM-A are
critical mediators of efficient interactions with 1. However,
efficient binding and infectivity of CHO cells expressing
mutant forms of JAM-A is achieved whether there is an aspar-
tate or glutamate at position 61 or an arginine or lysine at posi-
tion 63. These results demonstrate that the side chain charge of
residues at positions 61 and 63 is important for 1 binding,
whereas the length of the side chain is not. Because the charged
residues required for efficient 1 binding participate in salt-
bridge interactions that stabilize the dimer interface, we think
that charged residues in 1 form similar salt-bridge interac-
tions with JAM-A, mimicking the dimer interface. There are
several clusters of solvent-exposed charged residues in 1. Fur-
thermore, -sheet BADG in 1 can be superimposed onto
JAM-A -sheet GFCC with low root mean square deviations
(31). Using a newly developed plasmid-based reverse genetics
system for reovirus (40), we canmake directedmutations in the
JAM-A binding region of 1 to directly test this hypothesis.
Non-JAM-A-binding reoviruses might prove invaluable as
tools to define the independent contributions of JAM-A and
carbohydrate co-receptors to tropism in vivo.
In this study, we identified reovirus binding determinants in
the most membrane-distal Ig-like domain of JAM-A. We also
provided the first evidence that reoviruses of different sero-
types engage JAM-A via distinct contact residues. It is interest-
ing that so many viruses have adapted to utilize Ig superfamily
members as attachment moieties (19, 41–50). Even more
intriguing is the observation that viruses as evolutionarily
diverse as adenovirus, HIV, and reovirus bind the same struc-
tural regions of Ig superfamily molecules (51, 52). Perhaps this
family of molecules, which mediate diverse protein-protein
recognition functions such as cell-cell adhesion and high affin-
ity antigen binding, are well suited to serve as virus receptors
due to the adhesive nature of their D1 domains (53). Future
studies with reovirus and other virusesmay serve to enhance an
understanding of the co-evolution of cell-adhesion molecules,
viral attachment proteins, and immune recognition.
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Mammalian orthoreoviruses (reoviruses) are
highly tractable experimental models for stud-
ies of double-stranded (ds) RNA virus rep-
lication and pathogenesis. Reoviruses infect
respiratory and intestinal epithelium and dis-
seminate systemically in newborn animals. Until
now, a strategy to rescue infectious virus from
cloned cDNA has not been available for any
member of the Reoviridae family of dsRNA
viruses. We report the generation of viable reo-
virus following plasmid transfection of murine
L929 (L) cells using a strategy free of helper vi-
rus and independent of selection. We used the
reovirus reverse genetics system to introduce
mutations into viral capsid proteins s1 and s3
and to rescue a virus that expresses a green
fluorescent protein (GFP) transgene, thus dem-
onstrating the tractability of this technology.
The plasmid-based reverse genetics approach
described here can be exploited for studies
of reovirus replication and pathogenesis and
used to develop reovirus as a vaccine vector.
INTRODUCTION
Reoviruses are members of the Reoviridae family, which
includes several genera that cause disease in humans
and animals. Chief among these are the rotaviruses, which
are the most common cause of viral gastroenteritis in hu-
man infants (Kapikian et al., 2001). Reoviruses infect the
respiratory and gastrointestinal tracts of virtually all mam-
mals, including humans (Tyler, 2001). However, disease
associated with reovirus infection occurs primarily in the
very young (Tyler et al., 2004). Reoviruses are highly viru-
lent in newborn mice, the preferred experimental system
for studies of reovirus pathogenesis, and produce injuryCeto a variety of host tissues, including the central nervous
system (CNS), heart, and liver (Tyler, 2001).
Reoviruses contain a genome of 10 dsRNA gene seg-
ments enclosed in two concentric protein shells, termed
outer capsid and core. Reovirus infection is initiated by
viral attachment to host cells via the filamentous attach-
ment protein s1 (Furlong et al., 1988). The s1 protein en-
gages cell-surface carbohydrate (Chappell et al., 1997,
2000) and junctional adhesion molecule-A (JAM-A) (Bar-
ton et al., 2001b; Campbell et al., 2005), an integral com-
ponent of intercellular tight junctions (Martin-Padura et al.,
1998). Following attachment to the cell surface, reovirus
internalization is mediated by b1 integrins (Maginnis
et al., 2006), most likely via clathrin-dependent endocyto-
sis (Ehrlich et al., 2004). In the endocytic compartment, vi-
ral outer-capsid proteins s3 and m1/m1C are cleaved by
acid-dependent cysteine proteases (Baer and Dermody,
1997; Ebert et al., 2002), resulting in generation of infec-
tious subvirion particles (ISVPs) (Borsa et al., 1981). During
ISVP formation, s3 is removed and a hydrophobic con-
former of m1/m1C is exposed, facilitating endosomal mem-
brane penetration and delivery of transcriptionally active
reovirus core particles into the cytoplasm (Chandran
et al., 2002; Odegard et al., 2004), where the remainder
of the replication cycle occurs.
With the exception of dsRNA viruses, a plasmid-based
reverse genetics system exists for all major groups of an-
imal RNA viruses, including bornaviruses, bunyaviruses,
coronaviruses, flaviviruses, orthomyxoviruses, paramyxo-
viruses, picornaviruses, and rhabdoviruses (Table S1 in
the Supplemental Data available with this article online).
Despite extensive efforts in several laboratories, genera-
tion of an animal dsRNA virus entirely from cloned cDNAs
has not been achieved. This critical technological gap is
perhaps the single most important limitation to studies
of these viruses. Previous efforts on reovirus and rotavirus
reverse genetics have resulted in entirely RNA-based
(Roner et al., 1997) or partially plasmid-based (Komoto
et al., 2006) systems that permit replacement of one or
two viral genes. These approaches have been used toll Host & Microbe 1, 147–157, April 2007 ª2007 Elsevier Inc. 147
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Reverse Genetics for ReovirusFigure 1. Experimental Strategy to Generate Reovirus from Cloned cDNA
(A) Prototype reovirus gene segment cDNA in plasmid. Cloned cDNAs representing each of the ten full-length reovirus RNA gene segments are
flanked by the bacteriophage T7 RNA polymerase promoter (T7P) and the antigenomic hepatitis delta virus (HDV) ribozyme (Rib).
(B) Schematic of approach. The ten reovirus cDNA constructs are transfected into murine L cells expressing T7 RNA polymerase from recombinant
vaccinia virus strain rDIs-T7pol, which is replication defective. Nascent transcripts correspond to viral mRNAs containing the native 50 end. Self
cleavage by the HDV ribozyme generates the native viral 30 end. Following 5 days of incubation, transfected cells are lysed by freeze-thaw, and viable
viruses rescued from cloned cDNAs are isolated by plaque assay using L cells.
(C) Kinetics of virus production following plasmid transfection of L cells. Cells were transfected with plasmid DNA according to the protocol in (B) and
lysed at the intervals shown. Viral titers in cell lysates were determined by plaque assay.
(D) Infectious center assay following plasmid transfection of L cells. Cells were transfected with plasmid DNA, trypsinized at the intervals shown post-
transfection, washed, counted, diluted, and applied directly to monolayers of untreated L cells. The number of the infectious centers was determined
by plaque assay.rescue temperature-sensitive reovirus strains (Roner
et al., 1997), define packaging signals in reovirus RNAs
(Roner and Steele, 2007), and isolate rotaviruses contain-
ing engineered changes in the viral attachment protein
(Komoto et al., 2006). However, neither the reovirus nor
rotavirus reverse genetics systems in their current config-
urations permit selective introduction and recovery of
desired mutations in each viral gene segment.
We report the development of an entirely plasmid-
based reverse genetics system for mammalian reovirus
in which viable viruses are generated from cloned cDNAs.
Neither helper virus nor coexpression of viral replication
proteins is required for recovery of wild-type (WT) virus
or engineered viral mutants. Point mutations introduced
into viral capsid proteins s1 and s3 were used to define
sequences that govern susceptibility to cleavage by intes-
tinal proteases. We also recovered a recombinant virus
that expresses green fluorescent protein (GFP) by re-
placement of the s3 open reading frame (ORF) with
GFP. The establishment of plasmid-based reverse genet-
ics for reovirus will allow heretofore technically unap-
proachable problems in dsRNA virus biology to be stud-
ied, provide a platform for development of analogous
marker rescue systems for other segmented dsRNA
viruses, and foster exploration of reovirus as a vaccine148 Cell Host & Microbe 1, 147–157, April 2007 ª2007 Elseviervector to elicit protective immunity against a variety of
mucosal pathogens.
RESULTS
Generation of Viable Reovirus from Cloned cDNA
To generate recombinant reovirus from cloned cDNAs,
plasmids encoding each of the ten viral gene segments
were engineered to facilitate transcription of full-length vi-
ral mRNAs under control of the bacteriophage T7 RNA
polymerase promoter, which directs transcription initia-
tion preferentially from a juxtaposed guanosine residue
(Milligan et al., 1987). As all reovirus (+)-sense RNAs are
terminated with a 50 guanosine (Furuichi et al., 1975a,
1975b), plasmid-generated transcripts are anticipated to
possess native 50 ends (Roner and Joklik, 2001) (Fig-
ure 1A). Murine L929 fibroblast (L) cells, which efficiently
support reovirus replication (Barton et al., 2001a), were in-
fected with the attenuated, T7 RNA polymerase-express-
ing vaccinia virus strain rDIs-T7pol 1 hr prior to transfec-
tion with the ten reovirus cDNA plasmids (Figure 1B).
Nascent transcripts were synthesized with the hepatitis
delta virus (HDV) ribozyme fused to the 30 terminus, which
is expected to generate a native 30 end upon autocatalytic
removal (Roner and Joklik, 2001) (Figure 1A). Thus, thisInc.
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Reverse Genetics for ReovirusFigure 2. Rescue of rsT3D and rsT3D/
T1LS1
(A) Electropherotypes of T1L, T3D, rsT3D, and
rsT3D/T1LS1. Viral dsRNA was extracted from
purified virions and electrophoresed in an
SDS-polyacrylamide gel, followed by ethidium
bromide staining to visualize viral gene seg-
ments. Size classes of gene segments (L, M,
S) are indicated.
(B) Recombinant viruses contain a novel muta-
tion in the L1 gene. The single nucleotide differ-
ence in L1 unique to rsT3D and rsT3D/T1LS1
is shown in the alignment as an asterisk. The
G/A substitution at position 2205 is a signa-
ture change engineered into the cloned T3D
L1 cDNA used for marker rescue.
(C) Sequence analysis of L1 gene RT-PCR
products from rescued reoviruses. A fragment
of the L1 gene was amplified by one-step RT-PCR performed using viral dsRNA extracted from purified virions of T3D, rsT3D, and rsT3D/T1LS1.
Products were subjected to direct sequence analysis and compared to the L1 sequence of T3D. Shown are sequence chromatograms demonstrating
G/A substitution at position 2205 of the rsT3D and rsT3D/T1LS1 L1 genes.expression strategy should yield ten unique reovirus
mRNA species competent to complete all steps in the viral
RNA life cycle. Accordingly, rescued viruses were recov-
ered from cell-culture supernatants by plaque assay on
L cell monolayers (Figure 1C).
To ensure that viruses isolated following plasmid trans-
fection represented single clones, and to preclude con-
tamination of reovirus stocks by rDIs-T7pol, all viruses
were isolated by plaque purification using L cell mono-
layers. rDIs-T7pol is replication defective and produces
no detectable growth in mammalian cells (Ishii et al.,
2002). Concordantly, no viral plaques arose on L cell
monolayers when the cotransfections were prepared
with nine of the ten reovirus marker-rescue plasmids
(data not shown). Furthermore, vaccinia virus proteins
were not detected by immunoblot analysis of second-
passage stocks of plaque-purified reoviruses (data not
shown).
Infectious center assays were performed to assess the
efficiency of reovirus infection in plasmid-transfected L
cells. At 24–48 hr posttransfection, times corresponding
to the primary round of infection, eight or fewer infectious
centers per 106 cells were detected (Figure 1D). The num-
ber of infectious centers increased substantially between
48 and 72 hr posttransfection to 18 to 90 per 106 cells,
suggesting that a secondary round of infection had en-
sued by the 72 hr time point. Viral titer in transfection ly-
sates was below the limit of detection (10 PFU/ml) at
24 hr but was detectable at 48 hr and increased logarith-
mically at time points thereafter (Figure 1C). The ratio of
viral PFU in transfection lysates to infectious centers
was 10 to 100 at 48 and 72 hr. These results indicate
that initiation of productive reovirus replication from trans-
fected plasmids is inefficient, with approximately 1 cell per
105 to 106 cells giving rise to, on average, 10 to 100 viable
virus particles that establish infection of the culture. In our
experiments, yields of WT virus 5 days after plasmid
transfection are regularly in the range of 104–106 PFU/ml
(Figure 1C).Cell HSeparation of reovirus genomic dsRNA using SDS-
PAGE produces unique electrophoretic patterns that can
be used to discriminate different viral strains (Barton
et al., 2001a). To confirm that viruses isolated using the
plasmid-based rescue procedure contained the expected
combination of gene segments, genomic dsRNA isolated
from recombinant strain (rs) T3D and rsT3D/T1LS1was re-
solved in SDS-polyacrylamide gels and visualized by
ethidium bromide staining (Figure 2A). The electrophero-
type of rsT3D was indistinguishable from that of strain
T3D, the origin of the cloned cDNA sequences used to
generate rsT3D. Likewise, rsT3D/T1LS1 displayed an
electropherotype consistent with nine cloned gene seg-
ments derived from T3D and a single cloned gene seg-
ment, S1, derived from strain T1L. To exclude the possibil-
ity of contamination, a silent point mutation, G to A at
nucleotide 2205, was introduced into the L1 gene of all
virus strains generated from cloned cDNAs (Figure 2B).
This change has not been observed in any reported T3D
L1 sequence (Wiener and Joklik, 1989) and serves as a sig-
nature for viruses derived through plasmid-based rescue.
As anticipated, sequence analysis of rsT3D and rsT3D/
T1LS1 revealed the expected G to A substitution (Fig-
ure 2C), confirming the plasmid origins of these isolates.
Characterization of Reoviruses Generated
by Plasmid Transfection
Reoviruses replicate and assemble within cytoplasmic in-
clusions in infected cells (Fields, 1971). Viral inclusions
contain dsRNA (Silverstein and Schur, 1970), viral proteins
(Fields, 1971), and both complete and incomplete viral
particles (Fields, 1971). Reovirus strain T3D forms large
globular inclusions that localize to the perinuclear space
(Parker et al., 2002). To determine whether rsT3D forms vi-
ral inclusions in a manner similar to native T3D, cells were
infected with T3D and rsT3D and processed 18 hr postin-
fection for image analysis by confocal microscopy (Fig-
ure 3A). Both T3D and rsT3D formed morphologically
indistinguishable large globular inclusions that wereost & Microbe 1, 147–157, April 2007 ª2007 Elsevier Inc. 149
Cell Host & Microbe
Reverse Genetics for ReovirusFigure 3. Infectivity of Native and Re-
combinant Reoviruses
(A) Immunofluorescence of cells infected with
T3D and rsT3D. L cells were mock infected or
infected with either T3D or rsT3D, stained at
18 hr postinfection with anti-mNS antiserum to
visualize reovirus inclusions (green) and TO-
PRO3 to visualize nuclei (blue), and imaged
by confocal laser scanning microscopy. Rep-
resentative digital fluorescence (top panel)
and DIC images (bottom panel) for mock-,
T3D-, and rsT3D-infected cells are shown.
Scale bar, 10 mM.
(B) One-step growth curve for T1L, T3D, rsT3D,
and rsT3D/T1LS1 in L cells (left) and MEL cells
(right). Cells were infectedwith virus, incubated
for the intervals shown, and lysed by freeze-
thaw. Viral titers in cell lysates were determined
by plaque assay. The results are presented as
the mean viral titers for triplicate experiments.
Error bars indicate SD.localized to the perinuclear compartment. We conclude
that recombinant rsT3D recapitulates a hallmark of native
T3D infection in cultured cells.
To confirm that the recombinant viruses exhibit replica-
tion kinetics similar to the native strains, T1L, T3D, rsT3D,
and rsT3D/T1LS1 were tested for infection of L cells and
MEL cells (Figure 3B). L cells support replication of all reo-
virus strains tested in our laboratory. In contrast, MEL cells
support replication of only sialic acid-binding reovirus
strains (Rubin et al., 1992; Chappell et al., 1997). T1L,
rsT3D/T1LS1, T3D, and rsT3D produced 1000-fold
yields of viral progeny in L cells. However, only sialic
acid-binding strains T3D and rsT3D were capable of effi-
ciently infecting MEL cells, producing yields in each
case of 100-fold, whereas strains T1L and rsT3D/
T1LS1 produced minimal yields of viral progeny in these
cells (<10-fold). Together, these data indicate that re-
combinant reoviruses display replication characteristics
indistinguishable from native strains.
Susceptibility of Attachment Protein s1
to Proteolytic Cleavage Attenuates Reovirus
Intestinal Infection and Systemic Spread
The s1 protein exhibits strain-specific differences in sus-
ceptibility to cleavage following in vitro treatment with in-
testinal proteases to generate ISVPs (Nibert et al., 1995;
Chappell et al., 1998). This difference in cleavage suscep-
tibility segregates with a single amino acid polymorphism150 Cell Host & Microbe 1, 147–157, April 2007 ª2007 Elseviein the tail domain of s1 (Figure 4A). Strains with a threonine
at residue 249 in s1 are susceptible to cleavage by trypsin
after Arg245, whereas those with an isoleucine at residue
249 are resistant to cleavage (Chappell et al., 1998). The
importance of sequence polymorphism at residue 249
has been confirmed in studies using expressed protein
(Chappell et al., 1998) and recoated core particles (Chan-
dran et al., 2001) but not with intact virions.
To determine whether the single Thr-Ile polymorphism
at residue 249 in s1 protein is sufficient to alter s1 cleav-
age susceptibility during treatment of virions with intesti-
nal proteases to generate ISVPs, we used plasmid-based
rescue to generate rsT3D-s1T249I, which differs from
rsT3D by the presence of an isoleucine in s1 at residue
249 (Table S2). Purified virions of rsT3D and rsT3D-
s1T249I were treated with trypsin and analyzed by SDS-
PAGE. As expected, a digestion pattern consistent with
formation of ISVPs (loss of s3 protein and generation of
the d fragment of m1C protein) was observed for both vi-
ruses (Figure 4B). However, the stability of rsT3D and
rsT3D-s1T249I s1 proteins differed. The band corre-
sponding to rsT3D s1 diminished in intensity immediately
after trypsin addition until it was eventually undetectable
(Figure 4B). However, the rsT3D-s1T249I s1 band was in-
tact even after 60 min of digestion. Thus, the T249I poly-
morphism is an independent determinant of s1 cleavage
susceptibility.
Proteolytic cleavage of s1 at a site adjacent to Thr249
releases the JAM-A-binding s1 head domain, leading tor Inc.
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(A) Model of s1 generated by adding five b spiral repeats to the N terminus of the crystallized fragment of s1 (Chappell et al., 2002). The three mono-
mers in the crystallized fragment are shown in red, yellow, and blue; themodel is shown in gray. The inset shows an enlarged view of the b spiral region
in s1 that influences susceptibility of the molecule to cleavage by intestinal proteases (Chappell et al., 1998). Side chains of Arg245 and Thr249 are
depicted in ball-and-stick representation.
(B) Electrophoretic analysis of viral structural proteins of rsT3D and rsT3D-s1T249I during treatment with trypsin to generate ISVPs. Purified
35S-methionine-labeled virions were treated with trypsin for the indicated intervals and loaded into wells of a 4%–20% polyacrylamide gradient
gel. After electrophoresis, the gel was prepared for fluorography and exposed to film. Samples of untreated virions appear in the lanes labeled
‘‘V.’’ Viral proteins are labeled. Positions of molecular weight standards (in kDa) are indicated. The experiments shown are representative of two per-
formed for each virus.
(C) Infectivity of rsT3D and rsT3D-s1T249I during treatment with trypsin to generate ISVPs. Purified virions were treated with trypsin at 37C for the
intervals shown. Titers of virus in the treatment mixtures were determined by plaque assay. The results are presented as the mean viral titers for trip-
licate experiments. Error bars indicate SD.diminished viral infectivity (Nibert et al., 1995). To test
whether rsT3D and rsT3D-s1T249I differ in infectivity after
protease treatment to generate ISVPs, purified virions of
each strain were exposed to trypsin for various intervals,
and titers of infectious virus in the treatment mixtures
were determined by plaque assay (Figure 4C). As ob-
served with WT T3D in previous experiments (Nibert
et al., 1995), rsT3D lost infectious titer rapidly after prote-
ase treatment. In contrast, titers of rsT3D-s1T249I re-
mained relatively stable throughout the assay time course.
Loss of infectivity of rsT3D correlated with kinetics of s1
cleavage (compare Figures 4B and 4C), indicating that
changes in viral infectivity after trypsin treatment are gov-
erned by the cleavage state of s1. Furthermore, both phe-
notypes are linked to a single s1 polymorphism at amino
acid 249.
Reovirus strains T1L and T3D differ in the capacity to in-
fect the murine intestine after peroral (PO) inoculation
(Bodkin et al., 1989), a property that segregates with the
viral S1 (encoding s1 and s1s) and L2 (encoding l2) genes
(Bodkin and Fields, 1989). Exposure of T3D to an intestinalCell Hwash results in s1 cleavage (Chappell et al., 1998), raising
the possibility that failure of T3D to infect the intestine is in
part attributable to s1 cleavage susceptibility. To test
whether susceptibility of s1 to proteolytic cleavage is as-
sociated with diminished T3D growth in animals, we as-
sessed the capacity of rsT3D and rsT3D-s1T249I to infect
the intestine and disseminate systemically following PO
inoculation (Figure 5A). Newborn mice were inoculated
perorally with each strain, and viral titers in the intestine
and brain were determined at 4, 8, and 12 days after inoc-
ulation. At all time points tested, titers of rsT3D-s1T249I in
the intestine were greater than those produced by rsT3D.
Furthermore, rsT3D-s1T249I produced greater titers in
the brain at days 8 and 12 than did rsT3D. However,
when inoculated by the intracranial (IC) route, rsT3D and
rsT3D-s1T249I produced equivalent titers (Figure 5B), al-
though rsT3D reached peak titers at earlier time points
than did rsT3D-s1T249I. These findings indicate that
a Thr-Ile polymorphism at amino acid 249 in T3D s1 con-
trols viral growth in the murine intestine and systemic
spread to the CNS.ost & Microbe 1, 147–157, April 2007 ª2007 Elsevier Inc. 151
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Polymorphism in Outer-Capsid Protein s3
Previous studies identified a tyrosine-to-histidine substi-
tution at amino acid 354 in T3D s3 as a key regulator of
the kinetics of virion-to-ISVP conversion in vitro (Wetzel
et al., 1997) and viral resistance to growth inhibition by
the cysteine protease inhibitor E64 (Baer and Dermody,
1997; Ebert et al., 2001). Tyr354 is located in the virion-
distal lobe of s3 adjacent to sites in the protein that are
cleaved during formation of ISVPs (Ebert et al., 2002)
(Figure 6A). The importance of this residue in viral replica-
tion has been deduced by analysis of reassortant viruses
containing WT and mutant s3 proteins (Wetzel et al.,
1997; Ebert et al., 2001; Clark et al., 2006) and analysis
of ISVPs recoated withWT andmutant forms ofs3 (Wilson
et al., 2002; Clark et al., 2006).
To determine whether the Y354H mutation in s3 is suf-
ficient to confer enhanced virion-to-ISVP conversion and
resistance to E64, we generated rsT3D-s3Y354H (Table
S2) and compared this virus to rsT3D for kinetics of s3
proteolysis following protease treatment in vitro. Virions
of each strain were treated with chymotrypsin for various
intervals and processed for analysis of viral structural
proteins by SDS-PAGE (Figure 6B). Treatment of rsT3D
and rsT3D-s3Y354H virions with chymotrypsin resulted
in degradation of s3 and cleavage of m1C to form d, indic-
Figure 5. rsT3D-s1T249I Infects the Murine Intestine and
Disseminates to the CNS
Titers of rsT3D and rsT3D-s1T249I after either PO (A) or IC (B) inocu-
lation. Mice were inoculated with virus and euthanized at the indicated
times postinoculation. Viral titers in organ homogenates were deter-
mined by plaque assay. The limit of detectionwas 100 PFU/ml of organ
homogenate. Each data point represents the average viral titer from 3
to 12 mice. Error bars indicate SD.152 Cell Host & Microbe 1, 147–157, April 2007 ª2007 Elsevierative of ISVP formation. Proteolysis of rsT3D-s3Y354H s3
during chymotrypsin treatment occurred with substan-
tially faster kinetics than that of rsT3D s3. This result indi-
cates that amino acid 354 in s3 protein is an independent
determinant of virion susceptibility to proteolytic digestion
and likely functions as an autonomous regulator of viral
disassembly in cellular endosomes.
The role of s3 mutation Y354H in virion disassembly in
cyto was investigated by quantifying yields of rsT3D and
rsT3D-s3Y354H after 24 hr of growth in L cells treated
with 0–200 mM E64 (Figure 6C). Both strains produced
yields of 1000 fold following growth in untreated cells.
However, yields of rsT3D-s3Y354H were 100-fold
greater than those of rsT3D following growth in cells
treated with 200 mM E64 (the highest concentration
tested). Therefore, a single mutation in s3, Y354H, regu-
lates resistance of reovirus to an inhibitor of cysteine pro-
teases within cellular endosomes.
Transduction of GFP by a Recombinant Reovirus
To determine whether reoviruses capable of expressing
a foreign gene can be recovered following plasmid trans-
fection, we introduced sequences encoding GFP into the
s3 ORF of the T3D S4 plasmid (Figure 7A). In this con-
figuration, GFP is expressed as a fusion protein incorpo-
rating amino acids 1–39 of s3 protein at the N terminus.
Recombinant virus rsT3D/S4-GFP was recovered follow-
ing plasmid transfection of L cells stably expressing WT
s3 protein, which is required for propagation of this strain
(Figure S1). RT-PCR analysis using primers specific for
T3DS4andGFPconfirmed incorporation of a recombinant
S4-GFP gene segment into rsT3D/S4-GFP (Figure 7B). In-
fection of L cells with rsT3D/S4-GFP resulted in expres-
sion of GFP and viral inclusion-forming proteins mNS and
sNS but not s3 (Figures 7C and 7D). The capacity of
rsT3D/S4-GFP to express GFP was not altered through
four passages (data not shown). These results demon-
strate that reovirus can be engineered to express foreign
genes.
DISCUSSION
The absence of DNA intermediates in the life cycle of RNA
viruses poses a technical challenge to genetic analysis of
viral phenotypes. Prior to the development of reverse ge-
netics, or ‘‘marker rescue,’’ for RNA viruses of animals, in
which plasmid-borne cDNAs of viral genomes initiate syn-
thesis of replication-competent RNAs, classical Darwinian
methods were used to select viral mutants that could be
subjected to correlative genetic studies—so-called ‘‘for-
ward genetics.’’ However, reverse genetics technology
permits testing of tightly focused, rational hypotheses
about complex questions of virus structure, virus-cell in-
teractions, and viral pathogenesis through direct engi-
neering of the viral genome without a need to devise com-
plicated selection strategies for isolation of viral mutants.
Furthermore, reverse genetics of RNA viruses has sup-
ported rapid generation of vaccines against these and
other infectious agents and propelled their use as geneInc.
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erates Proteolytic Disassembly of Reovirus
(A) Crystal structure of T3D s3 (Olland et al., 2001), in which cathepsin
L cleavage sites are depicted in blue between amino acids 243 and 244
and between 250 and 251 (Ebert et al., 2002). Surrounding residues,
from amino acids 241 to 253, are shown in yellow. The C-terminal res-
idues of s3, from amino acids 340–365, are colored red. Tyr354, which
is altered in several PI (Wetzel et al., 1997), D-EA (Ebert et al., 2001),
and ACA-D viruses (Clark et al., 2006), is shown in green. The virion-
distal end of s3 is at the top of the figure, and the virion-proximal
end and N terminus are at the bottom. The inset shows an enlarged
view of the boxed region of s3 using the same color scheme. Side
chains of amino acids 243, 244, 250, 251, and 354 are depicted in
ball-and-stick representation.
(B) Chymotrypsin treatment of rsT3D and rsT3D-s3Y354H. Purified
virions were treated with chymotrypsin for the indicated intervals
and loaded into wells of 10% polyacrylamide gels. After electrophore-
sis, the gels were stained with Coomassie blue. Viral proteins are la-
beled. The experiments shown are representative of two performed
for each virus.
(C) Growth of rsT3D and rsT3D-s3Y354H in L cells treated with E64. L
cells were preincubated in medium with or without E64 at the concen-
trations shown. The medium was removed, cells were adsorbed withCell Hdelivery vehicles (Blaney et al., 2006; Horimoto and
Kawaoka, 2006; Riezebos-Brilman et al., 2006).
We developed a fully plasmid-based reverse genetics
technology for mammalian reoviruses. This system per-
mits selective introduction of desired mutations into
cloned cDNAs encoding each of the ten viral gene seg-
ments, followed by isolation of mutant viruses from cells
transfected with the plasmid constructs. Moreover, gene
segment cDNAs can be manipulated to facilitate expres-
sion of a transgene. Importantly, recombinant viruses
are generated without a requirement for helper virus and
free of any selection. Thus, this new technology provides
virus for 1 hr, and fresh medium with or without E64 was added. After
24 hr incubation, viral titers in cell lysates were determined by plaque
assay. The results are presented as themean viral yields, calculated by
dividing titer at 24 hr by titer at 0 hr for each concentration of E64, for
triplicate experiments. Error bars indicate SD.
Figure 7. Expression of GFP by rsT3D/S4-GFP
(A) Schematic of pT7-S4GFP. The GFP ORF is flanked by S4 gene nu-
cleotides 1–149 and 769–1196.
(B) RT-PCR analysis of rsT3D and rsT3D/S4-GFP. Viral dsRNAwas ex-
tracted from purified virions and subjected to RT-PCR using primers
specific for T3D S4 and GFP sequences. Numbers delineate the S4
RNA nucleotide position corresponding to the 50 end of S4-specific
primers.
(C) Viral protein expression in cells infected with rsT3D/S4-GFP. L cells
were infected with rsT3D or rsT3D/S4-GFP at an MOI of 1 PFU per cell
and incubated for 24 hr. Cell lysates were analyzed by immunoblotting
using antibodies specific for mNS, sNS, and s3 proteins.
(D) Image analysis of cells infected with rsT3D/S4-GFP. L cells were in-
fected with rsT3D/S4-GFP, stained with antibodies specific for mNS
(blue) and s3 (red) proteins at 24 hr postinfection, and imaged by con-
focal laser scanning microscopy. Scale bar, 10 mM.ost & Microbe 1, 147–157, April 2007 ª2007 Elsevier Inc. 153
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nome in the context of infectious virus.
We used the newly developed plasmid-based reovirus
reverse genetics system to engineer mutations in the s1
and s3 proteins. These proteins form part of the viral outer
capsid, which is responsible for numerous major events in
reovirus interaction with the cell and host, including at-
tachment, disassembly within endosomes, penetration
of cell membranes, induction of apoptosis, growth in the
intestine, pathways of spread, neurovirulence, and tro-
pism within the CNS (for reviews, see Chandran and
Nibert, 2003; O’Donnell et al., 2003; Guglielmi et al., 2006).
Therefore, we initially applied reverse genetics technology
to the study of outer-capsid proteins to better understand
how these proteins mediate critical steps in reovirus
replication and disease.
The infectivity of ISVPs of reovirus strain T1L in L cells is
approximately 10-fold greater than that of T3D ISVPs
(Nibert et al., 1995). This difference in infectivity is hypoth-
esized to be a direct result of s1 cleavage (Nibert et al.,
1995; Chappell et al., 1998), presumably due to removal
of the JAM-A-binding region of the molecule. Although
the T249I substitution in expressed T3D s1 renders it re-
sistant to cleavage by trypsin (Chappell et al., 1998), until
now it has not been possible to define the role of s1 cleav-
age in T3D infectivity for lack of means to generate a mu-
tant T3D virus with the T249I change. This virus has been
generated using reverse genetics, and our findings indi-
cate that cleavage susceptibility of viral attachment pro-
tein s1 due to a single polymorphism at amino acid posi-
tion 249 is the basis for reduced infectivity of T3D ISVPs
relative to virions (Figure 4C) and contributes to dimin-
ished growth of T3D in the murine intestine following PO
inoculation (Figure 5A).
Previous studies of T3D-derived reovirus strains with
altered disassembly kinetics point to a critical role for
sequences in the virion-distal, C-terminal lobe of s3 in
susceptibility to acid-dependent proteolysis. A C-terminal
Y354H mutation in s3 protein of strain T3D was selected
during persistent infection of L cells (PI viruses) (Wetzel
et al., 1997) and by serial passage of virus in L cells treated
with either E64 (D-EA viruses) (Ebert et al., 2001) or ammo-
nium chloride (ACA-D viruses) (Clark et al., 2006). Using
reovirus reverse genetics, the Y354H substitution was in-
troduced into a WT T3D genetic background, and the re-
sultant virus, rsT3D-s3Y354H, demonstrated accelerated
kinetics of s3 cleavage (Figure 6B) and diminished sensi-
tivity to the growth-inhibitory effects of E64 (Figure 6C).
Residue 354 is located in a position thought to be impor-
tant for controlling access to protease-hypersensitive re-
gions in s3, residues 208–214 and 238–242, thereby influ-
encing s3 cleavage kinetics (Jane´-Valbuena et al., 2002).
Therefore, it appears that residue 354 ins3 is a gatekeeper
for the viral outer capsid, serving to regulate the balance
between viral stability and an irreversible, proteolytically
triggered disassembly cascade committing the virion par-
ticle to either replication or inactivation.
We exploited the reovirus reverse genetics system to
develop a gene-delivery vehicle by replacing thes3ORF in154 Cell Host & Microbe 1, 147–157, April 2007 ª2007 Elsevierthe S4 plasmid with a GFP-encoding cDNA (Figure 7). The
resultant virus, rsT3D/S4-GFP, expresses GFP through
successive passages in cell culture. These results reveal
the potential for exploitation of reovirus as a gene-trans-
duction vector with application in the development of
new mucosal vaccines, more effective oncolytic agents
(Coffey et al., 1998), and high-level expression of foreign
genes in animal cells. Ideal reovirus vectors will contain
stable s1 proteins and combine excellent extracellular
stability with highly efficient intracellular disassembly.
We find that each of these parameters can be indepen-
dently adjusted through strategic alterations in outer-
capsid proteins. Manipulation of inner-capsid proteins
and the genomic RNA itself should allow construction of
viruses able to circumvent other aspects of virus-cell
and virus-host interactions that pose potential barriers to
antigen and gene delivery by reovirus.
Our results indicate that productive viral infection is es-
tablished in a small fraction of L cells, approximately 1 in
105–106 cells, transfected with plasmids encoding the
ten reovirus gene segments (Figure 1D). Thus, the reovirus
plasmid-based marker rescue system is suited to the iso-
lation of viable viral clones by plaque assay, followed by
expansion in cell culture to attain quantities of virus suffi-
cient for phenotypic analyses. Manipulations that severely
cripple viral replication or particle assembly aremore chal-
lenging to study because these changes may prohibit
virus isolation. However, recovery of a GFP-expressing vi-
rus, rsT3D/S4-GFP, demonstrates that marker rescue of
lethal mutations is possible by transcomplementation (in
this case with WT s3 protein) (Figure 7 and Figure S1).
This result also agrees with our previous finding that inhi-
bition of reovirus replication by RNAi-mediated reduction
of viral protein synthesis is reversible by transcomplemen-
tation with ectopically expressed WT protein (Kobayashi
et al., 2006). Furthermore, transcomplementation allows
precise definition through systematic mutational analysis
of functional domains in reovirus proteins that are essen-
tial for viral replication (Kobayashi et al., 2006). It should
be possible to apply this technique to the newmarker res-
cue system for delineation of structure-function relation-
ships in reovirus proteins and RNA.
Quantitative success of plasmid-initiated reovirus infec-
tion in this reverse genetics system probably is not limited
by the amount of template or transfection efficiency, since
the molar ratio of plasmid to target cell is approximately
5 3 104, and increasing the amount of plasmid does not
effect higher viral yields from cotransfection lysates
(data not shown). Furthermore, it does not appear that in-
fection efficiency is limited by the absence of viral replica-
tion proteins during early steps of replication because
high-level expression of the replication proteins m2, mNS,
and sNS, which collaborate to form viral inclusions in in-
fected cells (Mbisa et al., 2000; Broering et al., 2002;
Becker et al., 2003; Miller et al., 2003), did not enhance
viral recovery (data not shown). Perhaps the presence
of other viral or cellular factors associated with natural
infection by intact virion particles is required for maximal
reovirus infectivity.Inc.
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system has been described for any other dsRNA virus of
animals. Although each genus within this constellation of
viruses bears unique biologic characteristics and physio-
chemical properties, there are nonetheless numerous uni-
fying features of virion particle structure and replication
mechanisms that should allow principles and techniques
established in this study to be applied broadly across the
group. We expect that new insights into mammalian reovi-
rus replication learnedwith the use of this reverse genetics
system will be quickly extrapolated to other Reoviridae
family members, leading to accelerated development of
analogous marker-rescue technologies for those viruses.
EXPERIMENTAL PROCEDURES
Cells and Viruses
L cells and HeLa cells were maintained as described (Barton et al.,
2001a). Reovirus strains T1L and T3D are laboratory stocks originally
obtained from Dr. Bernard Fields. Virus was purified after growth in
L cells by CsCl-gradient centrifugation (Furlong et al., 1988). Purified
35S-methionine-labeled virions were prepared as described (Nibert
et al., 1995). Attenuated vaccinia virus strain rDIs-T7pol expressing
T7 RNA polymerase was propagated in chick embryo fibroblasts as
described (Ishii et al., 2002).
Plasmid Construction
Full-length reovirus cDNAs were amplified by RT-PCR using viral
dsRNA extracted from purified virions as template. Amplified cDNAs
were initially cloned into pBluescript II SK () (Stratagene) for the
T3D L1, L2, and L3 genes or pCR 2.1 (Invitrogen) for the T3D M1,
M2, M3, S1, S2, S3, and S4 genes and the T1L S1 gene (Table S3).
To generate pT7-L1T3D, pT7-L2T3D, pT7-L3T3D, pT7-M1T3D,
pT7-M2T3D, pT7-M3T3D, pT7-S2T3D, pT7-S3T3D, and pT7-S4T3D,
viral cDNA-containing fragments were subcloned into p3E5EGFP (Wa-
tanabe et al., 2004). Viral cDNAs fused at their native 50 termini to the
phage T7 RNA polymerase promoter were inserted into p3E5EGFP
by partial or complete replacement of plasmid sequences encoding
GFP and the Ebola virus leader and trailer, resulting in ligation of native
30 termini to the HDV ribozyme sequence. To generate pBacT7-S1T3D
and pBacT7-S1T1L, encoding the T3D S1 and T1L S1 genes, respec-
tively, S1 cDNAs fused to the T7 promoter and a portion of the HDV ri-
bozyme were first cloned into the BseRI site of p3E5EGFP, and frag-
ments containing the S1 gene flanked 50 by the T7 promoter and 30
by the HDV ribozyme and T7 terminator sequences were subcloned
into the XbaI site of pBacPAK8 (Clontech). pBacT7-S1T3D and pT7-
S4T3D were used as templates to generate mutant constructs
pBacT7-S1T3DT249I and pT7-S4T3DY354H, respectively, by intro-
duction of specific nucleotide substitutions using the QuickChange
site-directed mutagenesis kit (Stratagene) (Table S4). To generate
pT7-S4GFP, S4 nucleotide sequences 150–768 within pT7-S4T3D
were replaced with the GFP ORF. Nucleotide sequences of recombi-
nant plasmids were confirmed by DNA sequencing. Detailed descrip-
tion of cloning strategies is provided in the Supplemental Data.
Plasmid Transfection and Recovery of Recombinant Virus
Monolayers of L cells at approximately 90% confluence (33 106 cells)
in 60 mm dishes (Costar) were infected with rDIs-T7pol at an MOI of
0.5 TCID50. At 1 hr postinfection, cells were cotransfected with ten
plasmid constructs representing the cloned T3D genome—pT7-
L1T3D (2 mg), pT7-L2T3D (2 mg), pT7-L3T3D (2 mg), pT7-M1T3D
(1.75 mg), pT7-M2T3D (1.75 mg), pT7-M3T3D (1.75 mg), pBacT7-
S1T3D (2 mg), pT7-S2T3D (1.5 mg), pT7-S3T3D (1.5 mg), and pT7-
S4T3D (1.5 mg)—using 3 ml of TransIT-LT1 transfection reagent (Mirus)
per microgram of plasmid DNA. Following 0–5 days of incubation,
recombinant virus was isolated from transfected cells by plaque puri-Cell Hfication on monolayers of L cells (Virgin et al., 1988). Electrophoretic
analysis of viral dsRNA was performed as described (Wilson et al.,
1996). Confirmation of mutations in the S1, S4, and L1 genes of
recombinant viruses was performed using the Onestep RT-PCR kit
(Qiagen), gene-specific primer sets, and viral dsRNA extracted from
purified virions as template. PCR products were analyzed following
electrophoresis in Tris-borate-EDTA agarose gels or purified and sub-
jected directly to sequence analysis.
Infectious Center and Viral Yield Assays
L cells were cotransfected with ten plasmids corresponding to the T3D
genome as described. For infectious center assays, transfected cells
were released from plates by trypsin treatment at various intervals
posttransfection, washed, counted, diluted, and applied directly to
monolayers of untreated L cells (Dermody et al., 1995), which were
processed for plaque assay (Virgin et al., 1988). For viral yield assays,
transfected L cells were lysed by freezing and thawing, and viral titers
in cell lysates were determined by plaque assay (Virgin et al., 1988).
Immunofluorescence Detection of Reovirus Infection
Parental L cells or L cell transfectants selected for stable expression of
s3 protein (5 3 104) were plated on glass coverslips in 24-well plates
(Costar) and infected at an MOI of 10,000 (T3D and rsT3D) or 20,000
(rsT3D/S4-GFP) particles per cell. Following incubation at 37C for var-
ious intervals, cells were fixed and stained for mNS and s3 proteins as
described (Maginnis et al., 2006). Images were acquired using a Zeiss
LSM 510 META inverted confocal system (Carl Zeiss) with a Zeiss
inverted Axiovert 200M microscope and a Plan-APOCHROMAT
633/1.4 NA oil immersion DIC objective. Images were processed
using MetaMorph image analysis software (Molecular Devices).
Infectivity of Recombinant Viruses
Monolayers of L or L-s3 cells (2.5 to 5 3 105) in 24-well plates or sus-
pension cultures of MEL cells (53 105 cells/ml) were infectedwith virus
at an MOI of 1–2 PFU/cell. After 1 hr adsorption at room temperature,
the inoculum was removed, cells were washed twice with PBS, and
fresh medium was added. Cells were incubated at 37C for various in-
tervals, and viral titers in cell lysates were determined by plaque assay
(Virgin et al., 1988).
Analysis of Viral Capsid Proteins after Protease Treatment
Purified virions at a concentration of either 23 1012 particles/ml (tryp-
sin) or 9 3 1012 particles/ml (chymotrypsin) were digested with either
50 mg/ml of N a-p-tosyl-L-sulfonyl phenylalanyl chloromethyl ketone-
treated bovine trypsin (Sigma) or 200 mg/ml of Na-p-tosyl-L-lysine
chloromethyl ketone-treated bovine a-chymotrypsin (Sigma) for vari-
ous intervals at either 25C (trypsin) or 8C (chymotrypsin) as described
(Nibert et al., 1995; Wetzel et al., 1997). Protease digestion was
stopped by adding either 0.5 mg/ml soybean trypsin inhibitor (trypsin)
(Sigma) or 5mMphenylmethyl-sulfonyl fluoride (chymotrypsin) (Sigma)
to the treatment mixtures and cooling at 0C. Viral proteins were re-
solved by SDS-PAGE and visualized by either autoradiography (Nibert
et al., 1995) or staining with Coomassie blue (Wetzel et al., 1997).
Infection of Mice
Newborn C57/BL6 mice weighing 2.0–2.5 grams (2–4 days old) were
inoculated perorally or intracranially with 103 or 102 PFU, respectively,
of purified reovirus virions diluted in PBS. PO inoculations (50 ml) were
delivered intragastrically as described (Rubin and Fields, 1980). IC in-
oculations (5 ml) were delivered to the left cerebral hemisphere using
a Hamilton syringe and 30-gauge needle (Tyler et al., 1985). At various
intervals following inoculation, mice were euthanized, and organs were
harvested into 1ml of PBS and homogenized by freezing, thawing, and
sonication. Viral titers in organ homogenates were determined by pla-
que assay (Virgin et al., 1988). Animal husbandry and experimental
procedures were performed in accordance with Public Health Service
policy and approved by the Vanderbilt University School of Medicine
Institutional Animal Care and Use Committee.ost & Microbe 1, 147–157, April 2007 ª2007 Elsevier Inc. 155
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Monolayers of L cells (2 3 105) in 24-well plates were preincubated in
medium supplemented with 0–200 mM E64 (Sigma) for 4 hr. The me-
dium was removed, and cells were adsorbed with virus at an MOI of
2 PFU/cell. After incubation at 4C for 1 hr, the inoculumwas removed,
cells were washed with PBS, and 1 ml of fresh medium supplemented
with 0 to 200 mM E64 was added. Cells were incubated at 37C for
24 hr and frozen and thawed twice. Viral titers in cell lysates were
determined by plaque assay (Virgin et al., 1988).
Generation of s3-Expressing Cells
L cells stably expressing s3 protein (L-s3 cells) were selected by trans-
fection of cells with pCXN-S4T3D, which encodes the entire T3D s3
ORF, and incubation in the presence of 1mg/ml of geneticin (Invitrogen).
Supplemental Data
The Supplemental Data include Supplemental Experimental Proce-
dures, four supplemental tables, and one supplemental figure and
can be foundwith this article online at http://www.cellhostandmicrobe.
com/cgi/content/full/1/2/147/DC1/.
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